{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "import requests as rq\n",
    "import pubchempy as pcp"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "cid =2123\n",
    "url = f'https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/compound/{cid}/JSON'\n",
    "response_json = rq.get(url).json()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'Altretamine'"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "response_json['Record']['RecordTitle']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'Record': {'RecordType': 'CID',\n",
       "  'RecordNumber': 2123,\n",
       "  'RecordTitle': 'Altretamine',\n",
       "  'Section': [{'TOCHeading': 'Structures',\n",
       "    'Description': 'Structure depictions of this compound, including computationally generated two-dimensional (2D) and three-dimensional (3D) structures, as well as experimentally determined 3D single-crystal structures.',\n",
       "    'Section': [{'TOCHeading': '2D Structure',\n",
       "      'Description': 'A two-dimensional (2D) structure representation of the compound.  Because this structure is processed through chemical structure standardization (HÃ¤hnke et al., J. Cheminform. 2018, 10, 36), it is not necessarily the same as the structures provided by individual data contributors.  ',\n",
       "      'URL': 'https://doi.org/10.1186/s13321-018-0293-8',\n",
       "      'DisplayControls': {'MoveToTop': True},\n",
       "      'Information': [{'ReferenceNumber': 50, 'Value': {'Boolean': [True]}}]},\n",
       "     {'TOCHeading': '3D Conformer',\n",
       "      'Description': 'A three-dimensional (3D) structure representation of the compound.  This 3D structure is not experimentally determined, but computed by PubChem.  This structure may or may not be the same as the inherent structure of the compound you would expect to see in vacuum or in the gas phase, because the underlying computational algorithm aims to generate a protein-bound structure, which would be observed in a protein-ligand complex.  More detailed information on this conformer model can be found in Kim et al., J. Cheminform. 2013, 5, 1.',\n",
       "      'URL': 'https://doi.org/10.1186/1758-2946-5-1',\n",
       "      'DisplayControls': {'MoveToTop': True},\n",
       "      'Information': [{'ReferenceNumber': 50,\n",
       "        'Description': 'Altretamine',\n",
       "        'Value': {'Number': [2123]}}]}]},\n",
       "   {'TOCHeading': 'Chemical Safety',\n",
       "    'Description': 'Link to the Safety and Hazard section of this page and link to the Laboratory Chemical Safety Summary (LCSS) datasheet for this compound.',\n",
       "    'DisplayControls': {'HideThisSection': True, 'MoveToTop': True},\n",
       "    'Information': [{'ReferenceNumber': 50,\n",
       "      'Name': 'Chemical Safety',\n",
       "      'Value': {'StringWithMarkup': [{'String': '          ',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 1,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS07.svg',\n",
       "           'Type': 'Icon',\n",
       "           'Extra': 'Irritant'}]}]}}]},\n",
       "   {'TOCHeading': 'Names and Identifiers',\n",
       "    'Description': 'Chemical names, synonyms, identifiers, and descriptors.',\n",
       "    'Section': [{'TOCHeading': 'Record Description',\n",
       "      'Description': 'Summary Information',\n",
       "      'DisplayControls': {'HideThisSection': True, 'MoveToTop': True},\n",
       "      'Information': [{'ReferenceNumber': 1,\n",
       "        'Description': 'Physical Description',\n",
       "        'Reference': ['National Toxicology Program, Institute of Environmental Health Sciences, National Institutes of Health (NTP). 1992. National Toxicology Program Chemical Repository Database. Research Triangle Park, North Carolina.'],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Hexamethylmelamine is a colorless crystalline solid. Insoluble in water. (NTP, 1992)',\n",
       "           'Markup': [{'Start': 0,\n",
       "             'Length': 18,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Hexamethylmelamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'},\n",
       "            {'Start': 66,\n",
       "             'Length': 5,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/water',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-962'}]}]}},\n",
       "       {'ReferenceNumber': 4,\n",
       "        'Name': 'Record Description',\n",
       "        'Description': 'Ontology Summary',\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Hexamethylmelamine is a triamino-1,3,5-triazine.',\n",
       "           'Markup': [{'Start': 0,\n",
       "             'Length': 18,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Hexamethylmelamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}},\n",
       "       {'ReferenceNumber': 12,\n",
       "        'Value': {'StringWithMarkup': [{'String': 'An alkylating agent proposed as an antineoplastic. It also acts as a chemosterilant for male houseflies and other insects.'}]}},\n",
       "       {'ReferenceNumber': 20,\n",
       "        'Description': 'FDA Pharmacology Summary',\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Altretamine is an Alkylating Drug. The mechanism of action of altretamine is as an Alkylating Activity.',\n",
       "           'Markup': [{'Start': 0,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'},\n",
       "            {'Start': 62,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}},\n",
       "       {'ReferenceNumber': 27,\n",
       "        'Description': 'LiverTox Summary',\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Altretamine is an orally administered alkylating agent, formerly known as hexamethylmelamine, which is currently used as a secondary therapy for advanced ovarian carcinoma. Altretamine therapy has been associated with low rates of serum enzyme elevations during therapy and with rare instances of acute, clinically apparent injury.',\n",
       "           'Markup': [{'Start': 0,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'},\n",
       "            {'Start': 74,\n",
       "             'Length': 18,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/hexamethylmelamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'},\n",
       "            {'Start': 173,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}},\n",
       "       {'ReferenceNumber': 31,\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Altretamine is a synthetic cytotoxic s-triazine derivative similar in structure to alkylating agent triethylenemelamin with antineoplastic activity.  Although the precise mechanism by which altretamine exerts its cytotoxic effect is unknown, N-demethylation of altretamine may produce reactive intermediates which covalently bind to DNA, resulting in DNA damage. (NCI04)',\n",
       "           'Markup': [{'Start': 0,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'},\n",
       "            {'Start': 37,\n",
       "             'Length': 10,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/s-triazine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-9262'},\n",
       "            {'Start': 190,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'},\n",
       "            {'Start': 261,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}},\n",
       "       {'ReferenceNumber': 49,\n",
       "        'Value': {'StringWithMarkup': [{'String': 'A hexamethyl-2,4,6-triamine derivative of 1,3,5-triazine.'}]}}]},\n",
       "     {'TOCHeading': 'Computed Descriptors',\n",
       "      'Description': 'Structural descriptors generated or computed for the structures of this compound, including the IUPAC name, InChI/InChIKey, and canonical/isomeric SMILES.',\n",
       "      'Section': [{'TOCHeading': 'IUPAC Name',\n",
       "        'Description': 'Chemical name of this compound, computed from its structure based on the International Union of Pure and Applied Chemistry (IUPAC) nomenclature standards.',\n",
       "        'URL': 'https://iupac.org/what-we-do/nomenclature/',\n",
       "        'Information': [{'ReferenceNumber': 50,\n",
       "          'Reference': ['Computed by Lexichem TK 2.7.0 (PubChem release 2021.05.07)'],\n",
       "          'Value': {'StringWithMarkup': [{'String': '2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine',\n",
       "             'Markup': [{'Start': 2, 'Length': 1, 'Type': 'Italics'},\n",
       "              {'Start': 6, 'Length': 1, 'Type': 'Italics'},\n",
       "              {'Start': 10, 'Length': 1, 'Type': 'Italics'},\n",
       "              {'Start': 14, 'Length': 1, 'Type': 'Italics'},\n",
       "              {'Start': 18, 'Length': 1, 'Type': 'Italics'},\n",
       "              {'Start': 22, 'Length': 1, 'Type': 'Italics'}]}]}}]},\n",
       "       {'TOCHeading': 'InChI',\n",
       "        'Description': 'The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard.',\n",
       "        'URL': 'https://iupac.org/who-we-are/divisions/division-details/inchi/',\n",
       "        'Information': [{'ReferenceNumber': 50,\n",
       "          'Reference': ['Computed by InChI 1.0.6 (PubChem release 2021.05.07)'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'InChI=1S/C9H18N6/c1-13(2)7-10-8(14(3)4)12-9(11-7)15(5)6/h1-6H3'}]}}]},\n",
       "       {'TOCHeading': 'InChIKey',\n",
       "        'Description': 'An InChIKey is a 27-character hash code derived from an InChI.  The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard. ',\n",
       "        'URL': 'https://iupac.org/who-we-are/divisions/division-details/inchi/',\n",
       "        'Information': [{'ReferenceNumber': 50,\n",
       "          'Reference': ['Computed by InChI 1.0.6 (PubChem release 2021.05.07)'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'UUVWYPNAQBNQJQ-UHFFFAOYSA-N'}]}}]},\n",
       "       {'TOCHeading': 'Canonical SMILES',\n",
       "        'Description': 'The Simplified Molecular-Input Line-Entry System (SMILES) is a widely-used line notation for chemical structures.  PubChem computes two kinds of SMILES strings for compounds: canonical SMILES (computed from chemical structures devoid of isotopic and stereochemical information), and isomeric SMILES (computed from chemical structures containing isotopic and stereochemical information).  This section shows the canonical SMILES of the compound.',\n",
       "        'URL': 'https://www.daylight.com/dayhtml/doc/theory/theory.smiles.html',\n",
       "        'Information': [{'ReferenceNumber': 50,\n",
       "          'Reference': ['Computed by OEChem 2.3.0 (PubChem release 2021.05.07)'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C'}]}}]}]},\n",
       "     {'TOCHeading': 'Molecular Formula',\n",
       "      'Description': 'A chemical formula is a way of expressing information about the proportions of atoms that constitute a particular chemical compound, using a single line of chemical element symbols and numbers. PubChem uses the Hill system, whereby the number of carbon atoms in a molecule is indicated first, the number of hydrogen atoms second, and then the number of all other chemical elements in alphabetical order. When the formula contains no carbon, all the elements, including hydrogen, are listed alphabetically. Sources other than PubChem may include a variant of the formula that is more structural or natural to chemists, for example, H2SO4 for sulfuric acid, rather than the Hill version H2O4S.',\n",
       "      'URL': 'https://pubs.acs.org/doi/abs/10.1021/ja02046a005',\n",
       "      'DisplayControls': {'MoveToTop': True},\n",
       "      'Information': [{'ReferenceNumber': 1,\n",
       "        'Value': {'StringWithMarkup': [{'String': 'C9H18N6'}]}},\n",
       "       {'ReferenceNumber': 50,\n",
       "        'Reference': ['Computed by PubChem 2.1 (PubChem release 2021.05.07)'],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'C9H18N6'}]}}]},\n",
       "     {'TOCHeading': 'Other Identifiers',\n",
       "      'Description': 'Other identifiers assigned to this chemical.',\n",
       "      'Section': [{'TOCHeading': 'CAS',\n",
       "        'Description': 'A CAS Registry Number (also called CAS RN or CAS Number) is a proprietary registry number assigned by the Chemical Abstracts Service (CAS) division of the American Chemical Society (ACS).  It is a numeric identifier that can contain up to 10 digits, divided by hyphens into three parts.',\n",
       "        'URL': 'https://www.cas.org/support/documentation/chemical-substances/faqs',\n",
       "        'Information': [{'ReferenceNumber': 1,\n",
       "          'Value': {'StringWithMarkup': [{'String': '645-05-6'}]}},\n",
       "         {'ReferenceNumber': 2,\n",
       "          'URL': 'https://commonchemistry.cas.org/detail?cas_rn=645-05-6',\n",
       "          'Value': {'StringWithMarkup': [{'String': '645-05-6'}]}},\n",
       "         {'ReferenceNumber': 6,\n",
       "          'Value': {'StringWithMarkup': [{'String': '645-05-6'}]}},\n",
       "         {'ReferenceNumber': 12,\n",
       "          'Value': {'StringWithMarkup': [{'String': '645-05-6'}]}},\n",
       "         {'ReferenceNumber': 13,\n",
       "          'Name': 'CAS',\n",
       "          'Value': {'StringWithMarkup': [{'String': '645-05-6'}]}},\n",
       "         {'ReferenceNumber': 14,\n",
       "          'Name': 'CAS',\n",
       "          'Value': {'StringWithMarkup': [{'String': '645-05-6'}]}},\n",
       "         {'ReferenceNumber': 15,\n",
       "          'Value': {'StringWithMarkup': [{'String': '645-05-6'}]}},\n",
       "         {'ReferenceNumber': 17,\n",
       "          'Value': {'StringWithMarkup': [{'String': '645-05-6'}]}},\n",
       "         {'ReferenceNumber': 18,\n",
       "          'Value': {'StringWithMarkup': [{'String': '645-05-6'}]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Value': {'StringWithMarkup': [{'String': '645-05-6'}]}},\n",
       "         {'ReferenceNumber': 22,\n",
       "          'Value': {'StringWithMarkup': [{'String': '645-05-6'}]}}]},\n",
       "       {'TOCHeading': 'European Community (EC) Number',\n",
       "        'Description': 'The European Community (EC) number is a seven-digit identifier assigned by the European Chemicals Agency (ECHA) to substances for regulatory purposes within the European Union. EC numbers are sometimes referred to as EINECS, ELINCS, or NLP numbers, because the EC Inventory comprises three individual inventories (EINECS, ELINCS, and the NLP list).',\n",
       "        'URL': 'https://echa.europa.eu/information-on-chemicals/ec-inventory',\n",
       "        'Information': [{'ReferenceNumber': 17,\n",
       "          'URL': 'https://echa.europa.eu/substance-information/-/substanceinfo/100.010.391',\n",
       "          'Value': {'StringWithMarkup': [{'String': '211-428-4'}]}}]},\n",
       "       {'TOCHeading': 'NSC Number',\n",
       "        'Description': 'The National Service Center (NSC) number is a numeric identifier for substances submitted to the National Cancer Institute (NCI) for testing and evaluation. It is a registration number for the Developmental Therapeutics Program (DTP) repository.',\n",
       "        'URL': 'https://dtp.cancer.gov/organization/dscb/compoundSubmission/faqs.htm',\n",
       "        'Information': [{'ReferenceNumber': 13,\n",
       "          'Name': 'NSC Number',\n",
       "          'URL': 'https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=758231',\n",
       "          'Value': {'StringWithMarkup': [{'String': '758231'}]}},\n",
       "         {'ReferenceNumber': 14,\n",
       "          'Name': 'NSC Number',\n",
       "          'URL': 'https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=13875',\n",
       "          'Value': {'StringWithMarkup': [{'String': '13875'}]}}]},\n",
       "       {'TOCHeading': 'UNII',\n",
       "        'Description': 'UNique Ingredient Identifier (UNII) code for this chemical.  It is a non-proprietary registry number assigned by the U.S. Food and Drug Administration (FDA).',\n",
       "        'URL': 'https://www.fda.gov/industry/fda-data-standards-advisory-board/fdas-global-substance-registration-system',\n",
       "        'Information': [{'ReferenceNumber': 18,\n",
       "          'URL': 'https://gsrs.ncats.nih.gov/ginas/app/beta/substances/Q8BIH59O7H',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Q8BIH59O7H'}]}}]},\n",
       "       {'TOCHeading': 'DSSTox Substance ID',\n",
       "        'Description': 'Substance identifier used in the Distributed Structure-Searchable Toxicity (DSSTox) Database.',\n",
       "        'URL': 'https://www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database',\n",
       "        'Information': [{'ReferenceNumber': 15,\n",
       "          'URL': 'https://comptox.epa.gov/dashboard/DTXSID4022579',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'DTXSID4022579'}]}}]},\n",
       "       {'TOCHeading': 'Nikkaji Number',\n",
       "        'Description': 'Substance identifier used in the Japan Chemical Substance Dictionary (Nikkaji).',\n",
       "        'URL': 'https://jglobal.jst.go.jp/en/',\n",
       "        'Information': [{'ReferenceNumber': 26,\n",
       "          'URL': 'http://jglobal.jst.go.jp/en/redirect?Nikkaji_No=J7.067J',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'J7.067J'}]}}]},\n",
       "       {'TOCHeading': 'Wikipedia',\n",
       "        'Description': 'Wikidata entity identifier for this compound.',\n",
       "        'Information': [{'ReferenceNumber': 48,\n",
       "          'URL': 'https://en.wikipedia.org/wiki/Altretamine',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Altretamine'}]}}]},\n",
       "       {'TOCHeading': 'Wikidata',\n",
       "        'Description': 'Wikidata entity identifier for the given compound.',\n",
       "        'URL': 'https://www.wikidata.org/w/index.php?title=Special:WhatLinksHere/Property:P662',\n",
       "        'Information': [{'ReferenceNumber': 47,\n",
       "          'URL': 'https://www.wikidata.org/wiki/Q415242',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Q415242'}]}}]},\n",
       "       {'TOCHeading': 'NCI Thesaurus Code',\n",
       "        'Description': 'Stable, unique code for biomedical concept',\n",
       "        'URL': 'https://ncithesaurus.nci.nih.gov',\n",
       "        'Information': [{'ReferenceNumber': 31,\n",
       "          'URL': 'https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C544',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'C544'}]}}]},\n",
       "       {'TOCHeading': 'Metabolomics Workbench ID',\n",
       "        'Description': 'Registration number used by Metabolomics Workbench',\n",
       "        'URL': 'https://www.metabolomicsworkbench.org/',\n",
       "        'Information': [{'ReferenceNumber': 29,\n",
       "          'URL': 'https://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=42833',\n",
       "          'Value': {'StringWithMarkup': [{'String': '42833'}]}}]}]},\n",
       "     {'TOCHeading': 'Synonyms',\n",
       "      'Description': 'Alternative names for this PubChem Compound record.  A compound can have many different names.  For example, acetone (CH3C(=O)CH3) is also known as propanone, propan-2-one, or dimethyl ketone.  The brand name of a product is commonly used to indicate the primary chemical ingredient(s) in the product (e.g., Tylenol, a common pain killer, is often used for acetaminophen, its active ingredient).  Another example of common synonyms is record identifiers used in different data collections, such as Chemical Abstract Service (CAS) registry numbers, FDA UNII (Unique Ingredient Identifiers), and many others.  All these various names and identifiers that designate this compound are organized under the Synonyms section.',\n",
       "      'Section': [{'TOCHeading': 'MeSH Entry Terms',\n",
       "        'Description': 'Medical Subject Heading (MeSH) names or identifiers matching this PubChem Compound record.  The matching between the MeSH and compound records is performed by name matching (i.e., identical common names), as described in Kim et al., J. Cheminform., 2016, 8, 32.',\n",
       "        'URL': 'http://doi.org/10.1186/s13321-016-0142-6',\n",
       "        'DisplayControls': {'ListType': 'Columns'},\n",
       "        'Information': [{'ReferenceNumber': 49,\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Altretamine'},\n",
       "            {'String': 'Hemel'},\n",
       "            {'String': 'Hexalen'},\n",
       "            {'String': 'Hexamethylmelamine'},\n",
       "            {'String': 'Hexastat'},\n",
       "            {'String': 'Hexinawas'}]}}]},\n",
       "       {'TOCHeading': 'Depositor-Supplied Synonyms',\n",
       "        'Description': 'Chemical names provided by individual data contributors. Synonyms of Substances corresponding to a PubChem Compound record are combined. Some contributed names may be considered erroneous and filtered out. The link on each synonym shows which depositors provided that particular synonym for this structure.',\n",
       "        'DisplayControls': {'ListType': 'Columns', 'MoveToTop': True},\n",
       "        'Information': [{'ReferenceNumber': 50,\n",
       "          'Value': {'StringWithMarkup': [{'String': 'altretamine'},\n",
       "            {'String': '645-05-6'},\n",
       "            {'String': 'HEXAMETHYLMELAMINE'},\n",
       "            {'String': 'Hexalen'},\n",
       "            {'String': 'Hexastat'},\n",
       "            {'String': 'Hemel'},\n",
       "            {'String': '2,4,6-Tris(dimethylamino)-1,3,5-triazine'},\n",
       "            {'String': 'N2,N2,N4,N4,N6,N6-hexamethyl-1,3,5-triazine-2,4,6-triamine'},\n",
       "            {'String': 'Melamine, hexamethyl-'},\n",
       "            {'String': 'Altretaminum'},\n",
       "            {'String': 'Altretamina'},\n",
       "            {'String': 'Altretaminum [INN-Latin]'},\n",
       "            {'String': 'ENT 50852'},\n",
       "            {'String': 'NC 195'},\n",
       "            {'String': '2,4,6-Tris(dimethylamino)-s-triazine'},\n",
       "            {'String': 'NCI-C50259'},\n",
       "            {'String': 'HMM'},\n",
       "            {'String': 'Altretamine (Hexalen)'},\n",
       "            {'String': 'NSC 13875'},\n",
       "            {'String': 'HTM'},\n",
       "            {'String': 'HXM'},\n",
       "            {'String': '2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine'},\n",
       "            {'String': 's-Triazine, 2,4,6-tris(dimethylamino)-'},\n",
       "            {'String': \"1,3,5-Triazine-2,4,6-triamine, N,N,N',N',N'',N''-hexamethyl-\"},\n",
       "            {'String': 'NSC-13875'},\n",
       "            {'String': 'MLS000069621'},\n",
       "            {'String': \"N,N,N',N',N'',N''-hexamethyl-1,3,5-triazine-2,4,6-triamine\"},\n",
       "            {'String': 'NSC13875'},\n",
       "            {'String': 'Q8BIH59O7H'},\n",
       "            {'String': 'SMR000058181'},\n",
       "            {'String': '645-05-6 (free base)'},\n",
       "            {'String': 'DTXSID4022579'},\n",
       "            {'String': 'CHEBI:24564'},\n",
       "            {'String': 'NCGC00015100-02'},\n",
       "            {'String': 'ENT-50852;RB-1515;WR-95704'},\n",
       "            {'String': 'Altretamina [INN-Spanish]'},\n",
       "            {'String': 'DTXCID902579'},\n",
       "            {'String': 'CAS-645-05-6'},\n",
       "            {'String': 'Hexalen (TN)'},\n",
       "            {'String': 'CCRIS 5492'},\n",
       "            {'String': 'SR-01000000117'},\n",
       "            {'String': 'Hexalen [Antineoplastic]'},\n",
       "            {'String': 'Altretamine (USP/INN)'},\n",
       "            {'String': 'EINECS 211-428-4'},\n",
       "            {'String': 'UNII-Q8BIH59O7H'},\n",
       "            {'String': 'BRN 0195058'},\n",
       "            {'String': 'AI3-50852'},\n",
       "            {'String': 'HSDB 7559'},\n",
       "            {'String': 'Altretamine, solid'},\n",
       "            {'String': 'Altretamine [USAN:USP:INN:BAN]'},\n",
       "            {'String': 'KB-913'},\n",
       "            {'String': 'Spectrum_001308'},\n",
       "            {'String': 'ALTRETAMINE [MI]'},\n",
       "            {'String': 'Opera_ID_1095'},\n",
       "            {'String': 'Prestwick0_000946'},\n",
       "            {'String': 'Prestwick1_000946'},\n",
       "            {'String': 'Prestwick2_000946'},\n",
       "            {'String': 'Prestwick3_000946'},\n",
       "            {'String': 'Spectrum2_000907'},\n",
       "            {'String': 'Spectrum3_000951'},\n",
       "            {'String': 'Spectrum4_001064'},\n",
       "            {'String': 'Spectrum5_001092'},\n",
       "            {'String': 'ALTRETAMINE [INN]'},\n",
       "            {'String': 'Lopac-A-8723'},\n",
       "            {'String': 'ChemDiv2_005185'},\n",
       "            {'String': 'ALTRETAMINE [HSDB]'},\n",
       "            {'String': 'ALTRETAMINE [USAN]'},\n",
       "            {'String': '2,4, 6-Tris(dimethylamino)-1,3,5-triazine'},\n",
       "            {'String': 'A 8723'},\n",
       "            {'String': 'ALTRETAMINE [VANDF]'},\n",
       "            {'String': 'Cambridge id 5148727'},\n",
       "            {'String': 'cid_2123'},\n",
       "            {'String': 'SCHEMBL4206'},\n",
       "            {'String': 'ALTRETAMINE [MART.]'},\n",
       "            {'String': 'CHEMBL1455'},\n",
       "            {'String': 'Lopac0_000083'},\n",
       "            {'String': 'ALTRETAMINE [USP-RS]'},\n",
       "            {'String': 'ALTRETAMINE [WHO-DD]'},\n",
       "            {'String': 'BSPBio_000912'},\n",
       "            {'String': 'KBioGR_001388'},\n",
       "            {'String': 'KBioSS_001788'},\n",
       "            {'String': 'MLS001076123'},\n",
       "            {'String': 'DivK1c_000772'},\n",
       "            {'String': 'SPECTRUM1503065'},\n",
       "            {'String': 'SPBio_000754'},\n",
       "            {'String': 'SPBio_003071'},\n",
       "            {'String': 'BPBio1_001004'},\n",
       "            {'String': 'GTPL7112'},\n",
       "            {'String': 'BDBM37631'},\n",
       "            {'String': 'HMS502G14'},\n",
       "            {'String': 'KBio1_000772'},\n",
       "            {'String': 'KBio2_001788'},\n",
       "            {'String': 'KBio2_004356'},\n",
       "            {'String': 'KBio2_006924'},\n",
       "            {'String': 'KBio3_002042'},\n",
       "            {'String': 'ALTRETAMINE [ORANGE BOOK]'},\n",
       "            {'String': 'NINDS_000772'},\n",
       "            {'String': 'BCPP000413'},\n",
       "            {'String': 'HMS1383L15'},\n",
       "            {'String': 'HMS1570N14'},\n",
       "            {'String': 'HMS1922C05'},\n",
       "            {'String': 'HMS2090G17'},\n",
       "            {'String': 'HMS2092H16'},\n",
       "            {'String': 'HMS2097N14'},\n",
       "            {'String': 'HMS2234F09'},\n",
       "            {'String': 'HMS3259I20'},\n",
       "            {'String': 'HMS3260A08'},\n",
       "            {'String': 'HMS3372H17'},\n",
       "            {'String': 'HMS3654H11'},\n",
       "            {'String': 'HMS3714N14'},\n",
       "            {'String': 'Pharmakon1600-01503065'},\n",
       "            {'String': 'ALTRETAMINE [USP MONOGRAPH]'},\n",
       "            {'String': \"1,3,5-Triazine-2,4,6-triamine, N,N,N',N',N',N'-hexamethyl-\"},\n",
       "            {'String': 'BCP27675'},\n",
       "            {'String': 'CCG-2238'},\n",
       "            {'String': 'HY-B0181'},\n",
       "            {'String': '2,6-Tris(dimethylamino)-s-triazine'},\n",
       "            {'String': 'Tox21_110085'},\n",
       "            {'String': 'Tox21_202784'},\n",
       "            {'String': 'Tox21_500083'},\n",
       "            {'String': 'ENT-50852'},\n",
       "            {'String': 'MFCD00549245'},\n",
       "            {'String': 'NSC758231'},\n",
       "            {'String': 's1278'},\n",
       "            {'String': 'STK749184'},\n",
       "            {'String': 's-Triazine,4,6-tris(dimethylamino)-'},\n",
       "            {'String': 'AKOS001729401'},\n",
       "            {'String': 'Tox21_110085_1'},\n",
       "            {'String': '1,3,5-Tris(dimethylamino)-s-triazine'},\n",
       "            {'String': 'BCP9000278'},\n",
       "            {'String': 'CS-2061'},\n",
       "            {'String': 'DB00488'},\n",
       "            {'String': 'KS-5247'},\n",
       "            {'String': 'LP00083'},\n",
       "            {'String': 'NC00595'},\n",
       "            {'String': 'NSC-758231'},\n",
       "            {'String': 'RB-1515'},\n",
       "            {'String': 'SB73671'},\n",
       "            {'String': 'SDCCGSBI-0050071.P004'},\n",
       "            {'String': 'IDI1_000772'},\n",
       "            {'String': 'IDI1_003900'},\n",
       "            {'String': 'N~2~,N~2~,N~4~,N~4~,N~6~,N~6~-Hexamethyl-1,3,5-triazine-2,4,6-triamine'},\n",
       "            {'String': 'NCGC00015100-01'},\n",
       "            {'String': 'NCGC00015100-03'},\n",
       "            {'String': 'NCGC00015100-04'},\n",
       "            {'String': 'NCGC00015100-05'},\n",
       "            {'String': 'NCGC00015100-06'},\n",
       "            {'String': 'NCGC00015100-07'},\n",
       "            {'String': 'NCGC00015100-08'},\n",
       "            {'String': 'NCGC00015100-09'},\n",
       "            {'String': 'NCGC00015100-10'},\n",
       "            {'String': 'NCGC00015100-11'},\n",
       "            {'String': 'NCGC00015100-12'},\n",
       "            {'String': 'NCGC00015100-14'},\n",
       "            {'String': 'NCGC00015100-15'},\n",
       "            {'String': 'NCGC00015100-23'},\n",
       "            {'String': 'NCGC00021216-03'},\n",
       "            {'String': 'NCGC00021216-04'},\n",
       "            {'String': 'NCGC00021216-05'},\n",
       "            {'String': 'NCGC00021216-06'},\n",
       "            {'String': 'NCGC00021216-07'},\n",
       "            {'String': 'NCGC00260330-01'},\n",
       "            {'String': 'NCGC00260768-01'},\n",
       "            {'String': 'AC-12006'},\n",
       "            {'String': 'CAS-654-05-6'},\n",
       "            {'String': 'NCI60_000871'},\n",
       "            {'String': 'WR-95704'},\n",
       "            {'String': '2,6-Tris(dimethylamino)-1,3,5-triazine'},\n",
       "            {'String': 'SBI-0050071.P003'},\n",
       "            {'String': 'DB-054676'},\n",
       "            {'String': 'AB00052308'},\n",
       "            {'String': 'EU-0100083'},\n",
       "            {'String': 'FT-0651499'},\n",
       "            {'String': 'SW102053-5'},\n",
       "            {'String': 'C76020'},\n",
       "            {'String': 'D02841'},\n",
       "            {'String': 'EN300-122382'},\n",
       "            {'String': 'AB00052308-16'},\n",
       "            {'String': 'AB00052308-17'},\n",
       "            {'String': 'AB00052308-18'},\n",
       "            {'String': 'AB00052308_19'},\n",
       "            {'String': 'AB00052308_20'},\n",
       "            {'String': 'A834788'},\n",
       "            {'String': 'Q415242'},\n",
       "            {'String': 'WLN: T6N CN ENJ BN1&1 DN1&1 FN1&1'},\n",
       "            {'String': '2,4,6-Tris(dimethylamino)-1,3,5-triazine, 96%'},\n",
       "            {'String': 'J-523408'},\n",
       "            {'String': 'SR-01000000117-2'},\n",
       "            {'String': 'SR-01000000117-4'},\n",
       "            {'String': 'SR-01000000117-6'},\n",
       "            {'String': 'BRD-K67043667-001-04-1'},\n",
       "            {'String': 'BRD-K67043667-001-15-7'},\n",
       "            {'String': 'Z57931197'},\n",
       "            {'String': 'N2,N2,N4,N4,N6,N6-Hexamethyl-1,3,5-trazne-2,4,6-tramne'},\n",
       "            {'String': \"1,5-Triazine-2,4,6-triamine, N,N,N',N',N'',N''-hexamethyl-\"},\n",
       "            {'String': 'Altretamine, United States Pharmacopeia (USP) Reference Standard'},\n",
       "            {'String': 'N-[4,6-bis(dimethylamino)-1,3,5-triazin-2-yl]-N,N-dimethylamine'},\n",
       "            {'String': \"1,3,5-Triazine-2,4,6-triamine, N,N,N',N',N'', N''-hexamethyl-\"}]}}]},\n",
       "       {'TOCHeading': 'Removed Synonyms',\n",
       "        'Description': 'Potentially erroneous chemical names and identifiers provided by PubChem Substance records for the same chemical structure that were removed by name/structure consistency filtering.',\n",
       "        'DisplayControls': {'HideThisSection': True},\n",
       "        'Information': [{'ReferenceNumber': 50,\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Hexinawas'},\n",
       "            {'String': 'hexylen'},\n",
       "            {'String': 'Altretamine/'},\n",
       "            {'String': 'No-s-triazine'},\n",
       "            {'String': 'Hemel hydrochloride'},\n",
       "            {'String': 'Hexalen, Altretamine'},\n",
       "            {'String': 'Altretamine Bellon Brand'},\n",
       "            {'String': 'Altretamine Chiesi Brand'},\n",
       "            {'String': 'AC1L1CYX'},\n",
       "            {'String': 'Altretamine [USAN:INN:BAN]'},\n",
       "            {'String': 'C9H18N6'},\n",
       "            {'String': '2,4,6-Tris(dimethylami'},\n",
       "            {'String': 'D02LPF'},\n",
       "            {'String': 'Bellon Brand of Altretamine'},\n",
       "            {'String': 'Chiesi Brand of Altretamine'},\n",
       "            {'String': 'Altretamine Wassermann Brand'},\n",
       "            {'String': 'ZINC905'},\n",
       "            {'String': 'Altretamine [USAN:BAN:INN]'},\n",
       "            {'String': 'Hexamethylmelamine hydrochloride'},\n",
       "            {'String': 'UUVWYPNAQBNQJQ-UHFFFAOYSA-N'},\n",
       "            {'String': 'Wassermann Brand of Altretamine'},\n",
       "            {'String': 'C9-H18-N6.Cl-H'},\n",
       "            {'String': 'CTK8F7682'},\n",
       "            {'String': 'ERK5-2H04'},\n",
       "            {'String': 'MGI Pharma Brand of Altretamine'},\n",
       "            {'String': 'CID2123'},\n",
       "            {'String': 'KS-00001F6N'},\n",
       "            {'String': 'ABP000596'},\n",
       "            {'String': 'C9-H18-N6'},\n",
       "            {'String': 'ENT-50905'},\n",
       "            {'String': '2,4,6-Tris(dimethylamino-s-triazine'},\n",
       "            {'String': 'LS-1549'},\n",
       "            {'String': 'MCULE-1605383293'},\n",
       "            {'String': 'RP18094'},\n",
       "            {'String': 'VA10242'},\n",
       "            {'String': 'Rhone Poulenc Rorer Brand of Altretamine'},\n",
       "            {'String': 'Rhone-Poulenc Rorer Brand of Altretamine'},\n",
       "            {'String': 'AK431828'},\n",
       "            {'String': 'AN-47064'},\n",
       "            {'String': 'BC203873'},\n",
       "            {'String': 'CPD000058181'},\n",
       "            {'String': 'SAM002564241'},\n",
       "            {'String': 'SC-26614'},\n",
       "            {'String': 'ST086739'},\n",
       "            {'String': 'ZB000200'},\n",
       "            {'String': 'AB0007992'},\n",
       "            {'String': 'AB2000024'},\n",
       "            {'String': 'AI3-50905'},\n",
       "            {'String': 'MELAMINE, HEXAMETHYL-, HYDROCHLORIDE'},\n",
       "            {'String': '4-26-00-01256 (Beilstein Handbook Reference)'},\n",
       "            {'String': 'A10059'},\n",
       "            {'String': 'M-2093'},\n",
       "            {'String': '49712-EP2295426A1'},\n",
       "            {'String': '49712-EP2295427A1'},\n",
       "            {'String': '49712-EP2308833A2'},\n",
       "            {'String': '49712-EP2311825A1'},\n",
       "            {'String': '645A056'},\n",
       "            {'String': 'D006585'},\n",
       "            {'String': '2,4,6-Tris(dimethylamino)-s-triazine hydrochloride'},\n",
       "            {'String': 'I06-0604'},\n",
       "            {'String': 'A0567/0026158'},\n",
       "            {'String': 'Altretamine [2,4,6-Tris(dimethylamino)-1,3,5-triazine]'},\n",
       "            {'String': '[4,6-bis(dimethylamino)(1,3,5-triazin-2-yl)]dimethylamine'},\n",
       "            {'String': \"1,3,5-Triazine-2,4,6-triamine, N,N,N',N',N'',N''-hexamethyl-, hydrochloride\"},\n",
       "            {'String': 'InChI=1/C9H18N6/c1-13(2)7-10-8(14(3)4)12-9(11-7)15(5)6/h1-6H'},\n",
       "            {'String': '15468-34-5'},\n",
       "            {'String': 'ENT-50852;ENT 50852;ENT50852;ENT050852;WR-95704;WR95704;WR 95704;Hexalen; RB-1515; RB1515; RB 1515'}]}}]}]},\n",
       "     {'TOCHeading': 'Create Date',\n",
       "      'Description': 'Date when this compound record was created. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.',\n",
       "      'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/record-dates',\n",
       "      'DisplayControls': {'HideThisSection': True, 'MoveToTop': True},\n",
       "      'Information': [{'ReferenceNumber': 50,\n",
       "        'Value': {'DateISO8601': ['2005-03-25']}}]},\n",
       "     {'TOCHeading': 'Modify Date',\n",
       "      'Description': 'Date when this compound record was last modified. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.',\n",
       "      'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/record-dates',\n",
       "      'DisplayControls': {'HideThisSection': True, 'MoveToTop': True},\n",
       "      'Information': [{'ReferenceNumber': 50,\n",
       "        'Value': {'DateISO8601': ['2023-05-20']}}]}]},\n",
       "   {'TOCHeading': 'Chemical and Physical Properties',\n",
       "    'Description': 'Various chemical and physical properties that are experimentally determined for this compound.  See also the Safety and Hazard Properties section (if available), which has additional properties pertinent to chemical safety and hazards.',\n",
       "    'Section': [{'TOCHeading': 'Computed Properties',\n",
       "      'Description': 'Properties of this compound computed from its molecular formula and structure.',\n",
       "      'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections',\n",
       "        'NumberOfColumns': 3,\n",
       "        'ColumnHeadings': ['Property Name', 'Property Value', 'Reference'],\n",
       "        'ColumnContents': ['Name', 'Value', 'Reference']}},\n",
       "      'Section': [{'TOCHeading': 'Molecular Weight',\n",
       "        'Description': 'Molecular weight or molecular mass refers to the mass of a molecule. It is calculated as the sum of the mass of each constituent atom multiplied by the number of atoms of that element in the molecular formula.  The molecular weight is also called the relative molar mass, because molecular weights are reported in daltons, which is defined relative to the mass of the isotope 12C (carbon 12).',\n",
       "        'URL': 'https://www.degruyter.com/document/doi/10.1515/pac-2017-1002/html?lang=en',\n",
       "        'DisplayControls': {'MoveToTop': True},\n",
       "        'Information': [{'ReferenceNumber': 50,\n",
       "          'Reference': ['Computed by PubChem 2.1 (PubChem release 2021.05.07)'],\n",
       "          'Value': {'StringWithMarkup': [{'String': '210.28'}],\n",
       "           'Unit': 'g/mol'}}]},\n",
       "       {'TOCHeading': 'XLogP3',\n",
       "        'Description': 'XLogP3 is a predicted octanol-water partition coefficient, computed using the algorithm described in J. Chem. Inf. Model. 2007, 47, 6, 2140-2148. It is used as a measure of hydrophilicity or hydrophobicity of a molecule.',\n",
       "        'URL': 'https://pubmed.ncbi.nlm.nih.gov/17985865/',\n",
       "        'Information': [{'ReferenceNumber': 50,\n",
       "          'Reference': ['Computed by XLogP3 3.0 (PubChem release 2021.05.07)'],\n",
       "          'Value': {'Number': [2.7]}}]},\n",
       "       {'TOCHeading': 'Hydrogen Bond Donor Count',\n",
       "        'Description': 'The number of hydrogen bond donors in this compound.',\n",
       "        'Information': [{'ReferenceNumber': 50,\n",
       "          'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2021.05.07)'],\n",
       "          'Value': {'Number': [0]}}]},\n",
       "       {'TOCHeading': 'Hydrogen Bond Acceptor Count',\n",
       "        'Description': 'The number of hydrogen bond acceptors in this compound.',\n",
       "        'Information': [{'ReferenceNumber': 50,\n",
       "          'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2021.05.07)'],\n",
       "          'Value': {'Number': [6]}}]},\n",
       "       {'TOCHeading': 'Rotatable Bond Count',\n",
       "        'Description': 'A rotatable bond is defined as any single-order non-ring bond, where atoms on either side of the bond are in turn bound to nonterminal heavy (i.e., non-hydrogen) atoms. That is, where rotation around the bond axis changes the overall shape of the molecule, and generates conformers which can be distinguished by standard fast spectroscopic methods.',\n",
       "        'Information': [{'ReferenceNumber': 50,\n",
       "          'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2021.05.07)'],\n",
       "          'Value': {'Number': [3]}}]},\n",
       "       {'TOCHeading': 'Exact Mass',\n",
       "        'Description': 'The exact mass of an isotopic species is obtained by summing the masses of the individual isotopes of the molecule.',\n",
       "        'Information': [{'ReferenceNumber': 50,\n",
       "          'Reference': ['Computed by PubChem 2.1 (PubChem release 2021.05.07)'],\n",
       "          'Value': {'StringWithMarkup': [{'String': '210.15929460'}],\n",
       "           'Unit': 'g/mol'}}]},\n",
       "       {'TOCHeading': 'Monoisotopic Mass',\n",
       "        'Description': 'The monoisotopic mass is the sum of the masses of the atoms in a molecule using the unbound, ground-state, rest mass of the principal (most abundant) isotope for each element instead of the isotopic average mass.',\n",
       "        'Information': [{'ReferenceNumber': 50,\n",
       "          'Reference': ['Computed by PubChem 2.1 (PubChem release 2021.05.07)'],\n",
       "          'Value': {'StringWithMarkup': [{'String': '210.15929460'}],\n",
       "           'Unit': 'g/mol'}}]},\n",
       "       {'TOCHeading': 'Topological Polar Surface Area',\n",
       "        'Description': 'The topological polar surface area (TPSA) is an estimate of the polar surface area (in Angstroms^2) of a molecule, computed as the surface sum over polar atoms in the molecule.  The implementation follows the paper by Ertl et al. [J. Med. Chem. 2000, 43, 3714-3717]: only N and O are considered, 3D coordinates are not used, and there are various precomputed factors for different hybridizations, charges and participation in aromatic systems.',\n",
       "        'URL': 'https://pubmed.ncbi.nlm.nih.gov/11020286/',\n",
       "        'Information': [{'ReferenceNumber': 50,\n",
       "          'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2021.05.07)'],\n",
       "          'Value': {'Number': [48.4], 'Unit': 'â«Â²'}}]},\n",
       "       {'TOCHeading': 'Heavy Atom Count',\n",
       "        'Description': 'The number of heavy atoms (i.e., non-hydrogen atoms) in this compound.',\n",
       "        'Information': [{'ReferenceNumber': 50,\n",
       "          'Reference': ['Computed by PubChem'],\n",
       "          'Value': {'Number': [15]}}]},\n",
       "       {'TOCHeading': 'Formal Charge',\n",
       "        'Description': 'Formal charge is the difference between the number of valence electrons of each atom and the number of electrons the atom is associated with. Formal charge assumes any shared electrons are equally shared between the two bonded atoms.',\n",
       "        'Information': [{'ReferenceNumber': 50,\n",
       "          'Reference': ['Computed by PubChem'],\n",
       "          'Value': {'Number': [0]}}]},\n",
       "       {'TOCHeading': 'Complexity',\n",
       "        'Description': 'The complexity rating of a compound is a rough estimate of how complicated a structure is, seen from both the point of view of the elements contained and the displayed structural features including symmetry. This complexity rating is computed using the Bertz/Hendrickson/Ihlenfeldt formula.',\n",
       "        'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/glossary#section=Complexity',\n",
       "        'Information': [{'ReferenceNumber': 50,\n",
       "          'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2021.05.07)'],\n",
       "          'Value': {'Number': [148]}}]},\n",
       "       {'TOCHeading': 'Isotope Atom Count',\n",
       "        'Description': 'Isotope atom count is the number of isotopes that are not most abundant for the corresponding chemical elements.  Isotopes are variants of a chemical element which differ in neutron number.  For example, among three isotopes of carbon (i.e., C-12, C-13, and C-14), the isotope atom count considers the C-13 and C-14 atoms, because C-12 is the most abundant isotope of carbon.',\n",
       "        'Information': [{'ReferenceNumber': 50,\n",
       "          'Reference': ['Computed by PubChem'],\n",
       "          'Value': {'Number': [0]}}]},\n",
       "       {'TOCHeading': 'Defined Atom Stereocenter Count',\n",
       "        'Description': 'An atom stereocenter, also known as a chiral center, is an atom that is attached to four different types of atoms (or groups of atoms) in the tetrahedral arrangement. It can have either (R)- or (S)- configurations.  Some compounds, such as racemic mixtures, have an undefined atom stereocenter, whose (R/S)-configuration is not specifically defined.  The \"defined atom stereocenter count\" is the number of atom stereocenters whose configurations are specifically defined.  ',\n",
       "        'Information': [{'ReferenceNumber': 50,\n",
       "          'Reference': ['Computed by PubChem'],\n",
       "          'Value': {'Number': [0]}}]},\n",
       "       {'TOCHeading': 'Undefined Atom Stereocenter Count',\n",
       "        'Description': 'The number of atom stereocenters whose configurations are not specifically defined.  For the definition of atom stereocenters, see the \"defined atom stereocenter count\" above.',\n",
       "        'Information': [{'ReferenceNumber': 50,\n",
       "          'Reference': ['Computed by PubChem'],\n",
       "          'Value': {'Number': [0]}}]},\n",
       "       {'TOCHeading': 'Defined Bond Stereocenter Count',\n",
       "        'Description': 'A bond stereocenter is a non-rotatable bond around which two atoms can have different arrangement (as in cis- and trans-forms of butene around its double bond).  Some compounds have an undefined bond stereocenter, whose stereochemistry is not specifically defined.  The \"defined bond stereocenter count\" is the number of bond stereocenters whose configurations are specifically defined.  ',\n",
       "        'Information': [{'ReferenceNumber': 50,\n",
       "          'Reference': ['Computed by PubChem'],\n",
       "          'Value': {'Number': [0]}}]},\n",
       "       {'TOCHeading': 'Undefined Bond Stereocenter Count',\n",
       "        'Description': 'The number of bond stereocenters whose configurations are not specifically defined.  For the definition of bond stereocenters, see the \"defined bond stereocenter count\" above.',\n",
       "        'Information': [{'ReferenceNumber': 50,\n",
       "          'Reference': ['Computed by PubChem'],\n",
       "          'Value': {'Number': [0]}}]},\n",
       "       {'TOCHeading': 'Covalently-Bonded Unit Count',\n",
       "        'Description': 'A covalently-bonded unit is a group of atoms connected by covalent bonds, ignoring other bond types (or a single atom without covalent bonds).  The \"covalently-bonded unit count\" property is the number of such units in this compound compound.',\n",
       "        'Information': [{'ReferenceNumber': 50,\n",
       "          'Reference': ['Computed by PubChem'],\n",
       "          'Value': {'Number': [1]}}]},\n",
       "       {'TOCHeading': 'Compound Is Canonicalized',\n",
       "        'Description': \"Whether the compound has successfully passed PubChem's valence bond canonicalization procedure. Some large, complex, or highly symmetric structures may fail this process.\",\n",
       "        'Information': [{'ReferenceNumber': 50,\n",
       "          'Reference': ['Computed by PubChem (release 2021.05.07)'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Yes'}]}}]}]},\n",
       "     {'TOCHeading': 'Experimental Properties',\n",
       "      'Description': 'Various experimentally determined properties for this compound.  See also the Safety and Hazard Properties section (if available), which has additional properties pertinent to chemical safety and hazards.',\n",
       "      'Section': [{'TOCHeading': 'Physical Description',\n",
       "        'Description': 'The appearance or features of this compound, including color, odor, state, taste and more in general.',\n",
       "        'Information': [{'ReferenceNumber': 1,\n",
       "          'Reference': ['National Toxicology Program, Institute of Environmental Health Sciences, National Institutes of Health (NTP). 1992. National Toxicology Program Chemical Repository Database. Research Triangle Park, North Carolina.'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Hexamethylmelamine is a colorless crystalline solid. Insoluble in water. (NTP, 1992)',\n",
       "             'Markup': [{'Start': 0,\n",
       "               'Length': 18,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Hexamethylmelamine',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-2123'},\n",
       "              {'Start': 66,\n",
       "               'Length': 5,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/water',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-962'}]}]}},\n",
       "         {'ReferenceNumber': 22,\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Solid'}]}}]},\n",
       "       {'TOCHeading': 'Color/Form',\n",
       "        'Description': 'Color is the aspect of any object that may be described in terms of hue, lightness, and saturation.',\n",
       "        'URL': 'https://www.britannica.com/science/color',\n",
       "        'Information': [{'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': [\"O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ:  Merck and Co., Inc., 2006., p. 57\"],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Needles from absolute ethanol',\n",
       "             'Markup': [{'Start': 22,\n",
       "               'Length': 7,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/ethanol',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-702'}]}]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': [\"Lewis, R.J. Sr.; Hawley's Condensed Chemical Dictionary 14th Edition. John Wiley & Sons, Inc. New York, NY 2001., p. 561\"],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Solid'}]}}]},\n",
       "       {'TOCHeading': 'Melting Point',\n",
       "        'Description': 'This section provides the melting point and/or freezing point. The melting point is the temperature at which a substance changes state from solid to liquid at atmospheric pressure. When considered as the temperature of the reverse change (from liquid to solid), it is referred to as the freezing point.',\n",
       "        'URL': 'https://chem.libretexts.org/Bookshelves/Organic_Chemistry/Organic_Chemistry_Lab_Techniques_(Nichols)/06%3A_Miscellaneous_Techniques/6.01%3A_Melting_Point',\n",
       "        'Information': [{'ReferenceNumber': 12,\n",
       "          'Reference': ['von Brachel, H. and Kindler, H.; U.S. Patent 3,424,752; January 28, 1969; assigned to Casella Farbwerke Mainkur AG'],\n",
       "          'Value': {'Number': [168]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': [\"O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ:  Merck and Co., Inc., 2006., p. 57\"],\n",
       "          'Value': {'StringWithMarkup': [{'String': '172-174 Â°C'}]}},\n",
       "         {'ReferenceNumber': 22,\n",
       "          'Value': {'StringWithMarkup': [{'String': '172 - 174 Â°C'}]}}]},\n",
       "       {'TOCHeading': 'Solubility',\n",
       "        'Description': 'The solubility of a substance is the amount of that substance that will dissolve in a given amount of solvent. The default solvent is water, if not indicated.',\n",
       "        'URL': 'https://chem.libretexts.org/Courses/Purdue/Purdue%3A_Chem_26505%3A_Organic_Chemistry_I_(Lipton)/Chapter_4._Intermolecular_Forces_and_Physical_Properties/4.4_Solubility',\n",
       "        'Information': [{'ReferenceNumber': 1,\n",
       "          'Reference': ['National Toxicology Program, Institute of Environmental Health Sciences, National Institutes of Health (NTP). 1992. National Toxicology Program Chemical Repository Database. Research Triangle Park, North Carolina.'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Insoluble (NTP, 1992)'}]}},\n",
       "         {'ReferenceNumber': 12,\n",
       "          'Reference': ['YALKOWSKY,SH & DANNENFELSER,RM (1992)'],\n",
       "          'Value': {'Number': [91], 'Unit': 'mg/L (at 25 Â°C)'}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': [\"Lewis, R.J. Sr.; Hawley's Condensed Chemical Dictionary 14th Edition. John Wiley & Sons, Inc. New York, NY 2001., p. 561\"],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Soluble in acetone'}]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['Yalkowsky, S.H., He, Yan., Handbook of Aqueous Solubility  Data: An Extensive Compilation of Aqueous Solubility Data  for Organic Compounds Extracted from the  AQUASOL dATAbASE.  CRC Press LLC, Boca Raton, FL. 2003., p. 611'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'In water, 91 mg/L at 25 Â°C',\n",
       "             'Markup': [{'Start': 3,\n",
       "               'Length': 5,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/water',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-962'}]}]}},\n",
       "         {'ReferenceNumber': 22,\n",
       "          'Value': {'StringWithMarkup': [{'String': '3.10e+00 g/L'}]}},\n",
       "         {'ReferenceNumber': 30,\n",
       "          'Name': 'Solubility',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Water 0.92 (mg/mL)'}]}},\n",
       "         {'ReferenceNumber': 30,\n",
       "          'Name': 'Solubility',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Benzene 106 (mg/mL)'}]}},\n",
       "         {'ReferenceNumber': 30,\n",
       "          'Name': 'Solubility',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'CHCL3 220 (mg/mL)'}]}},\n",
       "         {'ReferenceNumber': 30,\n",
       "          'Name': 'Solubility',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'EtOAc 52 (mg/mL)'}]}},\n",
       "         {'ReferenceNumber': 30,\n",
       "          'Name': 'Solubility',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Et2O 47 (mg/mL)'}]}}]},\n",
       "       {'TOCHeading': 'Vapor Pressure',\n",
       "        'Description': 'Vapor pressure (or equilibrium vapor pressure) is the pressure of a vapor in thermodynamic equilibrium with its condensed phases in a closed system.',\n",
       "        'URL': 'https://chem.libretexts.org/Bookshelves/General_Chemistry/Map%3A_Chemistry_-_The_Central_Science_(Brown_et_al.)/11%3A_Liquids_and_Intermolecular_Forces/11.05%3A_Vapor_Pressure',\n",
       "        'Information': [{'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['US EPA; Estimation Program Interface (EPI) Suite. Ver.3.12. Nov 30, 2004. Available from, as of Oct 26, 2007: https://www.epa.gov/oppt/exposure/pubs/episuitedl.htm'],\n",
       "          'Value': {'StringWithMarkup': [{'String': '2.95X10-4 mm Hg at 25 Â°C (est)'}]}}]},\n",
       "       {'TOCHeading': 'LogP',\n",
       "        'Description': 'Log P is the partition coefficient expressed in logarithmic form.  The partition coefficient is the ratio of concentrations of a compound in a mixture of two immiscible solvents at equilibrium.  This ratio is therefore used to compare the solubilities of the solute in these two solvents.  Because octanol and water are the most commonly used pair of solvents for measuring partition coefficients, the Log P values listed in this section refer to octanol/water partition coefficients, unless indicated otherwise.',\n",
       "        'Information': [{'ReferenceNumber': 12,\n",
       "          'Reference': ['HANSCH,C ET AL. (1995)'],\n",
       "          'Value': {'Number': [2.73]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['Hansch, C., Leo, A., D. Hoekman. Exploring QSAR - Hydrophobic, Electronic, and Steric Constants. Washington, DC: American Chemical Society., 1995., p. 65'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'log Kow = 2.73'}]}},\n",
       "         {'ReferenceNumber': 22,\n",
       "          'Value': {'StringWithMarkup': [{'String': '1.7'}]}}]},\n",
       "       {'TOCHeading': \"Henry's Law Constant\",\n",
       "        'Description': \"Henry's law states that the amount of dissolved gas (in liquid, such as water) is proportional to its partial pressure in the gas phase. The proportionality factor is called the Henry's law constant and defined as the ratio of a compound's partial pressure in air to the concentration of the compound in water at a given temperature.\",\n",
       "        'URL': 'https://chem.libretexts.org/Bookshelves/Physical_and_Theoretical_Chemistry_Textbook_Maps/Supplemental_Modules_(Physical_and_Theoretical_Chemistry)/Physical_Properties_of_Matter/Solutions_and_Mixtures/Ideal_Solutions/Dissolving_Gases_In_Liquids%2C_Henry%27s_Law',\n",
       "        'Information': [{'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['US EPA; Estimation Program Interface (EPI) Suite. Ver.3.12. Nov 30, 2004. Available from, as of Oct 26, 2007: https://www.epa.gov/oppt/exposure/pubs/episuitedl.htm'],\n",
       "          'Value': {'StringWithMarkup': [{'String': \"Henry's Law constant = 1.72X10-8 atm-cu m/mol at 25 Â°C (est)\"}]}}]},\n",
       "       {'TOCHeading': 'Stability/Shelf Life',\n",
       "        'Description': 'Tendency of a material to resist change or decomposition due to internal reaction, or due to the action of air, heat, light, pressure, etc. See also the Stability and Reactivity subsection under the Safety and Hazards section on this page (when available).',\n",
       "        'Information': [{'ReferenceNumber': 30,\n",
       "          'Name': 'Stability',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Bulk: The bulk drug is stable at room temperature. \\nSolution: Aqueous solutions at pH 4, 7, and 10 are stable for 24 hours at room temperature (UV).'}]}}]},\n",
       "       {'TOCHeading': 'Dissociation Constants',\n",
       "        'Description': 'A specific type of equilibrium constant that measures the propensity of a larger object to separate (dissociate) reversibly into smaller components, as when a complex falls apart into its component molecules, or when a salt splits up into its component ions. This includes pKa (the negative logarithm of the acid dissociation constant) and pKb (the negative logarithm of the base dissociation constant).',\n",
       "        'Information': [{'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['SPARC; pKa/property server. Ver 3. Jan, 2006. Available from, as of Mar 21, 2008: https://ibmlc2.chem.uga.edu/sparc/'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'pKa1 = 4.88 (imine) (est)'}]}}]},\n",
       "       {'TOCHeading': 'Collision Cross Section',\n",
       "        'Description': 'Collision cross section (CCS) represents the effective area for the interaction between an individual ion and the neutral gas through which it is traveling (e.g., in ion mobility spectrometry (IMS) experiments).  It quantifies the probability of a collision taking place between two or more particles.',\n",
       "        'URL': 'https://pubmed.ncbi.nlm.nih.gov/28035808/',\n",
       "        'Information': [{'ReferenceNumber': 3,\n",
       "          'Reference': ['https://pubs.acs.org/doi/abs/10.1021/acs.analchem.7b01709'],\n",
       "          'Value': {'StringWithMarkup': [{'String': '145.6 â«Â² [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]',\n",
       "             'Markup': [{'Start': 14,\n",
       "               'Length': 1,\n",
       "               'Type': 'Superscript'}]}]}}]},\n",
       "       {'TOCHeading': 'Other Experimental Properties',\n",
       "        'Description': 'Other experimental properties of this chemical.',\n",
       "        'Information': [{'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['US EPA; Estimation Program Interface (EPI) Suite. Ver.3.12. Nov 30, 2004. Available from, as of Oct 26, 2007: https://www.epa.gov/oppt/exposure/pubs/episuitedl.htm'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Hydroxyl radical reaction rate constant = 8.25X10-12 cu cm/molec-sec at 25 Â°C (est)',\n",
       "             'Markup': [{'Start': 0,\n",
       "               'Length': 8,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Hydroxyl',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-157350'}]}]}}]}]},\n",
       "     {'TOCHeading': 'SpringerMaterials Properties',\n",
       "      'Description': 'List of properties available in SpringerMaterials, which has chemical and physical property data pertinent to materials science, physics, chemistry and engineering.',\n",
       "      'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/springermaterials',\n",
       "      'DisplayControls': {'ListType': 'Columns'},\n",
       "      'Information': [{'ReferenceNumber': 43,\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Fusion temperature',\n",
       "           'Markup': [{'Start': 0,\n",
       "             'Length': 18,\n",
       "             'URL': 'https://materials.springer.com/search?searchTerm=2%2C4%2C6-tris%28dimethylamino%29-1%2C3%2C5-triazine&propertyFacet=fusion%20temperature&substanceId=smsid_siulkegtazyazxdn'}]},\n",
       "          {'String': 'Melting temperature',\n",
       "           'Markup': [{'Start': 0,\n",
       "             'Length': 19,\n",
       "             'URL': 'https://materials.springer.com/search?searchTerm=2%2C4%2C6-tris%28dimethylamino%29-1%2C3%2C5-triazine&propertyFacet=melting%20temperature&substanceId=smsid_siulkegtazyazxdn'}]},\n",
       "          {'String': 'Phase transition',\n",
       "           'Markup': [{'Start': 0,\n",
       "             'Length': 16,\n",
       "             'URL': 'https://materials.springer.com/search?searchTerm=2%2C4%2C6-tris%28dimethylamino%29-1%2C3%2C5-triazine&propertyFacet=phase%20transition&substanceId=smsid_siulkegtazyazxdn'}]},\n",
       "          {'String': 'Transition enthalpy',\n",
       "           'Markup': [{'Start': 0,\n",
       "             'Length': 19,\n",
       "             'URL': 'https://materials.springer.com/search?searchTerm=2%2C4%2C6-tris%28dimethylamino%29-1%2C3%2C5-triazine&propertyFacet=transition%20enthalpy&substanceId=smsid_siulkegtazyazxdn'}]}]}}]}]},\n",
       "   {'TOCHeading': 'Spectral Information',\n",
       "    'Description': 'Spectral data for this compound, including 1-D and 2-D nuclear magnetic resonance (NMR), Infrared (IR), Raman, and Ultraviolet (UV) spectroscopy, mass spectrometry (MS), and chromatography.',\n",
       "    'Section': [{'TOCHeading': '1D NMR Spectra',\n",
       "      'Description': 'One-dimensional (1D) nuclear magnetic resonance (NMR) spectra.',\n",
       "      'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection',\n",
       "        'NumberOfColumns': 2,\n",
       "        'ColumnContents': ['Name', 'Value']},\n",
       "       'ShowAtMost': 2},\n",
       "      'Information': [{'ReferenceNumber': 37,\n",
       "        'Name': '1D NMR Spectra',\n",
       "        'Value': {'StringWithMarkup': [{'String': 'NMRShiftDB Link',\n",
       "           'Markup': [{'Start': 0,\n",
       "             'Length': 15,\n",
       "             'URL': 'http://nmrshiftdb.nmr.uni-koeln.de//portal/js_pane/P-Results/nmrshiftdbaction/showDetailsFromHome/molNumber/20146930'}]}]}}],\n",
       "      'Section': [{'TOCHeading': '13C NMR Spectra',\n",
       "        'Description': 'Carbon-13 nuclear magnetic resonance (NMR) spectroscopy (also known as 13C NMR) is a version of NMR spectroscopy used to elucidate the structure of carbon-containing compounds.',\n",
       "        'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection',\n",
       "          'NumberOfColumns': 2,\n",
       "          'ColumnContents': ['Name', 'Value']},\n",
       "         'ShowAtMost': 2},\n",
       "        'Information': [{'ReferenceNumber': 38,\n",
       "          'Name': 'Copyright',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Copyright Â© 2016-2021 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved.'}]}},\n",
       "         {'ReferenceNumber': 38,\n",
       "          'Name': 'Thumbnail',\n",
       "          'URL': 'https://spectrabase.com/spectrum/5lB7glbBkvK',\n",
       "          'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/4768287_1'],\n",
       "           'MimeType': 'image/png'}}]}]},\n",
       "     {'TOCHeading': 'Mass Spectrometry',\n",
       "      'Description': 'Mass spectrometry (MS or mass spec) is a technique to determine molecular structure through ionization and fragmentation of the parent compound into smaller components.',\n",
       "      'URL': 'https://chem.libretexts.org/Bookshelves/Organic_Chemistry/Supplemental_Modules_(Organic_Chemistry)/Spectroscopy/Mass_Spectrometry',\n",
       "      'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection',\n",
       "        'NumberOfColumns': 2,\n",
       "        'ColumnContents': ['Name', 'Value']},\n",
       "       'ShowAtMost': 2},\n",
       "      'Section': [{'TOCHeading': 'GC-MS',\n",
       "        'Description': 'Data from gas chromatography-mass spectrometry (GC-MS) experiments.',\n",
       "        'URL': 'https://chem.libretexts.org/Bookshelves/General_Chemistry/Book%3A_Structure_and_Reactivity_in_Organic_Biological_and_Inorganic_Chemistry_(Schaller)/II%3A_Practical_Aspects_of_Structure_-_Purification_and_Spectroscopy/06%3A_Introductory_Mass_Spectrometry/6.03%3A_GC-MS_and_LC-MS',\n",
       "        'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection',\n",
       "          'NumberOfColumns': 2,\n",
       "          'ColumnContents': ['Name', 'Value']},\n",
       "         'ShowAtMost': 2},\n",
       "        'Information': [{'ReferenceNumber': 32,\n",
       "          'Name': 'NIST Number',\n",
       "          'Value': {'Number': [341608]}},\n",
       "         {'ReferenceNumber': 32,\n",
       "          'Name': 'Library',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Main library'}]}},\n",
       "         {'ReferenceNumber': 32,\n",
       "          'Name': 'Total Peaks',\n",
       "          'Value': {'Number': [91]}},\n",
       "         {'ReferenceNumber': 32,\n",
       "          'Name': 'm/z Top Peak',\n",
       "          'Value': {'Number': [210]}},\n",
       "         {'ReferenceNumber': 32,\n",
       "          'Name': 'm/z 2nd Highest',\n",
       "          'Value': {'Number': [195]}},\n",
       "         {'ReferenceNumber': 32,\n",
       "          'Name': 'm/z 3rd Highest',\n",
       "          'Value': {'Number': [96]}},\n",
       "         {'ReferenceNumber': 32,\n",
       "          'Name': 'Thumbnail',\n",
       "          'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/195962_1'],\n",
       "           'MimeType': 'image/png'}},\n",
       "         {'ReferenceNumber': 33,\n",
       "          'Name': 'NIST Number',\n",
       "          'Value': {'Number': [76044]}},\n",
       "         {'ReferenceNumber': 33,\n",
       "          'Name': 'Library',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Replicate library'}]}},\n",
       "         {'ReferenceNumber': 33,\n",
       "          'Name': 'Total Peaks',\n",
       "          'Value': {'Number': [87]}},\n",
       "         {'ReferenceNumber': 33,\n",
       "          'Name': 'm/z Top Peak',\n",
       "          'Value': {'Number': [96]}},\n",
       "         {'ReferenceNumber': 33,\n",
       "          'Name': 'm/z 2nd Highest',\n",
       "          'Value': {'Number': [210]}},\n",
       "         {'ReferenceNumber': 33,\n",
       "          'Name': 'm/z 3rd Highest',\n",
       "          'Value': {'Number': [195]}},\n",
       "         {'ReferenceNumber': 33,\n",
       "          'Name': 'Thumbnail',\n",
       "          'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/262382_1'],\n",
       "           'MimeType': 'image/png'}},\n",
       "         {'ReferenceNumber': 34,\n",
       "          'Name': 'NIST Number',\n",
       "          'Value': {'Number': [408498]}},\n",
       "         {'ReferenceNumber': 34,\n",
       "          'Name': 'Library',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Replicate library'}]}},\n",
       "         {'ReferenceNumber': 34,\n",
       "          'Name': 'Total Peaks',\n",
       "          'Value': {'Number': [106]}},\n",
       "         {'ReferenceNumber': 34,\n",
       "          'Name': 'm/z Top Peak',\n",
       "          'Value': {'Number': [210]}},\n",
       "         {'ReferenceNumber': 34,\n",
       "          'Name': 'm/z 2nd Highest',\n",
       "          'Value': {'Number': [96]}},\n",
       "         {'ReferenceNumber': 34,\n",
       "          'Name': 'm/z 3rd Highest',\n",
       "          'Value': {'Number': [195]}},\n",
       "         {'ReferenceNumber': 34,\n",
       "          'Name': 'Thumbnail',\n",
       "          'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/276925_1'],\n",
       "           'MimeType': 'image/png'}},\n",
       "         {'ReferenceNumber': 35,\n",
       "          'Name': 'NIST Number',\n",
       "          'Value': {'Number': [131564]}},\n",
       "         {'ReferenceNumber': 35,\n",
       "          'Name': 'Library',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Replicate library'}]}},\n",
       "         {'ReferenceNumber': 35,\n",
       "          'Name': 'Total Peaks',\n",
       "          'Value': {'Number': [98]}},\n",
       "         {'ReferenceNumber': 35,\n",
       "          'Name': 'm/z Top Peak',\n",
       "          'Value': {'Number': [210]}},\n",
       "         {'ReferenceNumber': 35,\n",
       "          'Name': 'm/z 2nd Highest',\n",
       "          'Value': {'Number': [195]}},\n",
       "         {'ReferenceNumber': 35,\n",
       "          'Name': 'm/z 3rd Highest',\n",
       "          'Value': {'Number': [96]}},\n",
       "         {'ReferenceNumber': 35,\n",
       "          'Name': 'Thumbnail',\n",
       "          'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/276941_1'],\n",
       "           'MimeType': 'image/png'}},\n",
       "         {'ReferenceNumber': 39,\n",
       "          'Name': 'Technique',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'GC/MS'}]}},\n",
       "         {'ReferenceNumber': 39,\n",
       "          'Name': 'Source of Spectrum',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'DigiLab GmbH (C) 2021'}]}},\n",
       "         {'ReferenceNumber': 39,\n",
       "          'Name': 'Copyright',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Copyright Â© 2021 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved.'}]}},\n",
       "         {'ReferenceNumber': 39,\n",
       "          'Name': 'Thumbnail',\n",
       "          'URL': 'https://spectrabase.com/spectrum/FvbGVtIvisa',\n",
       "          'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/10090118_1'],\n",
       "           'MimeType': 'image/png'}},\n",
       "         {'ReferenceNumber': 40,\n",
       "          'Name': 'Source of Spectrum',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'W5-0-0-0'}]}},\n",
       "         {'ReferenceNumber': 40,\n",
       "          'Name': 'Copyright',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Copyright Â© 2020-2021 John Wiley & Sons, Inc. All Rights Reserved.'}]}},\n",
       "         {'ReferenceNumber': 40,\n",
       "          'Name': 'Thumbnail',\n",
       "          'URL': 'https://spectrabase.com/spectrum/5UoszugBcm0',\n",
       "          'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/10090119_1'],\n",
       "           'MimeType': 'image/png'}}]},\n",
       "       {'TOCHeading': 'MS-MS',\n",
       "        'Description': 'Data from tandem mass spectrometry (MS-MS) experiments.',\n",
       "        'URL': 'https://goldbook.iupac.org/terms/view/T06250',\n",
       "        'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection',\n",
       "          'NumberOfColumns': 2,\n",
       "          'ColumnContents': ['Name', 'Value']},\n",
       "         'ShowAtMost': 2},\n",
       "        'Information': [{'ReferenceNumber': 23,\n",
       "          'Name': 'Spectra ID',\n",
       "          'URL': 'https://hmdb.ca/spectra/m_ms/374910',\n",
       "          'Value': {'StringWithMarkup': [{'String': '374910'}]}},\n",
       "         {'ReferenceNumber': 23,\n",
       "          'Name': 'Instrument Type',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'LC-ESI-qTof'}]}},\n",
       "         {'ReferenceNumber': 23,\n",
       "          'Name': 'Ionization Mode',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Positive'}]}},\n",
       "         {'ReferenceNumber': 23,\n",
       "          'Name': 'SPLASH',\n",
       "          'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=splash.splash%3D%3D%22splash10-03dj-9781100000-4553bbbe9a30a0391bb4%22',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'splash10-03dj-9781100000-4553bbbe9a30a0391bb4'}]}},\n",
       "         {'ReferenceNumber': 23,\n",
       "          'Name': 'Top 5 Peaks',\n",
       "          'Value': {'StringWithMarkup': [{'String': '211.166611 95164'},\n",
       "            {'String': '96.056412 58576'},\n",
       "            {'String': '212.167892 11528'},\n",
       "            {'String': '168.124146 7040'},\n",
       "            {'String': '181.118683 6796'}]}},\n",
       "         {'ReferenceNumber': 23,\n",
       "          'Name': 'Thumbnail',\n",
       "          'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=211.166611:95164,96.056412:58576,212.167892:11528,168.124146:7040,181.118683:6796',\n",
       "          'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=211.166611:95164,96.056412:58576,212.167892:11528,168.124146:7040,181.118683:6796'],\n",
       "           'MimeType': 'image/svg'}},\n",
       "         {'ReferenceNumber': 23,\n",
       "          'Name': 'Notes',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'From GNPS Library'}]}},\n",
       "         {'ReferenceNumber': 24,\n",
       "          'Name': 'Spectra ID',\n",
       "          'URL': 'https://hmdb.ca/spectra/m_ms/450612',\n",
       "          'Value': {'StringWithMarkup': [{'String': '450612'}]}},\n",
       "         {'ReferenceNumber': 24,\n",
       "          'Name': 'Ionization Mode',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'positive'}]}},\n",
       "         {'ReferenceNumber': 24,\n",
       "          'Name': 'SPLASH',\n",
       "          'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=splash.splash%3D%3D%22splash10-03di-3490000000-4af5631898604d2cec10%22',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'splash10-03di-3490000000-4af5631898604d2cec10'}]}},\n",
       "         {'ReferenceNumber': 24,\n",
       "          'Name': 'Top 5 Peaks',\n",
       "          'Value': {'StringWithMarkup': [{'String': '211.168518 100'},\n",
       "            {'String': '212.169586 25.84'},\n",
       "            {'String': '96.056465 6.91'},\n",
       "            {'String': '211.644226 4.79'},\n",
       "            {'String': '168.125015 2.54'}]}},\n",
       "         {'ReferenceNumber': 24,\n",
       "          'Name': 'Thumbnail',\n",
       "          'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=211.168518:100,212.169586:25.84,96.056465:6.91,211.644226:4.79,168.125015:2.54',\n",
       "          'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=211.168518:100,212.169586:25.84,96.056465:6.91,211.644226:4.79,168.125015:2.54'],\n",
       "           'MimeType': 'image/svg'}},\n",
       "         {'ReferenceNumber': 24,\n",
       "          'Name': 'Notes',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'instrument=qTof'}]}},\n",
       "         {'ReferenceNumber': 25,\n",
       "          'Name': 'Spectra ID',\n",
       "          'URL': 'https://hmdb.ca/spectra/m_ms/451653',\n",
       "          'Value': {'StringWithMarkup': [{'String': '451653'}]}},\n",
       "         {'ReferenceNumber': 25,\n",
       "          'Name': 'Ionization Mode',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'positive'}]}},\n",
       "         {'ReferenceNumber': 25,\n",
       "          'Name': 'SPLASH',\n",
       "          'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=splash.splash%3D%3D%22splash10-03dj-9781100000-4553bbbe9a30a0391bb4%22',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'splash10-03dj-9781100000-4553bbbe9a30a0391bb4'}]}},\n",
       "         {'ReferenceNumber': 25,\n",
       "          'Name': 'Top 5 Peaks',\n",
       "          'Value': {'StringWithMarkup': [{'String': '211.166611 100'},\n",
       "            {'String': '96.056412 61.55'},\n",
       "            {'String': '212.167892 12.11'},\n",
       "            {'String': '168.124146 7.40'},\n",
       "            {'String': '181.118683 7.14'}]}},\n",
       "         {'ReferenceNumber': 25,\n",
       "          'Name': 'Thumbnail',\n",
       "          'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=211.166611:100,96.056412:61.55,212.167892:12.11,168.124146:7.40,181.118683:7.14',\n",
       "          'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=211.166611:100,96.056412:61.55,212.167892:12.11,168.124146:7.40,181.118683:7.14'],\n",
       "           'MimeType': 'image/svg'}},\n",
       "         {'ReferenceNumber': 25,\n",
       "          'Name': 'Notes',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'instrument=qTof'}]}},\n",
       "         {'ReferenceNumber': 36,\n",
       "          'Name': 'NIST Number',\n",
       "          'Value': {'Number': [1117649]}},\n",
       "         {'ReferenceNumber': 36,\n",
       "          'Name': 'Instrument Type',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'IT/ion trap'}]}},\n",
       "         {'ReferenceNumber': 36,\n",
       "          'Name': 'Collision Energy',\n",
       "          'Value': {'Number': [0]}},\n",
       "         {'ReferenceNumber': 36,\n",
       "          'Name': 'Spectrum Type',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'MS2'}]}},\n",
       "         {'ReferenceNumber': 36,\n",
       "          'Name': 'Precursor Type',\n",
       "          'Value': {'StringWithMarkup': [{'String': '[M+H]+'}]}},\n",
       "         {'ReferenceNumber': 36,\n",
       "          'Name': 'Precursor m/z',\n",
       "          'Value': {'Number': [211.1666]}},\n",
       "         {'ReferenceNumber': 36,\n",
       "          'Name': 'Total Peaks',\n",
       "          'Value': {'Number': [20]}},\n",
       "         {'ReferenceNumber': 36,\n",
       "          'Name': 'm/z Top Peak',\n",
       "          'Value': {'Number': [211.2]}},\n",
       "         {'ReferenceNumber': 36,\n",
       "          'Name': 'm/z 2nd Highest',\n",
       "          'Value': {'Number': [168.1]}},\n",
       "         {'ReferenceNumber': 36,\n",
       "          'Name': 'm/z 3rd Highest',\n",
       "          'Value': {'Number': [166.1]}},\n",
       "         {'ReferenceNumber': 36,\n",
       "          'Name': 'Thumbnail',\n",
       "          'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/290312_1'],\n",
       "           'MimeType': 'image/png'}}]},\n",
       "       {'TOCHeading': 'LC-MS',\n",
       "        'Description': 'Data from liquid chromatography-mass spectrometry (LC-MS) experiments.',\n",
       "        'URL': 'https://chem.libretexts.org/Bookshelves/General_Chemistry/Book%3A_Structure_and_Reactivity_in_Organic_Biological_and_Inorganic_Chemistry_(Schaller)/II%3A_Practical_Aspects_of_Structure_-_Purification_and_Spectroscopy/06%3A_Introductory_Mass_Spectrometry/6.03%3A_GC-MS_and_LC-MS',\n",
       "        'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection',\n",
       "          'NumberOfColumns': 2,\n",
       "          'ColumnContents': ['Name', 'Value']},\n",
       "         'ShowAtMost': 2},\n",
       "        'Information': [{'ReferenceNumber': 28,\n",
       "          'Name': 'MoNA ID',\n",
       "          'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/display/CCMSLIB00000078079',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'CCMSLIB00000078079'}]}},\n",
       "         {'ReferenceNumber': 28,\n",
       "          'Name': 'MS Category',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Experimental'}]}},\n",
       "         {'ReferenceNumber': 28,\n",
       "          'Name': 'MS Type',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'LC-MS'}]}},\n",
       "         {'ReferenceNumber': 28,\n",
       "          'Name': 'MS Level',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'MS2'}]}},\n",
       "         {'ReferenceNumber': 28,\n",
       "          'Name': 'Precursor Type',\n",
       "          'Value': {'StringWithMarkup': [{'String': '[M+H]+'}]}},\n",
       "         {'ReferenceNumber': 28,\n",
       "          'Name': 'Precursor m/z',\n",
       "          'Value': {'StringWithMarkup': [{'String': '211.167'}]}},\n",
       "         {'ReferenceNumber': 28,\n",
       "          'Name': 'Instrument',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'qTof'}]}},\n",
       "         {'ReferenceNumber': 28,\n",
       "          'Name': 'Ionization Mode',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'positive'}]}},\n",
       "         {'ReferenceNumber': 28,\n",
       "          'Name': 'Top 5 Peaks',\n",
       "          'Value': {'StringWithMarkup': [{'String': '211.168518 100'},\n",
       "            {'String': '212.169586 25.84'},\n",
       "            {'String': '96.056465 6.91'},\n",
       "            {'String': '211.644226 4.79'},\n",
       "            {'String': '168.125015 2.54'}]}},\n",
       "         {'ReferenceNumber': 28,\n",
       "          'Name': 'SPLASH',\n",
       "          'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=exists(splash.splash:%27splash10-03di-3490000000-4af5631898604d2cec10%27)',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'splash10-03di-3490000000-4af5631898604d2cec10'}]}},\n",
       "         {'ReferenceNumber': 28,\n",
       "          'Name': 'Thumbnail',\n",
       "          'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=211.168518:100,212.169586:25.84,96.056465:6.91,211.644226:4.79,168.125015:2.54',\n",
       "          'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=211.168518:100,212.169586:25.84,96.056465:6.91,211.644226:4.79,168.125015:2.54'],\n",
       "           'MimeType': 'image/svg'}}]}]},\n",
       "     {'TOCHeading': 'UV Spectra',\n",
       "      'Description': 'Ultraviolet (UV) spectroscopy (or Spectrophotometry) is an analytical technique used to measure how much a molecule absorbs light in the ultraviolet spectral region.  This technique is particularly useful to study aromatic, conjugated, and other substances containing a pi bond.  Modern ultraviolet spectrophotometers also cover the visible light range, in which case the technique is called ultraviolet-visible (UV-Vis) spectroscopy.',\n",
       "      'URL': 'https://chem.libretexts.org/Courses/Brevard_College/CHE_202%3A_Organic_Chemistry_II/05%3A_Structural__Determination_I/5.05%3A_Ultraviolet_and_visible_spectroscopy',\n",
       "      'Information': [{'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': [\"O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ:  Merck and Co., Inc., 2006., p. 57\"],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'UV max (ethanol): 226 nm (epsilon 49400)',\n",
       "           'Markup': [{'Start': 8,\n",
       "             'Length': 7,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/ethanol',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-702'}]}]}},\n",
       "       {'ReferenceNumber': 30,\n",
       "        'Name': 'UV Spectra',\n",
       "        'Value': {'StringWithMarkup': [{'String': '(Methanol) max = 227 Â± 2 nm E = 51,400 - 52,400',\n",
       "           'Markup': [{'Start': 1,\n",
       "             'Length': 8,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Methanol',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-887'}]}]}}]},\n",
       "     {'TOCHeading': 'IR Spectra',\n",
       "      'Description': 'Infrared spectroscopy (IR spectroscopy) is the spectroscopy that deals with the infrared region of the electromagnetic spectrum extending from 780 nm to about 20000 nm.  The IR spectra tells you what types of vibrational mode (motion) responses occur in a molecule interacting with infrared light.  It is used to help determine the functional groups in a molecule.',\n",
       "      'URL': 'https://chem.libretexts.org/Bookshelves/Physical_and_Theoretical_Chemistry_Textbook_Maps/Supplemental_Modules_(Physical_and_Theoretical_Chemistry)/Spectroscopy/Vibrational_Spectroscopy/Infrared_Spectroscopy',\n",
       "      'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection',\n",
       "        'NumberOfColumns': 2,\n",
       "        'ColumnContents': ['Name', 'Value']},\n",
       "       'ShowAtMost': 2},\n",
       "      'Section': [{'TOCHeading': 'ATR-IR Spectra',\n",
       "        'Description': 'Attenuated total reflection infrared (ATR-IR) spectral data.  ATR is a sampling technique that enables samples to be examined directly in the solid or liquid state without further preparation.  ATR-IR can be applied to the same chemical or biological systems as the transmission IR.  An advantage of ATR-IR over the transmission IR is the limited path length into the sample, because ATR-IR avoids the problem of strong attenuation of the IR signal in highly absorbing media such as aqueous solutions.',\n",
       "        'URL': 'https://chem.libretexts.org/Bookshelves/Analytical_Chemistry/Supplemental_Modules_(Analytical_Chemistry)/Instrumental_Analysis/Spectrometer/ATR-FTIR',\n",
       "        'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection',\n",
       "          'NumberOfColumns': 2,\n",
       "          'ColumnContents': ['Name', 'Value']},\n",
       "         'ShowAtMost': 2},\n",
       "        'Information': [{'ReferenceNumber': 41,\n",
       "          'Name': 'Source of Sample',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Aldrich'}]}},\n",
       "         {'ReferenceNumber': 41,\n",
       "          'Name': 'Catalog Number',\n",
       "          'Value': {'StringWithMarkup': [{'String': '549835'}]}},\n",
       "         {'ReferenceNumber': 41,\n",
       "          'Name': 'Copyright',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Copyright Â© 2018-2021 Sigma-Aldrich Co. LLC. - Database Compilation Copyright Â© 2018-2021 John Wiley & Sons, Inc. All Rights Reserved.'}]}},\n",
       "         {'ReferenceNumber': 41,\n",
       "          'Name': 'Thumbnail',\n",
       "          'URL': 'https://spectrabase.com/spectrum/4vJEUG2IL9D',\n",
       "          'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/10090122_1'],\n",
       "           'MimeType': 'image/png'}}]}]},\n",
       "     {'TOCHeading': 'Chromatograms',\n",
       "      'Description': 'Chromatograms are visible record (usually an image, such as a series of colored bands, or a graph) showing the result of separation of a mixture by chromatography.',\n",
       "      'URL': 'https://chem.libretexts.org/Courses/University_of_Kentucky/UK%3A_CHE_103_-_Chemistry_for_Allied_Health_(Soult)/Chapters/Chapter_5%3A_Properties_of_Compounds/5.4%3A_Chromatography',\n",
       "      'Section': [{'TOCHeading': 'GC',\n",
       "        'Description': 'Gas chromatography (GC) is a common type of chromatography used in analytical chemistry for separating and analyzing compounds that can be vaporized without decomposition.',\n",
       "        'URL': 'https://chem.libretexts.org/Bookshelves/Analytical_Chemistry/Supplemental_Modules_(Analytical_Chemistry)/Instrumental_Analysis/Chromatography/Gas_Chromatography',\n",
       "        'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection',\n",
       "          'NumberOfColumns': 2,\n",
       "          'ColumnContents': ['Name', 'Value']},\n",
       "         'ShowAtMost': 2},\n",
       "        'Information': [{'ReferenceNumber': 30,\n",
       "          'Name': 'GC',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Column: 10% SP -2100 on 80/120 Supelcoport; glass, 1.83 m x 2 mm i.d.\\nCarrier Gas: Helium\\nFlow Rate: 30 mL Helium/minute\\nTemperatures: Oven 155Â° C\\nIsothermal injector 250Â° C\\nDetector 250Â° C\\nDetection: Flame ionization\\nInternal Standard: Octadecane\\nRetention Times: 9.6 min (NSC - 13875)\\n17.8 min (I.S.)',\n",
       "             'Markup': [{'Start': 83,\n",
       "               'Length': 6,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Helium',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'Element-Helium'},\n",
       "              {'Start': 107,\n",
       "               'Length': 6,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Helium',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'Element-Helium'},\n",
       "              {'Start': 237,\n",
       "               'Length': 10,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Octadecane',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-11635'},\n",
       "              {'Start': 274,\n",
       "               'Length': 11,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/NSC-13875',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-2123'}]}]}}]}]}]},\n",
       "   {'TOCHeading': 'Related Records',\n",
       "    'Description': 'Records related to this compound.  This includes PubChem compound and substance records, as well as records in NCBI resources (e.g., PubMed, Gene, Protein Structure, and Taxonomy) and other databases external to NCBI.',\n",
       "    'Section': [{'TOCHeading': 'Related Compounds with Annotation',\n",
       "      'Description': 'Compound records that are closely related to this record AND that have biomedical annotations.  In essence, they are a subset of the compounds included in the \"Related Compounds\" section below this section.  The \"Related Compounds\" include the parent, components, mixtures, and salt forms of this compound record as well as the \"similar compounds\" and \"similar conformers\", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.',\n",
       "      'URL': 'https://doi.org/10.1186/s13321-016-0163-1',\n",
       "      'Information': [{'ReferenceNumber': 50, 'Value': {'Boolean': [True]}}]},\n",
       "     {'TOCHeading': 'Related Compounds',\n",
       "      'Description': 'Compound records closely related to this record.  It includes compounds which are the parent, components, mixtures, and salt forms of this compound record.  It also includes the \"similar compounds\" and \"similar conformers\", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.',\n",
       "      'URL': 'https://doi.org/10.1186/s13321-016-0163-1',\n",
       "      'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection',\n",
       "        'NumberOfColumns': 2,\n",
       "        'ColumnContents': ['Name', 'Value']},\n",
       "       'ShowAtMost': 1},\n",
       "      'Information': [{'ReferenceNumber': 50,\n",
       "        'Name': 'Same Connectivity Count',\n",
       "        'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/2123/cids/JSON?cids_type=same_connectivity&list_return=redirect',\n",
       "        'Value': {'Number': [10]}},\n",
       "       {'ReferenceNumber': 50,\n",
       "        'Name': 'Same Parent, Connectivity Count',\n",
       "        'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/2123/cids/JSON?cids_type=same_parent_connectivity&list_return=redirect',\n",
       "        'Value': {'Number': [28]}},\n",
       "       {'ReferenceNumber': 50,\n",
       "        'Name': 'Same Parent, Exact Count',\n",
       "        'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/2123/cids/JSON?cids_type=same_parent&list_return=redirect',\n",
       "        'Value': {'Number': [19]}},\n",
       "       {'ReferenceNumber': 50,\n",
       "        'Name': 'Mixtures, Components, and Neutralized Forms Count',\n",
       "        'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/2123/cids/JSON?cids_type=component&list_return=redirect',\n",
       "        'Value': {'Number': [92]}},\n",
       "       {'ReferenceNumber': 50,\n",
       "        'Name': 'Similar Compounds Count',\n",
       "        'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/2123/cids/JSON?cids_type=similar_2d&list_return=redirect',\n",
       "        'Value': {'Number': [35]}},\n",
       "       {'ReferenceNumber': 50,\n",
       "        'Name': 'Similar Conformers Count',\n",
       "        'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/2123/cids/JSON?cids_type=similar_3d&list_return=redirect',\n",
       "        'Value': {'Number': [752]}}]},\n",
       "     {'TOCHeading': 'Substances',\n",
       "      'Description': 'Substance records associated with this compound.  In PubChem, the term \"substance\" refers to depositor-provided data for a chemical..',\n",
       "      'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/substances',\n",
       "      'Section': [{'TOCHeading': 'Related Substances',\n",
       "        'Description': 'Substance records related to this compound (e.g., the standardized chemical structures of these substances are the same as this compound or correspond to a mixture containing this compound as a component).',\n",
       "        'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection',\n",
       "          'NumberOfColumns': 2,\n",
       "          'ColumnContents': ['Name', 'Value']},\n",
       "         'ShowAtMost': 1},\n",
       "        'Information': [{'ReferenceNumber': 50,\n",
       "          'Name': 'All Count',\n",
       "          'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/2123/sids/JSON?sids_type=all&list_return=redirect',\n",
       "          'Value': {'Number': [435]}},\n",
       "         {'ReferenceNumber': 50,\n",
       "          'Name': 'Same Count',\n",
       "          'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/2123/sids/JSON?sids_type=standardized&list_return=redirect',\n",
       "          'Value': {'Number': [290]}},\n",
       "         {'ReferenceNumber': 50,\n",
       "          'Name': 'Mixture Count',\n",
       "          'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/2123/sids/JSON?sids_type=component&list_return=redirect',\n",
       "          'Value': {'Number': [145]}}]},\n",
       "       {'TOCHeading': 'Substances by Category',\n",
       "        'Description': 'Substances associated with this compound, grouped by the category of the data sources who submitted the substances to PubChem (e.g., government organizations, chemical vendors, research and development, curation efforts, NIH initiatives, etc.).',\n",
       "        'Information': [{'ReferenceNumber': 50,\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Chemical Vendors'},\n",
       "            {'String': 'Curation Efforts'},\n",
       "            {'String': 'Governmental Organizations'},\n",
       "            {'String': 'Journal Publishers'},\n",
       "            {'String': 'Legacy Depositors'},\n",
       "            {'String': 'NIH Initiatives'},\n",
       "            {'String': 'Research and Development'},\n",
       "            {'String': 'Subscription Services'}]}}]}]},\n",
       "     {'TOCHeading': 'Entrez Crosslinks',\n",
       "      'Description': 'Cross-references to associated records in other Entrez databases such as PubMed, Gene, Protein, etc.',\n",
       "      'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection',\n",
       "        'NumberOfColumns': 2,\n",
       "        'ColumnContents': ['Name', 'Value']},\n",
       "       'ShowAtMost': 1},\n",
       "      'Information': [{'ReferenceNumber': 50,\n",
       "        'Name': 'PubMed Count',\n",
       "        'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed&db=pccompound&cmd=Link&from_uid=2123',\n",
       "        'Value': {'Number': [50]}},\n",
       "       {'ReferenceNumber': 50,\n",
       "        'Name': 'Taxonomy Count',\n",
       "        'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_taxonomy&db=pccompound&cmd=Link&from_uid=2123',\n",
       "        'Value': {'Number': [1]}},\n",
       "       {'ReferenceNumber': 50,\n",
       "        'Name': 'OMIM Count',\n",
       "        'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_omim&db=pccompound&cmd=Link&from_uid=2123',\n",
       "        'Value': {'Number': [2]}},\n",
       "       {'ReferenceNumber': 50,\n",
       "        'Name': 'Gene Count',\n",
       "        'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_gene&db=pccompound&cmd=Link&from_uid=2123',\n",
       "        'Value': {'Number': [1]}}]},\n",
       "     {'TOCHeading': 'NCBI LinkOut',\n",
       "      'Description': 'NCBI LinkOut is a service that allows one to link directly from NCBI databases to a wide range of information and services beyond NCBI systems.',\n",
       "      'URL': 'https://www.ncbi.nlm.nih.gov/projects/linkout/',\n",
       "      'Information': [{'ReferenceNumber': 70,\n",
       "        'Value': {'Boolean': [True]}}]}]},\n",
       "   {'TOCHeading': 'Chemical Vendors',\n",
       "    'Description': \"A list of chemical vendors that sell this compound. Note that the order of chemical vendors on the list is randomized, and that PubChem do not endorse any of the vendors. Each vendor may have multiple products containing the same chemical, but different in various aspects, such as amount and purity.  For each product, the external identifier used to locate the product on the vendor's website is provided under the Purchasable Chemical column, and clicking this identifier directs you to the vendor's website.  The information on the product provided by the vendor to PubChem can be accessed at the Summary page of the corresponding PubChem Substance ID (SID).  \",\n",
       "    'Information': [{'ReferenceNumber': 50, 'Value': {'Boolean': [True]}}]},\n",
       "   {'TOCHeading': 'Drug and Medication Information',\n",
       "    'Description': 'This section provides drug and medication information for this compound, including drug indications, labeling, clinical trials, idiosyncrasies, tolerance, reported fatal doses, etc.',\n",
       "    'Section': [{'TOCHeading': 'Drug Indication',\n",
       "      'Description': 'A drug indication refers to any valid reason (e.g., signs/symptoms or diseases/disorders) to use a certain drug.  Many indications are label indications, approved by a regulatory agency (e.g., the U.S. Food and Drug Administration or European Medical Agency), meaning that the manufacturer is allowed to market the drug for the approved indications.  However, some indications are not approved, and therefore, they are called off-label indications.  This section may include both label indications and off-label indications.',\n",
       "      'DisplayControls': {'ShowAtMost': 3},\n",
       "      'Information': [{'ReferenceNumber': 12,\n",
       "        'Value': {'StringWithMarkup': [{'String': 'For use as a single agent in the palliative treatment of patients with persistent or recurrent ovarian cancer following first-line therapy with a cisplatin and/or alkylating agent-based combination.',\n",
       "           'Markup': [{'Start': 146,\n",
       "             'Length': 9,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/cisplatin',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-5702198'}]}]}}]},\n",
       "     {'TOCHeading': 'LiverTox Summary',\n",
       "      'Description': 'Summary of liver toxicity for this compound, provided by LiverTox.  This section provides an overview of drug induced liver injury, diagnostic criteria, assessment of causality and severity, descriptions of different clinical patterns (phenotypes), information on management and treatment, and standardized nomenclature.  The role of liver biopsy and major histological patterns of drug induced liver disease are also given.',\n",
       "      'URL': 'https://www.ncbi.nlm.nih.gov/books/NBK547852/',\n",
       "      'Information': [{'ReferenceNumber': 27,\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Altretamine is an orally administered alkylating agent, formerly known as hexamethylmelamine, which is currently used as a secondary therapy for advanced ovarian carcinoma. Altretamine therapy has been associated with low rates of serum enzyme elevations during therapy and with rare instances of acute, clinically apparent injury.',\n",
       "           'Markup': [{'Start': 0,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'},\n",
       "            {'Start': 74,\n",
       "             'Length': 18,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/hexamethylmelamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'},\n",
       "            {'Start': 173,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}}]},\n",
       "     {'TOCHeading': 'Drug Classes',\n",
       "      'Description': 'Drug classes of this compound, based on its therapeutic uses and/or structure.  The data presented in this section is from LiverTox.',\n",
       "      'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/15404',\n",
       "      'Information': [{'ReferenceNumber': 27,\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Antineoplastic Agents, Alkylating Agents'}]}}]},\n",
       "     {'TOCHeading': 'FDA Orange Book',\n",
       "      'Description': 'The Orange Book identifies drug products approved on the basis of safety and effectiveness by the U.S. Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act and and related patent and exclusivity information.',\n",
       "      'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book',\n",
       "      'Information': [{'ReferenceNumber': 19,\n",
       "        'Value': {'ExternalTableName': 'fdaorangebook',\n",
       "         'ExternalTableNumRows': 1}}]},\n",
       "     {'TOCHeading': 'Clinical Trials',\n",
       "      'Description': 'Clinical trials are research studies performed in people to evaluate a medical, surgical, or behavioral intervention. They are the primary way that researchers find out if a new treatment (e.g., a drug or diet) or medical device (e.g., a pacemaker) is safe and effective in people.  This section provides information on clinical trials for this chemical.',\n",
       "      'Section': [{'TOCHeading': 'ClinicalTrials.gov',\n",
       "        'Description': 'Brief clinical trials summary from ClinicalTrials.gov at the U.S. National Library of Medicine.',\n",
       "        'URL': 'http://clinicaltrials.gov/',\n",
       "        'Information': [{'ReferenceNumber': 8,\n",
       "          'Name': 'ClinicalTrials.gov',\n",
       "          'Value': {'ExternalTableName': 'clinicaltrials',\n",
       "           'ExternalTableNumRows': 1}}]}]},\n",
       "     {'TOCHeading': 'Therapeutic Uses',\n",
       "      'Description': 'Therapeutic uses information for this compound, provided by the Hazardous Substances Data Bank (HSDB).',\n",
       "      'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/11933',\n",
       "      'Information': [{'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': [\"O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ:  Merck and Co., Inc., 2006., p. 57\"],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Antineoplastic'}]}},\n",
       "       {'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': ['Thomson/Micromedex. Drug Information for the Health Care  Professional. Volume 1,  Greenwood Village, CO. 2007.'],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Altretamine is indicated for use as a single agent in the palliative treatment of patients with persistent or recurrent epithelial ovarian cancer following first-line therapy with a cisplatin- and/or alkylating agent-based combination. /Included in US product label/',\n",
       "           'Markup': [{'Start': 0,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'},\n",
       "            {'Start': 182,\n",
       "             'Length': 9,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/cisplatin',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-5702198'}]}]}},\n",
       "       {'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': ['Thomson/Micromedex. Drug Information for the Health Care  Professional. Volume 1,  Greenwood Village, CO. 2007.'],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Altretamine, in combination therapy, is considered reasonable medical therapy at some point in the management of small cell lung carcinoma (Evidence rating: IA). /Not included in US product label/',\n",
       "           'Markup': [{'Start': 0,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}}]},\n",
       "     {'TOCHeading': 'Drug Warnings',\n",
       "      'Description': 'Drug warnings information collected by the Hazardous Substances Data Bank (HSDB) from various sources, including US Pharmacopeia (USP), physicians desk references, MSDS, etc.',\n",
       "      'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/11933',\n",
       "      'Information': [{'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': ['Thomson/Micromedex. Drug Information for the Health Care  Professional. Volume 1,  Greenwood Village, CO. 2007.'],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Secondary malignancies are potential delayed effects of many antineoplastic agents, although it is not clear whether the effect is related to their mutagenic or immunosuppressive action. The effect of dose and duration of therapy is also unknown, although risk seems to increase with long-term use. Although information is limited, available data seem to indicate that the carcinogenic risk is greatest with the alkylating agents.'}]}},\n",
       "       {'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': ['Thomson/Micromedex. Drug Information for the Health Care  Professional. Volume 1,  Greenwood Village, CO. 2007.'],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'The bone marrow depressant effects of altretamine may result in an increased incidence of microbial infection, delayed healing, and gingival bleeding. Dental work, whenever possible, should be completed prior to initiation of therapy or deferred until blood counts have returned to normal. Patients should be instructed in proper oral hygiene during treatment, including caution in use of regular toothbrushes, dental floss, and toothpicks.',\n",
       "           'Markup': [{'Start': 38,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}},\n",
       "       {'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': ['Thomson/Micromedex. Drug Information for the Health Care  Professional. Volume 1,  Greenwood Village, CO. 2007.'],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Adverse events ... indicating the need for medical attention /occurring/ at an incidence more frequent: Anemia (unusual tiredness); leukopenia (fever or chills; cough or hoarseness; lower back or side pain; painful or difficult urination); neurotoxicity, including central nervous system (CNS) effects (anxiety; clumsiness; confusion; dizziness; mental depression; weakness; seizures); neurotoxicity, including peripheral neuropathy (numbness in arms or legs); thrombocytopenia (unusual bleeding or bruising; black, tarry stools; blood in urine or stools; pinpoint red spots on skin). Incidence /occurring/ rarely Hepatotoxicity; skin rash or itching.'}]}},\n",
       "       {'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': ['Thomson/Micromedex. Drug Information for the Health Care  Professional. Volume 1,  Greenwood Village, CO. 2007.'],\n",
       "        'Value': {'StringWithMarkup': [{'String': '/Altretamine is/ contraindicated in patients with known sensitivity to altretamine.',\n",
       "           'Markup': [{'Start': 1,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'},\n",
       "            {'Start': 71,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}},\n",
       "       {'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Value': {'StringWithMarkup': [{'String': 'For more Drug Warnings (Complete) data for ALTRETAMINE (11 total), please visit the HSDB record page.',\n",
       "           'Markup': [{'Start': 84,\n",
       "             'Length': 16,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/hsdb/7559#section=Drug-Warnings-(Complete)'},\n",
       "            {'Start': 43,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/ALTRETAMINE',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}}]}]},\n",
       "   {'TOCHeading': 'Pharmacology and Biochemistry',\n",
       "    'Description': 'Pharmacology and biochemistry information related to this compound, including the pharmacodynamics, pharmacokinetics, metabolism, mechanism of action, biological half-life, biochemical reactions, and many others.',\n",
       "    'Section': [{'TOCHeading': 'Pharmacodynamics',\n",
       "      'Description': 'Pharmacodynamic information for this compound as a drug (i.e., what does this drug do to the body).  Pharmacodynamics is the study of the biochemical, physiologic, and molecular effects of drugs on the body.',\n",
       "      'URL': 'https://www.ncbi.nlm.nih.gov/books/NBK507791/',\n",
       "      'Information': [{'ReferenceNumber': 12,\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Altretamine is a novel antineoplastic agent. The precise mechanism by which altretamine exerts its cytotoxic effect is unknown, although a number of theoretical possibilities have been studied. Structurally, altretamine resembles the alkylating agent triethylenemelamine, yet <i>in vitro</i> tests for alkylating activity of altretamine and its metabolitics have been negative. Altretamine has been demonstrated to be efficacious for certain ovarian tumors resistant to classical alkylating agents. Metabolism of altretamine is a requirement of cytotoxicity. Synthetic monohydroxymethylmelamines, and products of altretamine metabolism, <i>in vitro</i> and <i>in vivo</i>, can form covalent adducts with tissue macromolecules including DNA, but the relevance of these reactions to antitumor activity is unknown.',\n",
       "           'Markup': [{'Start': 0,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'},\n",
       "            {'Start': 76,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'},\n",
       "            {'Start': 208,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'},\n",
       "            {'Start': 251,\n",
       "             'Length': 19,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/triethylenemelamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-5799'},\n",
       "            {'Start': 325,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'},\n",
       "            {'Start': 378,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'},\n",
       "            {'Start': 513,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'},\n",
       "            {'Start': 613,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}}]},\n",
       "     {'TOCHeading': 'MeSH Pharmacological Classification',\n",
       "      'Description': 'Pharmacological action classes from the Medical Subject Headings (MeSH) thesaurus.',\n",
       "      'URL': 'https://meshb.nlm.nih.gov/record/ui?ui=D020228',\n",
       "      'Information': [{'ReferenceNumber': 68,\n",
       "        'Name': 'Antineoplastic Agents, Alkylating',\n",
       "        'Value': {'StringWithMarkup': [{'String': 'A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)',\n",
       "           'Markup': [{'Start': 563,\n",
       "             'Length': 61,\n",
       "             'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?Db=pccompound&DbFrom=mesh&Cmd=Link&LinkName=mesh_pccompound&IdsFromResult=68018906'}]}]}}]},\n",
       "     {'TOCHeading': 'FDA Pharmacological Classification',\n",
       "      'Description': 'Pharmacologic Class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of three attributes of the active moiety: mechanism of action (MOA), physiologic effect (PE) and chemical structure (CS).  An FDA \"Established Pharmacologic Class\" (EPC) text phrase is a pharmacologic class associated with an approved indication of an active moiety that the FDA has determined to be scientifically valid and clinically meaningful.',\n",
       "      'URL': 'https://www.fda.gov/industry/structured-product-labeling-resources/pharmacologic-class',\n",
       "      'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection',\n",
       "        'NumberOfColumns': 2,\n",
       "        'ColumnContents': ['Name', 'Value']}},\n",
       "      'Information': [{'ReferenceNumber': 20,\n",
       "        'Name': 'FDA UNII',\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Q8BIH59O7H'}]}},\n",
       "       {'ReferenceNumber': 20,\n",
       "        'Name': 'Active Moiety',\n",
       "        'Value': {'StringWithMarkup': [{'String': 'ALTRETAMINE'}]}},\n",
       "       {'ReferenceNumber': 20,\n",
       "        'Name': 'Pharmacological Classes',\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Mechanisms of Action [MoA] - Alkylating Activity'}]}},\n",
       "       {'ReferenceNumber': 20,\n",
       "        'Name': 'Pharmacological Classes',\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Established Pharmacologic Class [EPC] - Alkylating Drug'}]}},\n",
       "       {'ReferenceNumber': 20,\n",
       "        'Name': 'FDA Pharmacology Summary',\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Altretamine is an Alkylating Drug. The mechanism of action of altretamine is as an Alkylating Activity.',\n",
       "           'Markup': [{'Start': 0,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'},\n",
       "            {'Start': 62,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}}]},\n",
       "     {'TOCHeading': 'ATC Code',\n",
       "      'Description': 'The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of drugs. This pharmaceutical coding system divides drugs into different groups according to the organ or system on which they act and/or their therapeutic and chemical characteristics. Each bottom-level ATC code stands for a pharmaceutically used substance, or a combination of substances, in a single indication (or use). This means that one drug can have more than one code: acetylsalicylic acid (aspirin), for example, has A01AD05 as a drug for local oral treatment, B01AC06 as a platelet inhibitor, and N02BA01 as an analgesic and antipyretic. On the other hand, several different brands share the same code if they have the same active substance and indications.',\n",
       "      'URL': 'https://www.whocc.no/atc/structure_and_principles/',\n",
       "      'Information': [{'ReferenceNumber': 46,\n",
       "        'Value': {'StringWithMarkup': [{'String': 'L - Antineoplastic and immunomodulating agents',\n",
       "           'Markup': [{'Start': 0,\n",
       "             'Length': 1,\n",
       "             'URL': 'https://www.whocc.no/atc_ddd_index/?code=L'}]},\n",
       "          {'String': 'L01 - Antineoplastic agents',\n",
       "           'Markup': [{'Start': 0,\n",
       "             'Length': 3,\n",
       "             'URL': 'https://www.whocc.no/atc_ddd_index/?code=L01'}]},\n",
       "          {'String': 'L01X - Other antineoplastic agents',\n",
       "           'Markup': [{'Start': 0,\n",
       "             'Length': 4,\n",
       "             'URL': 'https://www.whocc.no/atc_ddd_index/?code=L01X'}]},\n",
       "          {'String': 'L01XX - Other antineoplastic agents',\n",
       "           'Markup': [{'Start': 0,\n",
       "             'Length': 5,\n",
       "             'URL': 'https://www.whocc.no/atc_ddd_index/?code=L01XX'}]},\n",
       "          {'String': 'L01XX03 - Altretamine',\n",
       "           'Markup': [{'Start': 0,\n",
       "             'Length': 7,\n",
       "             'URL': 'https://www.whocc.no/atc_ddd_index/?code=L01XX03'}]}]}}]},\n",
       "     {'TOCHeading': 'Absorption, Distribution and Excretion',\n",
       "      'Information': [{'ReferenceNumber': 12,\n",
       "        'Name': 'Route of Elimination',\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Human urinary metabolites were Ndemethylated homologues of altretamine with <1% unmetabolized altretamine excreted at 24 hours.',\n",
       "           'Markup': [{'Start': 59,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}},\n",
       "       {'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': ['Thomson/Micromedex. Drug Information for the Health Care  Professional. Volume 1,  Greenwood Village, CO. 2007.'],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Rapidly and well-absorbed following oral administration; however, because of rapid hepatic metabolism, peak plasma concentrations are variable.'}]}},\n",
       "       {'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': ['PMID:7656502',\n",
       "         'Damia G et al; Clin Pharmacokinet 28 (6): 439-48 (1995)'],\n",
       "        'Value': {'StringWithMarkup': [{'String': '... The inter-hand intrapatient variability of the bioavailability of altretamine after oral administration represents an important drawback for effective clinical use of this drug. The variability appears to be mostly related to the first-pass effect and therefore may be overcome by intravenous administration of the drug. Attempts to administer the drug intravenously have not been successful in the past...',\n",
       "           'Markup': [{'Start': 70,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}},\n",
       "       {'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': ['Thomson/Micromedex. Drug Information for the Health Care  Professional. Volume 1,  Greenwood Village, CO. 2007.'],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Because it is highly lipid-soluble, altretamine is distributed to tissues with a high lipid component (e.g., omentum and subcutaneous tissues).',\n",
       "           'Markup': [{'Start': 36,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}},\n",
       "       {'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': ['Thomson/Micromedex. Drug Information for the Health Care  Professional. Volume 1,  Greenwood Village, CO. 2007.'],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Protein binding: Free fractions: Altretamine: 6%; Pentamethylmelamine: 25%; Tetramethylmelamine: 50%.',\n",
       "           'Markup': [{'Start': 33,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'},\n",
       "            {'Start': 50,\n",
       "             'Length': 19,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Pentamethylmelamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-27775'},\n",
       "            {'Start': 76,\n",
       "             'Length': 19,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tetramethylmelamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-17805'}]}]}},\n",
       "       {'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Value': {'StringWithMarkup': [{'String': 'For more Absorption, Distribution and Excretion (Complete) data for ALTRETAMINE (10 total), please visit the HSDB record page.',\n",
       "           'Markup': [{'Start': 109,\n",
       "             'Length': 16,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/hsdb/7559#section=Absorption-Distribution-and-Excretion-(Complete)'},\n",
       "            {'Start': 68,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/ALTRETAMINE',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}}]},\n",
       "     {'TOCHeading': 'Metabolism/Metabolites',\n",
       "      'Description': 'Metabolites are substances made or used when the body breaks down food, drugs or chemicals, or its own tissue (for example, fat or muscle tissue). This process is called metabolism and makes energy and the materials needed for growth, reproduction, and maintaining health. Metabolism also helps get rid of toxic substances.',\n",
       "      'Information': [{'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': ['Thomson/Micromedex. Drug Information for the Health Care  Professional. Volume 1,  Greenwood Village, CO. 2007.'],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Biotransformation /is/ Hepatic. Metabolism is required for activity. Altretamine undergoes rapid and extensive demethylation, catalyzed by cytochrome P450 enzymes.',\n",
       "           'Markup': [{'Start': 69,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}},\n",
       "       {'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': ['PMID:6411375',\n",
       "         'Garattini E, Colombo T et al; Cancer Chemother Pharmacol 11 (1): 51-5 (1983)'],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'The covalent binding of hexamethylmelamine (HMM) and its metabolites was studied in liver, tumor, blood, kidney, spleen, lung, brain, heart, and small intestine after a single ip injection of 2,4,6-14C-hexamethylmelamine (50 mg/kg) to C57Bl/6J female mice bearing 20-day-old M5076/73A ovarian cancer. ...  HMM metabolism was also studied. Tissue distribution of pentamethylmelamine (PMM), 2,2,4,6-tetramethylmelamine (TMM), and 2,4,6-trimethylmelamine (TriMM) was determined at the three times considered. At 2 hr the drug was already extensively metabolized, TriMM being the major metabolite among those determined.',\n",
       "           'Markup': [{'Start': 24,\n",
       "             'Length': 18,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/hexamethylmelamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'},\n",
       "            {'Start': 362,\n",
       "             'Length': 19,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/pentamethylmelamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-27775'},\n",
       "            {'Start': 389,\n",
       "             'Length': 27,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/2%2C2%2C4%2C6-tetramethylmelamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-27774'},\n",
       "            {'Start': 428,\n",
       "             'Length': 23,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/2%2C4%2C6-trimethylmelamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-17804'},\n",
       "            {'Start': 453,\n",
       "             'Length': 5,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/TriMM',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-17804'},\n",
       "            {'Start': 560,\n",
       "             'Length': 5,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/TriMM',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-17804'}]}]}},\n",
       "       {'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': ['PMID:7656502',\n",
       "         'Damia G et al; Clin Pharmacokinet 28 (6): 439-48 (1995)'],\n",
       "        'Value': {'StringWithMarkup': [{'String': '... In all animal species, including humans, altretamine undergoes oxidative N-demethylation with the formation of hydroxymethyl derivatives as intermediates. Hydroxymethylmelamines are believed to be responsible for the cytotoxic and antitumour activity of the drug. ...',\n",
       "           'Markup': [{'Start': 45,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}},\n",
       "       {'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': ['PMID:6814076',\n",
       "         'Colombo T, Broggini M et al; Xenobiotica 12 (5): 315-21 (1982)'],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'In the rat 40% of a dose of 25 mg/kg of hexamethylmelamine or pentamethylmelamine was excreted in the urine as metabolites, more than 95% of which were N2N4-dimethylmelamine and monomethylmelamine. Biliary excretion of hexamethylmelamine or pentamethylmelamine and their N-demethylated metabolites accounted for less than 2% of the administered dose. Only 3% was excreted with the feces, suggesting that there is intestinal reabsorption of a portion of the methylmelamines passing into the bile. Conjugates of methylmelamines with glucuronic acid or sulphate were found only in minute quantities in the urine or bile of rats treated with hexamethylmelamine or pentamethylmelamine. However a conjugation product of pentamethylmelamine, of as yet unknown nature, is a major metabolite after pentamethylmelamine treatment.',\n",
       "           'Markup': [{'Start': 40,\n",
       "             'Length': 18,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/hexamethylmelamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'},\n",
       "            {'Start': 62,\n",
       "             'Length': 19,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/pentamethylmelamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-27775'},\n",
       "            {'Start': 157,\n",
       "             'Length': 16,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/dimethylmelamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-16134'},\n",
       "            {'Start': 178,\n",
       "             'Length': 18,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/monomethylmelamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-26029'},\n",
       "            {'Start': 219,\n",
       "             'Length': 18,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/hexamethylmelamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'},\n",
       "            {'Start': 241,\n",
       "             'Length': 19,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/pentamethylmelamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-27775'},\n",
       "            {'Start': 531,\n",
       "             'Length': 15,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/glucuronic%20acid',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-94715'},\n",
       "            {'Start': 550,\n",
       "             'Length': 8,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/sulphate',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-1117'},\n",
       "            {'Start': 638,\n",
       "             'Length': 18,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/hexamethylmelamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'},\n",
       "            {'Start': 660,\n",
       "             'Length': 19,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/pentamethylmelamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-27775'},\n",
       "            {'Start': 714,\n",
       "             'Length': 19,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/pentamethylmelamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-27775'},\n",
       "            {'Start': 789,\n",
       "             'Length': 19,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/pentamethylmelamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-27775'}]}]}}]},\n",
       "     {'TOCHeading': 'Biological Half-Life',\n",
       "      'Description': 'The time required for a biological system (e.g., human body) to eliminate, by natural processes, half of the amount of a chemical (e.g., alcohol, medication, or radioactive material) that has entered it.',\n",
       "      'Information': [{'ReferenceNumber': 12,\n",
       "        'Value': {'StringWithMarkup': [{'String': '4.7-10.2 hours'}]}},\n",
       "       {'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': ['Thomson/Micromedex. Drug Information for the Health Care  Professional. Volume 1,  Greenwood Village, CO. 2007.'],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Elimination /half-life/-Beta-phase: Range, 4.7 to 10.2 hours.'}]}}]},\n",
       "     {'TOCHeading': 'Mechanism of Action',\n",
       "      'Description': 'In medicine, the term \"mechanism of action\" (also called MOA) is used to describe how a drug or other substance produces an effect in the body. For example, a drug\\'s mechanism of action could be how it affects a specific target in a cell, such as an enzyme, or a cell function, such as cell growth. Knowing the mechanism of action of a drug may help provide information about the safety of the drug and how it affects the body. It may also help identify the right dose of a drug and which patients are most likely to respond to treatment.',\n",
       "      'Information': [{'ReferenceNumber': 12,\n",
       "        'Value': {'StringWithMarkup': [{'String': 'The precise mechanism by which altretamine exerts its cytotoxic effect is unknown although it is classified as an alkylating anti-neoplastic agent. Through this mechanism, the drug is metabolized into alkylating agents by N-demethylation. These alkylating species consequently damage tumor cells.',\n",
       "           'Markup': [{'Start': 31,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}},\n",
       "       {'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': ['Thomson/Micromedex. Drug Information for the Health Care  Professional. Volume 1,  Greenwood Village, CO. 2007.'],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'The exact mechanism of action is unknown. Although altretamine structurally resembles an alkylating agent, it has not been found to have alkylating activity in vitro. There is some evidence that it may inhibit DNA and RNA synthesis.',\n",
       "           'Markup': [{'Start': 51,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}},\n",
       "       {'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': ['PMID:7763301',\n",
       "         'Coley H, Brooks N et al; Biochem Pharmacol 49 (9): 1203-12 (1995)'],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'The hexamethylmelamine analogue trimelamol (tris-hydroxymethyl[trimethyl]melamine) and its equicytotoxic stable analogues CB 7547, CB 7639 and CB 7669 have been used to clarify the mechanism of action for the N-(hydroxymethyl)melamines as antitumour agents. Two main mechanisms have been proposed and explored: (i) formation of a reactive iminium species forming covalent adducts with DNA; and (ii) local formaldehyde release leading to cytotoxic damage. 32P-postlabelling and thermal denaturation experiments showed these compounds to be interactive with cytosine and guanine. Trimelamol gave rise to DNA-interstrand crosslinks in naked plasmid DNA and in cultured cell lines, whereas the analogues failed to do so under a variety of experimental conditions. Along with our observations that cell lines with acquired resistance to the N-(hydroxymethyl)melamines showed no significant cross-resistance to classical bifunctional alkylating agents, DNA crosslinking may play only a minor role in their mechanism of action. In cultured cell lines treatment with formaldehyde, trimelamol and CB 7639 gave rise to high levels of DNA-protein crosslinks with a gradual disappearance over a 24 hr period. Along with ... earlier observations that resistance to trimelamol coincides with cross-resistance to formaldehyde, /investigators/ conclude that formaldehyde-release may be an important factor in their cytotoxicity. Further, the cytotoxicity of trimelamol or formaldehyde towards human ovarian cancer cells was not influenced by glutathione depletion. /N-(hydroxymethyl)melamines/',\n",
       "           'Markup': [{'Start': 4,\n",
       "             'Length': 18,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/hexamethylmelamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'},\n",
       "            {'Start': 32,\n",
       "             'Length': 10,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/trimelamol',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-92368'},\n",
       "            {'Start': 405,\n",
       "             'Length': 12,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/formaldehyde',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-712'},\n",
       "            {'Start': 556,\n",
       "             'Length': 8,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/cytosine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-597'},\n",
       "            {'Start': 569,\n",
       "             'Length': 7,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/guanine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-135398634'},\n",
       "            {'Start': 578,\n",
       "             'Length': 10,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Trimelamol',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-92368'},\n",
       "            {'Start': 1059,\n",
       "             'Length': 12,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/formaldehyde',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-712'},\n",
       "            {'Start': 1073,\n",
       "             'Length': 10,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/trimelamol',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-92368'},\n",
       "            {'Start': 1252,\n",
       "             'Length': 10,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/trimelamol',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-92368'},\n",
       "            {'Start': 1298,\n",
       "             'Length': 12,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/formaldehyde',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-712'},\n",
       "            {'Start': 1342,\n",
       "             'Length': 12,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/formaldehyde',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-712'},\n",
       "            {'Start': 1442,\n",
       "             'Length': 10,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/trimelamol',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-92368'},\n",
       "            {'Start': 1456,\n",
       "             'Length': 12,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/formaldehyde',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-712'},\n",
       "            {'Start': 1526,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/glutathione',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-124886'}]}]}}]},\n",
       "     {'TOCHeading': 'Human Metabolite Information',\n",
       "      'Description': 'Information on metabolites generated from this compound in the human body.  The data in this section is from the Human Metabolome Database.',\n",
       "      'URL': 'https://hmdb.ca/',\n",
       "      'Section': [{'TOCHeading': 'Cellular Locations',\n",
       "        'Description': 'Cellular locations of this compound or its metabolites (e.g., cytoplasm, nucleus, lysosome, mitochondria, membrane, extracelluar).',\n",
       "        'DisplayControls': {'ListType': 'Columns'},\n",
       "        'Information': [{'ReferenceNumber': 22,\n",
       "          'Name': 'Cellular Locations',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Cytoplasm'}]}}]}]},\n",
       "     {'TOCHeading': 'Transformations',\n",
       "      'Description': 'Transformations indicate that a compound (predecessor) is transformed into another compound (successor) through a particular process (such as metabolism or fermentation) or medium (such as an animal or plant). The specificity of a transformation may vary depending on the available scientific evidence. A transformation may involve a series or cascade of changes between the predecessor (reactant) and successor (product). The presence of a successor in a sample may imply the predecessor. Predecessor: chemical being transformed. Transformation: process or medium. Successor: transformation product of predecessor. Evidence: the publication providing evidence for this transformation. Dataset: the integrated content containing the transformation information. Source: the entity or group that compiled the dataset containing the transformation information.',\n",
       "      'Information': [{'ReferenceNumber': 5,\n",
       "        'Value': {'ExternalTableName': 'collection=chemblmetabolism&view=concise_cid'}}]}]},\n",
       "   {'TOCHeading': 'Use and Manufacturing',\n",
       "    'Description': 'This section provides information on the use and manufacturing information for this chemical, such as uses, consumption patterns, manufacturing methods, and U.S. imports/exports/production.',\n",
       "    'Section': [{'TOCHeading': 'Uses',\n",
       "      'Description': 'Major uses of this chemical, including both consumer uses and industrial uses.',\n",
       "      'Information': [{'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': ['US FDA; FDA Oncology Tools Approval Summary for altretamine. Available from, as of Oct 29, 2007: https://www.accessdata.fda.gov/scripts/cder/onctools/summary.cfm?ID=104'],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Single agent palliative treatment of patients with persistent or recurrent ovarian cancer following first-line therapy with a cisplatin and/or alkylating agent based combination.',\n",
       "           'Markup': [{'Start': 126,\n",
       "             'Length': 9,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/cisplatin',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-5702198'}]}]}},\n",
       "       {'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': [\"O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ:  Merck and Co., Inc., 2006., p. 57\"],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Experimental insect chemosterilant.'}]}},\n",
       "       {'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': [\"O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ:  Merck and Co., Inc., 2006., p. 57\"],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'THERAP CAT: Antineoplastic'}]}},\n",
       "       {'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Value': {'StringWithMarkup': [{'String': 'MEDICATION'}]}}],\n",
       "      'Section': [{'TOCHeading': 'Use Classification',\n",
       "        'Description': 'This section contains use classification/category information for this compound from various sources.',\n",
       "        'Information': [{'ReferenceNumber': 19,\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients'}]}}]}]},\n",
       "     {'TOCHeading': 'Methods of Manufacturing',\n",
       "      'Description': 'Methods of producing this compound in an industrial scale, provided by the Hazardous Substances Data Bank (HSDB).',\n",
       "      'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/11933',\n",
       "      'Information': [{'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': [\"O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ:  Merck and Co., Inc., 2006., p. 57\"],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Production process: H. von Brachel, H. Kindler, DE 1240870; eidem, US 3424752 (1967, 1969 both to Casella Farbwerke)'}]}}]},\n",
       "     {'TOCHeading': 'Formulations/Preparations',\n",
       "      'Description': 'Information on Formulations/Preparations of this chemical, collected by the Hazardous Substances Data Bank (HSDB) from various sources.',\n",
       "      'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/11933',\n",
       "      'Information': [{'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': ['Thomson/Micromedex. Drug Information for the Health Care  Professional. Volume 1,  Greenwood Village, CO. 2007.'],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'U.S.: 50 mg (Rx) [Hexalen (lactose)]. Canada: 50 mg (Rx) [Hexalen].',\n",
       "           'Markup': [{'Start': 18,\n",
       "             'Length': 7,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Hexalen',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'},\n",
       "            {'Start': 27,\n",
       "             'Length': 7,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/lactose',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-6134'},\n",
       "            {'Start': 58,\n",
       "             'Length': 7,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Hexalen',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}}]}]},\n",
       "   {'TOCHeading': 'Identification',\n",
       "    'Description': 'This section contains laboratory methods used to identify this chemical.',\n",
       "    'Section': [{'TOCHeading': 'Analytic Laboratory Methods',\n",
       "      'Description': 'Analytic laboratory methods for analyzing this compound in a sample. The information in this section is collected by the Hazardous Substances Data Bank (HSDB) from various sources.',\n",
       "      'Information': [{'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': ['U.S. Pharmacopeia. The United States Pharmacopeia, USP 30/The National Formulary, NF 25; Rockville, MD: U.S. Pharmacopeial Convention, Inc., p.1330 (2007)'],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Analyte: altretamine; matrix: chemical identification; procedure: infrared absorption spectrophotometry with comparison to standards',\n",
       "           'Markup': [{'Start': 9,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}},\n",
       "       {'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': ['U.S. Pharmacopeia. The United States Pharmacopeia, USP 30/The National Formulary, NF 25; Rockville, MD: U.S. Pharmacopeial Convention, Inc., p.1330 (2007)'],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Analyte: altretamine; matrix: chemical identification; procedure: retention time of the major peak of the liquid chromatogram with comparison to standards',\n",
       "           'Markup': [{'Start': 9,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}},\n",
       "       {'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': ['U.S. Pharmacopeia. The United States Pharmacopeia, USP 30/The National Formulary, NF 25; Rockville, MD: U.S. Pharmacopeial Convention, Inc., p.1330 (2007)'],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Analyte: altretamine; matrix: chemical purity; procedure: liquid chromatography with detection at 227 nm and comparison to standards',\n",
       "           'Markup': [{'Start': 9,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}},\n",
       "       {'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': ['U.S. Pharmacopeia. The United States Pharmacopeia, USP 30/The National Formulary, NF 25; Rockville, MD: U.S. Pharmacopeial Convention, Inc., p.1331 (2007)'],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Analyte: altretamine; matrix: pharmaceutical preparation (capsule); procedure: infrared absorption spectrophotometry with comparison to standards (chemical identification)',\n",
       "           'Markup': [{'Start': 9,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}},\n",
       "       {'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Value': {'StringWithMarkup': [{'String': 'For more Analytic Laboratory Methods (Complete) data for ALTRETAMINE (6 total), please visit the HSDB record page.',\n",
       "           'Markup': [{'Start': 97,\n",
       "             'Length': 16,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/hsdb/7559#section=Analytic-Laboratory-Methods-(Complete)'},\n",
       "            {'Start': 57,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/ALTRETAMINE',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}}]},\n",
       "     {'TOCHeading': 'Clinical Laboratory Methods',\n",
       "      'Description': 'Clinical laboratory methods for detecting, isolating, separating, and/or analyzing this compound in a sample.  The information in this section is collected by the Hazardous Substances Data Bank (HSDB) from various sources.',\n",
       "      'Information': [{'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': ['Barker IK et al; J Chromatogr B 660: 121-126 (1994). As cited in: Lunn G; HPLC and CE Methods for Pharmaceutical Analysis. CD-ROM. New York, NY: John Wiley & Sons (2000)'],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Analyte: altretamine; matrix: blood (plasma, serum); procedure: high-performance liquid chromatography with ultraviolet detection at 230 nm; limit of quantitation: 150 ng/mL',\n",
       "           'Markup': [{'Start': 9,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}},\n",
       "       {'ReferenceNumber': 21,\n",
       "        'Description': 'PEER REVIEWED',\n",
       "        'Reference': ['Gaillard Y, PÃ©pin G; J Chromatogr A 763: 149-163 (1997). As cited in: Lunn G; HPLC and CE Methods for Pharmaceutical Analysis. CD-ROM. New York, NY: John Wiley & Sons (2000)'],\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Analyte: altretamine; matrix: blood (whole), urine; procedure: high-performance liquid chromatography with ultraviolet detection at 229.9 nm; limit of quantitation: 150 ng/mL',\n",
       "           'Markup': [{'Start': 9,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}}]}]},\n",
       "   {'TOCHeading': 'Safety and Hazards',\n",
       "    'Description': 'Information on safety and hazards for this compound, including safety/hazards properties, reactivity, incompatibilities, management techniques, first aid treatments, and more.  For toxicity and related information, please see the Toxicity section.',\n",
       "    'Section': [{'TOCHeading': 'Hazards Identification',\n",
       "      'Description': 'This section identifies the hazards of the chemical presented on the safety data sheet (SDS) and the appropriate warning information associated with those hazards.  The information in this section includes, but are not limited to, the hazard classification of the chemical, signal word, pictograms, hazard statements and precautionary statements.',\n",
       "      'URL': 'https://www.osha.gov/sites/default/files/publications/OSHA3514.pdf',\n",
       "      'Section': [{'TOCHeading': 'GHS Classification',\n",
       "        'Description': 'GHS (Globally Harmonized System of Classification and Labelling of Chemicals) is a United Nations system to identify hazardous chemicals and to inform users about these hazards. GHS has been adopted by many countries around the world and is now also used as the basis for international and national transport regulations for dangerous goods. The GHS hazard statements, class categories, pictograms, signal words, and the precautionary statements can be found on the PubChem GHS page.',\n",
       "        'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/',\n",
       "        'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection',\n",
       "          'NumberOfColumns': 2,\n",
       "          'ColumnContents': ['Name', 'Value']},\n",
       "         'ShowAtMost': 1},\n",
       "        'Information': [{'ReferenceNumber': 16,\n",
       "          'Name': 'Pictogram(s)',\n",
       "          'Value': {'StringWithMarkup': [{'String': '          ',\n",
       "             'Markup': [{'Start': 0,\n",
       "               'Length': 1,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS07.svg',\n",
       "               'Type': 'Icon',\n",
       "               'Extra': 'Irritant'}]}]}},\n",
       "         {'ReferenceNumber': 16,\n",
       "          'Name': 'Signal',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Warning',\n",
       "             'Markup': [{'Start': 0,\n",
       "               'Length': 7,\n",
       "               'Type': 'Color',\n",
       "               'Extra': 'GHSWarning'}]}]}},\n",
       "         {'ReferenceNumber': 16,\n",
       "          'Name': 'GHS Hazard Statements',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]',\n",
       "             'Markup': [{'Start': 35,\n",
       "               'Length': 7,\n",
       "               'Type': 'Color',\n",
       "               'Extra': 'GHSWarning'}]},\n",
       "            {'String': 'H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]',\n",
       "             'Markup': [{'Start': 37,\n",
       "               'Length': 7,\n",
       "               'Type': 'Color',\n",
       "               'Extra': 'GHSWarning'}]},\n",
       "            {'String': 'H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]',\n",
       "             'Markup': [{'Start': 44,\n",
       "               'Length': 7,\n",
       "               'Type': 'Color',\n",
       "               'Extra': 'GHSWarning'}]},\n",
       "            {'String': 'H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]',\n",
       "             'Markup': [{'Start': 47,\n",
       "               'Length': 7,\n",
       "               'Type': 'Color',\n",
       "               'Extra': 'GHSWarning'}]}]}},\n",
       "         {'ReferenceNumber': 16,\n",
       "          'Name': 'Precautionary Statement Codes',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501'},\n",
       "            {'String': '(The corresponding statement to each P-code can be found at the GHS Classification page.)',\n",
       "             'Markup': [{'Start': 64,\n",
       "               'Length': 18,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#_prec'}]}]}},\n",
       "         {'ReferenceNumber': 16,\n",
       "          'Name': 'ECHA C&L Notifications Summary',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Aggregated GHS information provided by 41 companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.',\n",
       "             'Markup': [{'Start': 0, 'Length': 164, 'Type': 'Italics'}]},\n",
       "            {'String': 'Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown.',\n",
       "             'Markup': [{'Start': 0, 'Length': 281, 'Type': 'Italics'}]}]}}]},\n",
       "       {'TOCHeading': 'Hazard Classes and Categories',\n",
       "        'Description': 'The Hazard Classes and Categories are aligned with GHS (Globally Harmonized System of Classification and Labelling of Chemicals) hazard statement codes.  The percentage data in the parenthesis from ECHA indicates that the hazard classes and categories information are consolidated from multiple companies.  Also, see the detailed explanation from the above GHS classification section.',\n",
       "        'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/',\n",
       "        'DisplayControls': {'ShowAtMost': 2},\n",
       "        'Information': [{'ReferenceNumber': 16,\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Acute Tox. 4 (100%)'},\n",
       "            {'String': 'Skin Irrit. 2 (100%)'},\n",
       "            {'String': 'Eye Irrit. 2A (100%)'},\n",
       "            {'String': 'STOT SE 3 (100%)'}]}}]},\n",
       "       {'TOCHeading': 'Health Hazards',\n",
       "        'Description': \"Description of the chemical's health hazards (e.g., toxicity, corrosivity, and flammability) that can have negative impacts on our short- or long-term health.\",\n",
       "        'Information': [{'ReferenceNumber': 1,\n",
       "          'Reference': ['National Toxicology Program, Institute of Environmental Health Sciences, National Institutes of Health (NTP). 1992. National Toxicology Program Chemical Repository Database. Research Triangle Park, North Carolina.'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'SYMPTOMS: Nausea and vomiting, possibly parathesia, numbness, depression, confusion, drowsiness and hallucinations.  ACUTE/CHRONIC HAZARDS: This chemical is toxic. (NTP, 1992)'}]}}]}]},\n",
       "     {'TOCHeading': 'First Aid Measures',\n",
       "      'Description': 'This section describes the initial care that should be given to an individual who has been exposed to the chemical.  The information in this section includes the description of the symptoms or effects of exposure to the chemical, necessary first-aid instructions by relevant routes of exposure (inhalation, skin and eye contact, and ingestion), and recommendations for immediate medical care and special treatment needed, when necessary.',\n",
       "      'URL': 'https://www.osha.gov/sites/default/files/publications/OSHA3514.pdf',\n",
       "      'Section': [{'TOCHeading': 'First Aid',\n",
       "        'Description': 'First aid measures for exposure to this chemical through various routes (for example, ingestion, inhalation, skin contact, and eye contact).',\n",
       "        'Information': [{'ReferenceNumber': 1,\n",
       "          'Reference': ['National Toxicology Program, Institute of Environmental Health Sciences, National Institutes of Health (NTP). 1992. National Toxicology Program Chemical Repository Database. Research Triangle Park, North Carolina.'],\n",
       "          'Value': {'StringWithMarkup': [{'String': \"EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.  SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment.  INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop, call a physician and be prepared to transport the victim to a hospital. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) should be used; if not available, use a level of protection greater than or equal to that advised under Protective Clothing.  INGESTION: DO NOT INDUCE VOMITING. If the victim is conscious and not convulsing, give 1 or 2 glasses of water to dilute the chemical and IMMEDIATELY call a hospital or poison control center. Be prepared to transport the victim to a hospital if advised by a physician. If the victim is convulsing or unconscious, do not give anything by mouth, ensure that the victim's airway is open and lay the victim on his/her side with the head lower than the body. DO NOT INDUCE VOMITING. IMMEDIATELY transport the victim to a hospital. (NTP, 1992)\",\n",
       "             'Markup': [{'Start': 96,\n",
       "               'Length': 5,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/water',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-962'},\n",
       "              {'Start': 105,\n",
       "               'Length': 13,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/normal%20saline',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-5234'},\n",
       "              {'Start': 502,\n",
       "               'Length': 5,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/water',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-962'},\n",
       "              {'Start': 625,\n",
       "               'Length': 5,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/water',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-962'},\n",
       "              {'Start': 1427,\n",
       "               'Length': 5,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/water',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-962'}]}]}}]}]},\n",
       "     {'TOCHeading': 'Accidental Release Measures',\n",
       "      'Description': 'This section provides recommendations on the appropriate response to spills, leaks, or releases, including containment and cleanup practices to prevent or minimize exposure to people, properties, or the environment. It may also include recommendations distinguishing between responses for large and small spills where the spill volume has a significant impact on the hazard.',\n",
       "      'URL': 'https://www.osha.gov/sites/default/files/publications/OSHA3514.pdf',\n",
       "      'Section': [{'TOCHeading': 'Disposal Methods',\n",
       "        'Description': 'Disposal methods or procedures for this chemical or hazardous waste containing it.',\n",
       "        'Information': [{'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.'}]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2004. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2004 (Plus Supplements)., p. 875'],\n",
       "          'Value': {'StringWithMarkup': [{'String': '/PRECAUTIONS FOR ANTINEOPLASTIC AGENTS:/ All contaminated disposables should be contained in sealable bags for transfer to larger waste containers. /Antineoplastic agents/'}]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2004. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2004 (Plus Supplements)., p. 875'],\n",
       "          'Value': {'StringWithMarkup': [{'String': '/PRECAUTIONS FOR ANTINEOPLASTIC AGENTS:/ All bottles must be discarded as contaminated waste after decontamination of the biohazard cabinet. All protective apparel (gown, gloves, goggles, and respirator) should be discarded as contaminated waste. /Antineoplastic agents/'}]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2004. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2004 (Plus Supplements)., p. 875'],\n",
       "          'Value': {'StringWithMarkup': [{'String': '/PRECAUTIONS FOR ANTINEOPLASTIC AGENTS:/ The contaminated filters must be removed, bagged in thick plastic and prepared for disposal in a hazardous waste dump site or incinerator licensed by the Environmental Protection Agency (EPA). /Antineoplastic agents/'}]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'For more Disposal Methods (Complete) data for ALTRETAMINE (8 total), please visit the HSDB record page.',\n",
       "             'Markup': [{'Start': 86,\n",
       "               'Length': 16,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/hsdb/7559#section=Disposal-Methods-(Complete)'},\n",
       "              {'Start': 46,\n",
       "               'Length': 11,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/ALTRETAMINE',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-2123'}]}]}}]},\n",
       "       {'TOCHeading': 'Preventive Measures',\n",
       "        'Description': 'Preventive measures to take to avoid suffering negative health effects from this chemical.',\n",
       "        'Information': [{'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2004. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2004 (Plus Supplements)., p. 875'],\n",
       "          'Value': {'StringWithMarkup': [{'String': '/PRECAUTIONS FOR ANTINEOPLASTIC AGENTS:/ Accidental contamination of the health-care environment, resulting in exposure of personnel, patients, visitors, and family members to hazardous substances, is prevented by maintaining the physical integrity and security of packages of hazardous drugs. 1. Access to all areas where hazardous drugs are stored is limited to specified authorized staff. 2. A method should be present for identifying to personnel those drugs that require special precautions (eg, cytotoxics). One way to accomplish this is to apply appropriate warning labels to all hazardous drug containers, shelves, and bins where the drug products are stored. ... 3. A method of identifying, for patients and family members, those drugs that require special precautions in the home should be in place. This may be accomplished in the health-care setting, by providing specific labeling for discharge medications, along with written instructions. 4. Methods for identifying shipping cartons of hazardous drugs should be required from manufacturers and distributors of these drugs. 5. Written procedures for handling damaged packages of hazardous drugs should be maintained. Personnel involved in shipping and receiving hazardous drugs should be trained in these procedures, including the proper use of protective garments and equipment. Damaged shipping cartons of hazardous drugs should be received and opened in an isolated area (eg, in a laboratory fume hood, if available, not in a vertical laminar airflow biological safety cabinet used for preparing sterile products). /Antineoplastic agents/'}]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2004. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2004 (Plus Supplements)., p. 875'],\n",
       "          'Value': {'StringWithMarkup': [{'String': '/PRECAUTIONS FOR ANTINEOPLASTIC AGENTS:/ Facilities (eg, shelves, carts, counters, and trays) for storing hazardous drugs are designed to prevent breakage and to limit contamination in the event of leakage. Bins, shelves with barriers at the front, or other design features that reduce the chance of drug containers falling to the floor should be used. Hazardous drugs requiring refrigeration should be stored separately from nonhazardous drugs in individual bins designed to prevent breakage and to contain leakage. /Antineoplastic agents/'}]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2004. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2004 (Plus Supplements)., p. 875'],\n",
       "          'Value': {'StringWithMarkup': [{'String': '/PRECAUTIONS FOR ANTINEOPLASTIC AGENTS:/ Until the reproductive risks (or lack thereof) associated with handling hazardous drugs within a safety program have been substantiated, staff who are pregnant or breast-feeding should be allowed to avoid contact with these drugs. Policies should be in effect that provide these individuals with alternative tasks or responsibilities if they so desire. /Antineoplastic agents/'}]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2004. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2004 (Plus Supplements)., p. 875'],\n",
       "          'Value': {'StringWithMarkup': [{'String': '/PRECAUTIONS FOR ANTINEOPLASTIC AGENTS:/ The pharmacy should provide access to information on toxicity, treatment of acute exposure (if available), chemical inactivators, solubility and stability of hazardous drugs (including investigational agents) used in the workplace. /Antineoplastic agents/'}]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'For more Preventive Measures (Complete) data for ALTRETAMINE (20 total), please visit the HSDB record page.',\n",
       "             'Markup': [{'Start': 90,\n",
       "               'Length': 16,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/hsdb/7559#section=Preventive-Measures-(Complete)'},\n",
       "              {'Start': 49,\n",
       "               'Length': 11,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/ALTRETAMINE',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-2123'}]}]}}]}]},\n",
       "     {'TOCHeading': 'Handling and Storage',\n",
       "      'Description': 'This section provides guidance on the safe handling practices and storage conditions for this chemical.  The information in this section includes precautions for safe handling, such as recommendations for handling incompatible chemicals, minimizing the release of the chemical into the environment, and providing advice on general hygiene practices (e.g., eating, drinking, and smoking in work areas is prohibited).  In addition, this section provides recommendations on the conditions for safe storage (including any incompatibilities) as well as advice on specific storage requirements (e.g., ventilation requirements).  ',\n",
       "      'URL': 'https://www.osha.gov/sites/default/files/publications/OSHA3514.pdf',\n",
       "      'Section': [{'TOCHeading': 'Nonfire Spill Response',\n",
       "        'Description': 'Emergency response measures to take in the event of a chemical spill (without a fire).',\n",
       "        'Information': [{'ReferenceNumber': 1,\n",
       "          'Reference': ['National Toxicology Program, Institute of Environmental Health Sciences, National Institutes of Health (NTP). 1992. National Toxicology Program Chemical Repository Database. Research Triangle Park, North Carolina.'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'SMALL SPILLS AND LEAKAGE: Should a spill occur while you are handling this chemical, FIRST REMOVE ALL SOURCES OF IGNITION, then you should dampen the solid spill material with ethanol and transfer the dampened material to a suitable container. Use absorbent paper dampened with ethanol to pick up any remaining material. Seal the absorbent paper, and any of your clothes, which may be contaminated, in a vapor-tight plastic bag for eventual disposal. Solvent wash all contaminated surfaces with ethanol followed by washing with a soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned.  STORAGE PRECAUTIONS: You should keep this material in a tightly-closed container under an inert atmosphere, and store it in a freezer. (NTP, 1992)',\n",
       "             'Markup': [{'Start': 176,\n",
       "               'Length': 7,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/ethanol',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-702'},\n",
       "              {'Start': 278,\n",
       "               'Length': 7,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/ethanol',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-702'},\n",
       "              {'Start': 495,\n",
       "               'Length': 7,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/ethanol',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-702'},\n",
       "              {'Start': 539,\n",
       "               'Length': 5,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/water',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-962'}]}]}}]},\n",
       "       {'TOCHeading': 'Storage Conditions',\n",
       "        'Description': 'Conditions for safe storage of this compound, including any incompatible chemicals and specific storage requirements (e.g., ventilation requirements).',\n",
       "        'Information': [{'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['Thomson/Micromedex. Drug Information for the Health Care  Professional. Volume 1,  Greenwood Village, CO. 2007.'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Store below 40 Â°C (104 Â°F), preferably between 15 and 30 Â°C (59 and 86 Â°F), unless otherwise specified by manufacturer.'}]}}]}]},\n",
       "     {'TOCHeading': 'Exposure Control and Personal Protection',\n",
       "      'Description': 'This section provides information on the exposure limits, engineering controls, and personal protective measures that can be used to minimize worker exposure.  The information in this section includes OSHA Permissible Exposure Limits (PELs), American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Values (TLVs), and any other exposure limit used or recommended by the chemical manufacturer, importer, or employer preparing the safety data sheet, where available. In addition, this section contains information on appropriate engineering controls (e.g., use local exhaust ventilation, or use only in an enclosed system) as well as recommendations for personal protective measures to prevent illness or injury from exposure to chemicals, such as personal protective equipment (PPE) (e.g., appropriate types of eye, face, skin or respiratory protection needed based on hazards and potential exposure).',\n",
       "      'URL': 'https://www.osha.gov/sites/default/files/publications/OSHA3514.pdf',\n",
       "      'Section': [{'TOCHeading': 'Personal Protective Equipment (PPE)',\n",
       "        'Description': 'Personal protective equipment (PPE) to use when handling this chemical.',\n",
       "        'Information': [{'ReferenceNumber': 1,\n",
       "          'Reference': ['National Toxicology Program, Institute of Environmental Health Sciences, National Institutes of Health (NTP). 1992. National Toxicology Program Chemical Repository Database. Research Triangle Park, North Carolina.'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with an organic vapor/acid gas cartridge (specific for organic vapors, HCl, acid gas and SO2) with a dust/mist filter. (NTP, 1992)'}]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2004. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2004 (Plus Supplements)., p. 875'],\n",
       "          'Value': {'StringWithMarkup': [{'String': '/PRECAUTIONS FOR ANTINEOPLASTIC AGENTS:/ Protective apparel: Disposable closed-front gown or coveralls, disposable utility gloves over disposable latex gloves, NIOSH-approved air-purifying half-mask respirator equipped with a high efficiency filter, and eye protection should be worn. /Antineoplastic agents/'}]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2004. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2004 (Plus Supplements)., p. 875'],\n",
       "          'Value': {'StringWithMarkup': [{'String': '/PRECAUTIONS FOR ANTINEOPLASTIC AGENTS:/ Class 100 clean-air work stations, both horizontal and vertical airflow (with no containment characteristics), are inappropriate engineering controls for handling hazardous drugs because they provide no personnel protection and permit environmental contamination. Although there are no engineering controls designed specifically for the safe handling of hazardous chemicals as sterile products, Class II contained vertical-flow biological safety cabinets (biohazard cabinets) have been adopted for this use. Biohazard cabinetry is, however, designed for the handling of infectious agents, not hazardous chemicals. ... Based on design, ease of use, and cost considerations, Class II contained-vertical-flow biohazard cabinetry is currently recommended for use in preparing sterile doses of hazardous drugs. Class II cabinetry design and performance specifications are defined in NSF Standard 49. Biological safety cabinets selected for use with hazardous drugs should meet NSF Standard 49 specifications to ensure the maximum protection from these engineering controls. /Antineoplastic agents/'}]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2004. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2004 (Plus Supplements)., p. 875'],\n",
       "          'Value': {'StringWithMarkup': [{'String': '/PRECAUTIONS FOR ANTINEOPLASTIC AGENTS:/ Workers should wear powder free, disposable surgical latex gloves of good quality when preparing hazardous drugs. Selection criteria for gloves should include thickness (especially at the fingertips where stress is the greatest), fit, length, and tactile sensation. ... The practice of double gloving is supported by research that indicates that many glove materials vary in drug permeability even within lots; therefore, double gloving is recommended. ... In general, surgical latex gloves fit better, have appropriate elasticity for double gloving and maintaining the integrity of the glove-gown interface, and have sufficient tactile sensation (even during double gloving) for stringent aseptic procedures. ... Powdered gloves should be avoided. /Antineoplastic agents/'}]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2004. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2004 (Plus Supplements)., p. 875'],\n",
       "          'Value': {'StringWithMarkup': [{'String': '/PRECAUTIONS FOR ANTINEOPLASTIC AGENTS:/ Workers who are not protected by the containment environment of a biohazard cabinet should use respiratory protection when handling hazardous drugs. Respiratory protection should be an adjunct to and not a substitute for engineering controls. Surgical masks of all types provide no respiratory protection against powdered or liquid aerosols of hazardous drugs. In situations where workers may be exposed to potential eye contact with hazardous drugs, an appropriate plastic face shield or splash goggles should be worn. /Antineoplastic agents/'}]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2004. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2004 (Plus Supplements)., p. 875'],\n",
       "          'Value': {'StringWithMarkup': [{'String': '/PRECAUTIONS FOR ANTINEOPLASTIC AGENTS:/ During compounding of hazardous drugs (eg, crushing, dissolving, and preparing an ointment), workers should wear low permeability gowns and double gloves. Compounding should take place in a protective area such as a disposable glove box. If compounding must be done in the open, an area away from drafts and traffic must be selected, and the worker should use appropriate respiratory protection. /Antineoplastic agents/'}]}}]}]},\n",
       "     {'TOCHeading': 'Stability and Reactivity',\n",
       "      'Description': 'This section describes the stability and reactivity hazards of the chemical.  For some compounds, related information may also be found in the \"Stability/Shelf Life\" section under Experimental Properties (if available).',\n",
       "      'URL': 'https://www.osha.gov/sites/default/files/publications/OSHA3514.pdf',\n",
       "      'Section': [{'TOCHeading': 'Air and Water Reactions',\n",
       "        'Description': 'Special alerts if this chemical reacts with air, water, or moisture. ',\n",
       "        'Information': [{'ReferenceNumber': 1,\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Insoluble in water.'}]}}]},\n",
       "       {'TOCHeading': 'Reactive Group',\n",
       "        'Description': 'List of reactive groups that this chemical belongs to, according to CAMEO Chemicals at the U.S. National Oceanic and Atmospheric Administration (NOAA).',\n",
       "        'URL': 'https://cameochemicals.noaa.gov/help/reactivity/reactive_groups.htm',\n",
       "        'Information': [{'ReferenceNumber': 1,\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Amines, Phosphines, and Pyridines'}]}}]},\n",
       "       {'TOCHeading': 'Reactivity Profile',\n",
       "        'Description': \"Description of the chemical's potential reactivity with other chemicals, air, and water. Also it includes any other intrinsic reactive hazards (such as polymerizable or peroxidizable).\",\n",
       "        'Information': [{'ReferenceNumber': 1,\n",
       "          'Value': {'StringWithMarkup': [{'String': 'HEXAMETHYLMELAMINE neutralizes acids in exothermic reactions to form salts plus water. May be incompatible with isocyanates, halogenated organics, peroxides, phenols (acidic), epoxides, anhydrides, and acid halides. Flammable gaseous hydrogen may be generated in combination with strong reducing agents, such as hydrides.',\n",
       "             'Markup': [{'Start': 0,\n",
       "               'Length': 18,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/HEXAMETHYLMELAMINE',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-2123'},\n",
       "              {'Start': 80,\n",
       "               'Length': 5,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/water',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-962'},\n",
       "              {'Start': 234,\n",
       "               'Length': 8,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Hydrogen',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'Element-Hydrogen'}]}]}}]}]},\n",
       "     {'TOCHeading': 'Transport Information',\n",
       "      'Description': 'Transport information lists the U.S. Department of Transportation (DOT) requirements and related information for shipping and transporting of hazardous chemical(s) by road, air, rail, or sea.',\n",
       "      'URL': 'https://www.phmsa.dot.gov/hazmat/erg/emergency-response-guidebook-erg',\n",
       "      'Section': [{'TOCHeading': 'Shipment Methods and Regulations',\n",
       "        'Description': 'Shipment methods and regulations of this compound.  The information in this section includes the U.S. Hazardous Materials Regulations (49 CFR Subchapter C), the International Air Transport Association (IATA) Dangerous Goods Regulations, the International Maritime Dangerous Goods (IMDG) Code, and other regulations.',\n",
       "        'URL': 'https://www.govinfo.gov/content/pkg/CFR-2009-title49-vol2/pdf/CFR-2009-title49-vol2-part171.pdf',\n",
       "        'Information': [{'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2004. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2004 (Plus Supplements)., p. 875'],\n",
       "          'Value': {'StringWithMarkup': [{'String': '/PRECAUTIONS FOR ANTINEOPLASTIC AGENTS:/ Methods for transporting hazardous drugs to the health-care setting should be consistent with environmental protection and national or local regulations for transporting hazardous substances. When hazardous drugs are being transported to the home-care setting, appropriate containers (eg, lined cardboard boxes) and procedures should be used to prevent breakage and contain leakage. ... The drugs must be securely capped or sealed and properly packaged and protected during transport to reduce further the chance of breakage and spillage in a public area such as a corridor or elevator. /Antineoplastic agents/'}]}}]}]},\n",
       "     {'TOCHeading': 'Regulatory Information',\n",
       "      'Description': 'This section lists the safety, health, and environmental regulations concerning the chemical and products containing it.  The information may include any national and/or regional regulatory information of the chemical or mixtures.',\n",
       "      'Section': [{'TOCHeading': 'FDA Requirements',\n",
       "        'Description': 'FDA requirements regarding this chemical and products containing it.  FDA Requirements means any requirements of the Federal Food, Drug and Cosmetic Act (FDCA), as amended, and any rules or regulations promulgated thereunder which are or may be applicable to the manufacture, sale, labeling or distribution of the products regulated by FDA (e.g., drugs, biologics, dietary supplements, foods, cosmetics, tobacco products, etc.).',\n",
       "        'URL': 'https://www.fda.gov/regulatory-information/laws-enforced-fda/federal-food-drug-and-cosmetic-act-fdc-act',\n",
       "        'Information': [{'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['DHHS/FDA; Electronic Orange Book-Approved Drug Products with Therapeutic Equivalence Evaluations. Available from, as of November 9, 2007: https://www.fda.gov/cder/ob/'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'The Approved Drug Products with Therapeutic Equivalence Evaluations List identifies currently marketed prescription drug products, incl altretamine approved on the basis of safety and effectiveness by FDA under sections 505 of the Federal Food, Drug, and Cosmetic Act.',\n",
       "             'Markup': [{'Start': 136,\n",
       "               'Length': 11,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-2123'}]}]}}]}]}]},\n",
       "   {'TOCHeading': 'Toxicity',\n",
       "    'Description': 'Toxicity information related to this compound, including routes of exposure, related symptoms, acute and chronic effects, and numerical measures of toxicity.',\n",
       "    'Section': [{'TOCHeading': 'Toxicological Information',\n",
       "      'Description': 'This section provides toxicological and health effects information for the chemical.  It includes the likely routes of exposure (inhalation, ingestion, skin and eye contact), and the delayed, immediate, or chronic effects/symptoms from short- and long-term exposure, and the numerical measures of toxicity [e.g., acute toxicity estimates such as the LD50 (median lethal dose, the estimated amount of a chemical expected to kill 50% of test animals in a single dose)].  This section also includes information on whether the chemical is considered as a potential carcinogen according to authoritative sources such as the National Toxicology Program (NTP) Report on Carcinogens and the International agency for Research on Cancer (IARC) Monographs.',\n",
       "      'Section': [{'TOCHeading': 'Hepatotoxicity',\n",
       "        'Description': 'This section provides a short description about the hepatotoxicity associated with this compound, the rate of serum enzyme elevations during use, and the frequency and character of the clinically apparent liver injury associated with the compound.',\n",
       "        'Information': [{'ReferenceNumber': 27,\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Altretamine therapy is associated with a low rate of serum enzyme elevations, but these are generally mild and self limited, not requiring dose adjustment. Rare instances of clinically apparent acute liver injury attributed to altretamine have been reported, but the clinical features have not been characterized. Altretamine has not been linked specifically to sinusoidal obstruction syndrome, but it is rarely used in high doses in neoplastic disease or in conditioning regimens for bone marrow transplantation, situations in which alkylating agents are commonly associated with this complication.',\n",
       "             'Markup': [{'Start': 0,\n",
       "               'Length': 11,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Altretamine',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-2123'},\n",
       "              {'Start': 227,\n",
       "               'Length': 11,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-2123'},\n",
       "              {'Start': 314,\n",
       "               'Length': 11,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Altretamine',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-2123'}]},\n",
       "            {'String': 'Likelihood score: E* (unlikely but suspected rare cause of liver injury).'}]}}]},\n",
       "       {'TOCHeading': 'Drug Induced Liver Injury',\n",
       "        'Description': \"This compound's potential to cause drug-induced liver injury.  This information is from the FDA's Drug-Induced Liver Injury Rank (DILIrank) dataset.  DILIrank groups more than 1,000 FDA-approved drugs into 4 categories (most-, less-, no-, and ambiguous-DILI-concerns).  DILIrank assigns a severity grade, ranging from 0 (no-DILI-concern) to 8 (fatal hepatotoxicity).\",\n",
       "        'URL': 'https://www.fda.gov/science-research/liver-toxicity-knowledge-base-ltkb/drug-induced-liver-injury-rank-dilirank-dataset',\n",
       "        'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection',\n",
       "          'NumberOfColumns': 2,\n",
       "          'ColumnContents': ['Name', 'Value']}},\n",
       "        'Information': [{'ReferenceNumber': 11,\n",
       "          'Name': 'Compound',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'altretamine'}]}},\n",
       "         {'ReferenceNumber': 11,\n",
       "          'Name': 'DILI Annotation',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Ambiguous DILI-concern'}]}},\n",
       "         {'ReferenceNumber': 11,\n",
       "          'Name': 'Severity Grade',\n",
       "          'Value': {'StringWithMarkup': [{'String': '2'}]}},\n",
       "         {'ReferenceNumber': 11,\n",
       "          'Name': 'Label Section',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Adverse reactions'}]}},\n",
       "         {'ReferenceNumber': 11,\n",
       "          'Name': 'References',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'M Chen, V Vijay, Q Shi, Z Liu, H Fang, W Tong. FDA-Approved Drug Labeling for the Study of Drug-Induced Liver Injury, Drug Discovery Today, 16(15-16):697-703, 2011. PMID:21624500 DOI:10.1016/j.drudis.2011.05.007',\n",
       "             'Markup': [{'Start': 165,\n",
       "               'Length': 13,\n",
       "               'URL': 'https://pubmed.ncbi.nlm.nih.gov/21624500/'},\n",
       "              {'Start': 179,\n",
       "               'Length': 32,\n",
       "               'URL': 'https://doi.org/10.1016/j.drudis.2011.05.007'}]},\n",
       "            {'String': 'M Chen, A Suzuki, S Thakkar, K Yu, C Hu, W Tong. DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug Discov Today 2016, 21(4): 648-653. PMID:26948801 DOI:10.1016/j.drudis.2016.02.015',\n",
       "             'Markup': [{'Start': 202,\n",
       "               'Length': 13,\n",
       "               'URL': 'https://pubmed.ncbi.nlm.nih.gov/26948801/'},\n",
       "              {'Start': 216,\n",
       "               'Length': 32,\n",
       "               'URL': 'https://doi.org/10.1016/j.drudis.2016.02.015'}]}]}}]},\n",
       "       {'TOCHeading': 'Acute Effects',\n",
       "        'Description': 'The results from acute animal tests and/or acute human studies are presented in this section. Acute animal studies consist of LD50 and LC50 tests, which present the median lethal dose (or concentration) to the animals. Acute human studies usually consist of case reports from accidental poisonings or industrial accidents. These case reports often help to define the levels at which acute toxic effects are seen in humans.',\n",
       "        'Information': [{'ReferenceNumber': 7,\n",
       "          'Value': {'ExternalTableName': 'chemidplus'}}]},\n",
       "       {'TOCHeading': 'Toxicity Data',\n",
       "        'Description': 'Numeric toxicity data for this compound, collected from multiple sources (including the NCI Investigational Drugs and Haz-Map).',\n",
       "        'Information': [{'ReferenceNumber': 30,\n",
       "          'Name': 'ToxicityData',\n",
       "          'Reference': ['Cancer Chemotherapy Reports, 56,505,(1972)'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Human(po): TDL0 8 mg/kg'}]}},\n",
       "         {'ReferenceNumber': 30,\n",
       "          'Name': 'ToxicityData',\n",
       "          'Reference': ['Principles of Insect Chemosterilization, 315,(1968)'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Rat(po): LD50 350 mg/kg'}]}},\n",
       "         {'ReferenceNumber': 30,\n",
       "          'Name': 'ToxicityData',\n",
       "          'Reference': ['Journal of Pharmacology & Experimental Therapeutics, 100,398,50'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Rat(ip): LD50 265 mg/kg'}]}},\n",
       "         {'ReferenceNumber': 30,\n",
       "          'Name': 'ToxicityData',\n",
       "          'Reference': ['Archives Internationales de Pharmacodynamie et de Therapie, 160,83,(1966)'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Mouse(po): LD50 437 mg/kg'}]}},\n",
       "         {'ReferenceNumber': 30,\n",
       "          'Name': 'ToxicityData',\n",
       "          'Reference': ['Cancer Research, 40,2762,(1980)'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Mouse(ip): LD50 200 mg/kg'}]}},\n",
       "         {'ReferenceNumber': 30,\n",
       "          'Name': 'ToxicityData',\n",
       "          'Reference': ['National Technical Information Service, PB293 -046'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Mouse(iv): LD50 171 mg/kg'}]}}]},\n",
       "       {'TOCHeading': 'Interactions',\n",
       "        'Description': 'Interactions of this compound with other chemicals, according to the Hazardous Substances Data Bank (HSDB).',\n",
       "        'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/11933',\n",
       "        'Information': [{'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['Thomson/Micromedex. Drug Information for the Health Care  Professional. Volume 1,  Greenwood Village, CO. 2007.'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Blood dyscrasia causing medications (leukopenic and/or thrombocytopenic effects of altretamine may be increased with concurrent or recent therapy if these medications cause the same effects; dosage adjustment of altretamine, if necessary, should be based on blood counts)',\n",
       "             'Markup': [{'Start': 83,\n",
       "               'Length': 11,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-2123'},\n",
       "              {'Start': 212,\n",
       "               'Length': 11,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-2123'}]}]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['Thomson/Micromedex. Drug Information for the Health Care  Professional. Volume 1,  Greenwood Village, CO. 2007.'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Additive bone marrow depression may occur /with radiation therapy/; dosage reduction may be required when two or more bone marrow depressants, including radiation, are used concurrently or consecutively.'}]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['Thomson/Micromedex. Drug Information for the Health Care  Professional. Volume 1,  Greenwood Village, CO. 2007.'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Concurrent use of altretamine with  monoamine oxidase (MAO) inhibitors, including furazolidone, procarbazine, and selegiline use may result in severe orthostatic hypotension.',\n",
       "             'Markup': [{'Start': 18,\n",
       "               'Length': 11,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-2123'},\n",
       "              {'Start': 82,\n",
       "               'Length': 12,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/furazolidone',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-3435'},\n",
       "              {'Start': 96,\n",
       "               'Length': 12,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/procarbazine',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-4915'},\n",
       "              {'Start': 114,\n",
       "               'Length': 10,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selegiline',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-26757'}]}]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['Thomson/Micromedex. Drug Information for the Health Care  Professional. Volume 1,  Greenwood Village, CO. 2007.'],\n",
       "          'Value': {'StringWithMarkup': [{'String': \"Because normal defense mechanisms may be suppressed by altretamine therapy, the patient's antibody response to /a killed/ vaccine may be decreased. The interval between discontinuation of medications that cause immunosuppression and restoration of the patient's ability to respond to the vaccine depends on the intensity and type of immunosuppression-causing medication used, the underlying disease, and other factors; estimates vary from 3 months to 1 year)\",\n",
       "             'Markup': [{'Start': 55,\n",
       "               'Length': 11,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-2123'}]}]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Value': {'StringWithMarkup': [{'String': 'For more Interactions (Complete) data for ALTRETAMINE (6 total), please visit the HSDB record page.',\n",
       "             'Markup': [{'Start': 82,\n",
       "               'Length': 16,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/hsdb/7559#section=Interactions-(Complete)'},\n",
       "              {'Start': 42,\n",
       "               'Length': 11,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/ALTRETAMINE',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-2123'}]}]}}]},\n",
       "       {'TOCHeading': 'Antidote and Emergency Treatment',\n",
       "        'Description': 'Information on antidote and emergency treatment when exposed to this chemical.  The information here is from the Hazardous Substances Data Bank (HSDB).',\n",
       "        'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/11933',\n",
       "        'Information': [{'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['Olson, K.R. (Ed.); Poisoning & Drug Overdose. 5th ed. Lange      Medical Books/McGraw-Hill. New York, N.Y. 2007., p. 101'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Emergency and supportive measures. Maintain an open airway and assist ventilation if necessary. Treat coma, seizures, hypotensin, and arrhythmias if they occur. Treat nausea and vomiting with metoclopramide and fluid loss caused by gastroenteritis with intravenous crystalloid fluids. /Antineoplastic agents/',\n",
       "             'Markup': [{'Start': 192,\n",
       "               'Length': 14,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/metoclopramide',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-4168'}]}]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['Olson, K.R. (Ed.); Poisoning & Drug Overdose. 5th ed. Lange      Medical Books/McGraw-Hill. New York, N.Y. 2007., p. 100'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Bone marrow depression should be treated with the assistance of an experienced hematologist or oncologist. /Antineoplastic agents/'}]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['Olson, K.R. (Ed.); Poisoning & Drug Overdose. 5th ed. Lange      Medical Books/McGraw-Hill. New York, N.Y. 2007., p. 107'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Decontamination. Administer activated charcoal orally if conditions are appropriate. Gastric lavage is not necessary after small to moderate ingestions if activated charcoal can be given promptly. /Antineoplastic agents/',\n",
       "             'Markup': [{'Start': 38,\n",
       "               'Length': 8,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/charcoal',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-5462310'},\n",
       "              {'Start': 165,\n",
       "               'Length': 8,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/charcoal',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-5462310'}]}]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['Olson, K.R. (Ed.); Poisoning & Drug Overdose. 5th ed. Lange      Medical Books/McGraw-Hill. New York, N.Y. 2007., p. 107'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'Enhanced elimination. Because of the rapid intracellular incorporation of most of these agents, dialysis and other extracorporeal removal procedures are generally not effective. /Antineoplastic agents/'}]}}]},\n",
       "       {'TOCHeading': 'Medical Surveillance',\n",
       "        'Description': 'Medical surveillance information for this compound.  Medical surveillance is the systematic assessment of employees exposed or potentially exposed to occupational hazards. This assessment monitors individuals for adverse health effects and determines the effectiveness of exposure prevention strategies.',\n",
       "        'Information': [{'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2004. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2004 (Plus Supplements)., p. 875'],\n",
       "          'Value': {'StringWithMarkup': [{'String': '/PRECAUTIONS FOR ANTINEOPLASTIC AGENTS:/ There is no method available for routine monitoring of personnel for evidence of hazardous drug exposure. Tests for the presence of mutagens or chromosomal damage are not drug specific and are of value only in controlled studies. Chemical analysis of urine for the presence of hazardous drugs at the sensitivity level needed to detect occupational exposure is limited to a few drugs and is not yet commercially available. /Antineoplastic agents/'}]}}]},\n",
       "       {'TOCHeading': 'Human Toxicity Excerpts',\n",
       "        'Description': 'Excerpts about human toxicity of this compound, extracted from authoritative documents, such as journal articles, government reports, and reference books.',\n",
       "        'Information': [{'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['PMID:3099573',\n",
       "           'Grubb B et al; Am J Med Sci. 292 (6): 393-4 (1986)'],\n",
       "          'Value': {'StringWithMarkup': [{'String': '/CASE REPORTS/ This case report describes a 76-year-old white woman who was found to have ovarian cancer and underwent chemotherapy with hexamethylmelamine. After 34 months of therapy, she developed an acute myelocytic leukemia.',\n",
       "             'Markup': [{'Start': 137,\n",
       "               'Length': 18,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/hexamethylmelamine',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-2123'}]}]}}]},\n",
       "       {'TOCHeading': 'Non-Human Toxicity Excerpts',\n",
       "        'Description': 'Excerpts about non-human toxicity of this compound, extracted from authoritative documents, such as journal articles, government reports, and reference books.',\n",
       "        'Information': [{'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['Thomson/Micromedex. Drug Information for the Health Care  Professional. Volume 1,  Greenwood Village, CO. 2007.'],\n",
       "          'Value': {'StringWithMarkup': [{'String': '/LABORATORY ANIMALS: Developmental or Reproductive Toxicity/ No adverse effect on fertility was found in female rats when altretamine was administered from 14 days prior to breeding through the gestation period. Administration to male rats in doses of 120 mg per square meter of body surface area per day for 60 days prior to mating resulted in testicular atrophy, reduced fertility, and a possible dominant lethal mutagenic effect; doses of 450 mg per square meter of body surface area per day for 10 days caused decreased spermatogenesis, atrophy of testes, seminal vesicles, and ventral prostate.',\n",
       "             'Markup': [{'Start': 122,\n",
       "               'Length': 11,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-2123'}]}]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['Thomson/Micromedex. Drug Information for the Health Care  Professional. Volume 1,  Greenwood Village, CO. 2007.'],\n",
       "          'Value': {'StringWithMarkup': [{'String': '/LABORATORY ANIMALS: Developmental or Reproductive Toxicity/ Altretamine is embryotoxic and teratogenic in rats and rabbits given 2 to 10 times the human dose.',\n",
       "             'Markup': [{'Start': 61,\n",
       "               'Length': 11,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Altretamine',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-2123'}]}]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['PMID:6420936',\n",
       "           'Thompson D, Dyke I et al; Toxicol Appl Pharmacol 72 (2): 245-54 (1984)'],\n",
       "          'Value': {'StringWithMarkup': [{'String': '/LABORATORY ANIMALS: Developmental or Reproductive Toxicity/ The antineoplastic drug hexamethylmelamine (HMM) was evaluated for effects on reproduction and postnatal development in the rat and on embryonal and fetal development in the rat and rabbit. Daily po treatment of male rats for 62 days with doses of 0, 10, 20, or 40 mg/kg/day resulted in testicular atrophy, reduced fertility, and a possible dominant lethal mutagenic effect at the higher two dose levels. Alterations in morphology and function of the beta cells of the pancreatic islets were observed after treatment of males for more than 28 days with 20 or 40 mg/kg/day. The same dose levels administered to female rats for 14 days prior to breeding and through Day 13 or 20 of gestation had no adverse effects on fertility, but the highest dose was embryocidal and postnatal survival was decreased at both the 20- and 40-mg/kg/day dose levels. Similar effects on postnatal survival were observed when the drug was administered by gavage to rats during the last week of gestation and throughout the lactation period. Treatment of pregnant rats throughout organogenesis (Days 6 to 15) or for 4-day intervals during organogenesis (Days 6 to 9, 9 to 12, or 12 to 15) with po doses ranging from 20 to 80 mg/kg/day resulted in decreased body weight gain and food consumption, an increased resorption rate in dams receiving 80 mg/kg/day on Days 6 to 9, and decreased fetal weights at all dose levels and most treatment intervals. The incidence of minor skeletal defects was increased among litters of HMM-treated groups. Major fetal malformations were limited in number but were considered treatment related. Treatment of pregnant rabbits po on Days 6 to 18 of gestation with doses of 0, 20, 40, or 60 mg/kg/day did not result in an embryocidal or teratogenic effect. Treatment with 60 mg/kg/day did, however, result in decreased kit weights, indicating a mild embryo-fetotoxic effect.',\n",
       "             'Markup': [{'Start': 85,\n",
       "               'Length': 18,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/hexamethylmelamine',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-2123'}]}]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['PMID:7586186',\n",
       "           'Aguirrezabalaga I, Nivard M et al; Carcinogenesis 16 (11): 2679-83 (1995)'],\n",
       "          'Value': {'StringWithMarkup': [{'String': '/GENOTOXICITY/ It is of great interest to elucidate the mechanisms by which cytostatic drugs exert their mutagenic and/or carcinogenic activity besides the anticancer effect and the possible relationship among them. A useful and informative approach to this problem is the analysis of the mutation spectra induced by these drugs in eukaryotic organisms. Sequence analysis of the mutations induced by hexamethylmelamine, a crosslinking agent extensively used in the treatment of ovarian cancer, in male germ cells of Drosophila was conducted using the v locus as reporter gene. Both intra-locus and multi-locus deletions were induced whereas based changes were almost absent. Thus, it is proposed that deletions are likely to be involved in the generation of second malignancies in hexamethylmelamine-treated patients. It has to be stressed that systems, such as v, capable of efficiently recovering mutations caused by big losses of DNA, should be used for the study of mutational spectra induced by cross-linking agents.',\n",
       "             'Markup': [{'Start': 400,\n",
       "               'Length': 18,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/hexamethylmelamine',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-2123'},\n",
       "              {'Start': 781,\n",
       "               'Length': 18,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/hexamethylmelamine',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-2123'}]}]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['PMID:3919288',\n",
       "           'Ashby J, Callander R et al; Mutat Res 142 (3): 121-5 (1985)'],\n",
       "          'Value': {'StringWithMarkup': [{'String': '/GENOTOXICITY/ Hexamethylmelamine (HEMLA) is a metabolism-dependent formaldehyde-releasing agent ... known to be mutagenic to Drosophila. ... The present paper describes the mutagenicity of HEMLA to strain TA100 of Salmonella typhimurium. Activity is dependent upon both the use of a pre-incubation assay protocol and on high concentrations of Aroclor-induced rat liver in the S9 mix. ...',\n",
       "             'Markup': [{'Start': 15,\n",
       "               'Length': 18,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Hexamethylmelamine',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-2123'},\n",
       "              {'Start': 68,\n",
       "               'Length': 12,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/formaldehyde',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-712'}]}]}}]},\n",
       "       {'TOCHeading': 'Non-Human Toxicity Values',\n",
       "        'Description': 'Quantitative non-human toxicity values (e.g., lethal dose) for this compound.  The data shown here are mostly for lab animals (e.g., rat, mouse, guinea pig, and rabbit).',\n",
       "        'DisplayControls': {'ShowAtMost': 5},\n",
       "        'Information': [{'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': [\"O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ:  Merck and Co., Inc., 2006., p. 57\"],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'LD50 Rat oral 350 mg/kg'}]}},\n",
       "         {'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': [\"O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ:  Merck and Co., Inc., 2006., p. 57\"],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'LD50 Guinea pig oral 255 mg/kg'}]}}]},\n",
       "       {'TOCHeading': 'Protein Binding',\n",
       "        'Description': 'In this section, \"protein binding\" refers to the degree to which medications attach to plasma proteins (i.e., proteins within the blood, such as human serum albumin, lipoprotein, glycoprotein and globulins). A drug\\'s efficiency may be affected by the degree to which it binds to plasma proteins. The less bound a drug is, the more efficiently it can traverse cell membranes or diffuse.',\n",
       "        'Information': [{'ReferenceNumber': 12,\n",
       "          'Value': {'StringWithMarkup': [{'String': '94%'}]}}]}]},\n",
       "     {'TOCHeading': 'Ecological Information',\n",
       "      'Description': 'This section provides information to evaluate the environmental impact of the chemical if it were released to the environment. The information may include data from toxicity tests performed on aquatic and/or terrestrial organisms, where available (e.g., acute or chronic aquatic toxicity data for fish, algae, and crustaceans; toxicity data on birds, bees, and plants).  This section also includes information on whether there is a potential for the chemical to persist or degrade in the environment either through biodegradation or other processes (such as oxidation or hydrolysis) as well as the concentration or amount of the chemical found in the environment (e.g., in plants, animals as well as in the atmosphere or water).',\n",
       "      'Section': [{'TOCHeading': 'Environmental Water Concentrations',\n",
       "        'Description': 'Concentrations of this chemical in water in various stages of hydrologic cycle (e.g., drinking water, ground water, surface water, and rain/snow).',\n",
       "        'Information': [{'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['(1) Heberer T; Tox Lett 131: 5-17 (2002) (2) Koplin DW et al; Environ Sci Toxicol 36: 1202-211 (2002)'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'While data specific to altretamine were not located(SRC, 2007), the literature suggests that some pharmaceutically active compounds originating from human and veterinary therapy are not eliminated completely in municipal sewage treatment plants and are therefore discharged into receiving waters(1). Wastewater treatment processes often were not designed to remove them from the effluent(2). Selected organic waste compounds may be degrading to new and more persistent compounds that may be released instead of or in addition to the parent compound(2).',\n",
       "             'Markup': [{'Start': 23,\n",
       "               'Length': 11,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-2123'}]}]}}]},\n",
       "       {'TOCHeading': 'Milk Concentrations',\n",
       "        'Description': 'Concentrations of this compound in milk.',\n",
       "        'Information': [{'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['Thomson/Micromedex. Drug Information for the Health Care  Professional. Volume 1,  Greenwood Village, CO. 2007.'],\n",
       "          'Value': {'StringWithMarkup': [{'String': 'It is not known whether altretamine or its metabolites are distributed into breast milk.',\n",
       "             'Markup': [{'Start': 24,\n",
       "               'Length': 11,\n",
       "               'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "               'Type': 'PubChem Internal Link',\n",
       "               'Extra': 'CID-2123'}]}]}}]},\n",
       "       {'TOCHeading': 'Probable Routes of Human Exposure',\n",
       "        'Description': 'Potential way(s) in which people may come into contact with a hazardous chemical.  Examples of common exposure routes are inhalation, ingestion, skin/eye contact.',\n",
       "        'Information': [{'ReferenceNumber': 21,\n",
       "          'Description': 'PEER REVIEWED',\n",
       "          'Reference': ['McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2004. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2004 (Plus Supplements)., p. 875'],\n",
       "          'Value': {'StringWithMarkup': [{'String': \"/PRECAUTIONS FOR ANTINEOPLASTIC AGENTS:/ ... exposure may be through inadvertent ingestion of the drug on foodstuffs (eg, workers' lunches), inhalation of drug dusts or droplets or direct skin contact. /Antineoplastic agents/\"}]}}]}]}]},\n",
       "   {'TOCHeading': 'Associated Disorders and Diseases',\n",
       "    'Description': 'Disorders and diseases associated with the compound.  The contexts of the associations listed in this section vary. For example, a compound may cause its associated diseases (e.g., carcinogens and cancers) or have a therapeutic effect in treatment of the diseases (e.g., antihistamines and allergies), or be used as a marker/indicator for the diseases (e.g., glucose and diabetes).',\n",
       "    'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections',\n",
       "      'NumberOfColumns': 2,\n",
       "      'ColumnHeadings': ['Disease', 'References'],\n",
       "      'ColumnContents': ['Name', 'Value']}},\n",
       "    'Information': [{'ReferenceNumber': 9,\n",
       "      'Value': {'ExternalTableName': 'ctd_chemical_disease'}},\n",
       "     {'ReferenceNumber': 44,\n",
       "      'Value': {'ExternalTableName': 'collection=ttd_dd'}}]},\n",
       "   {'TOCHeading': 'Literature',\n",
       "    'Description': 'Scientific articles associated with this compound.  Some chemical-literature associations in this section are provided by data contributors or derived from MeSH annotations, as explained in Kim et al., J. Cheminform. 2016, 8, 32.  This section also provides the lists of chemicals, genes/proteins, and diseases, that are co-mentioned in scientific articles, as described in Zaslavsky et al., Front. Res. Metr. Anal., 2021, 6, 689059.',\n",
       "    'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/literature',\n",
       "    'Section': [{'TOCHeading': 'Consolidated References',\n",
       "      'Description': 'The consolidated references include literature data from all sources including Springer Nature, Thieme Chemistry, Wiley, Nature journals, depositor provided citations, and NLM curated PubMed citations.',\n",
       "      'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/literature',\n",
       "      'Information': [{'ReferenceNumber': 50,\n",
       "        'Value': {'ExternalTableName': 'literature'}}]},\n",
       "     {'TOCHeading': 'NLM Curated PubMed Citations',\n",
       "      'Description': 'The NLM Curated PubMed Citations section links to all PubMed records that are tagged with the same MeSH term that has been associated with a particular compound.',\n",
       "      'URL': 'https://jcheminf.biomedcentral.com/articles/10.1186/s13321-016-0142-6',\n",
       "      'Information': [{'ReferenceNumber': 50,\n",
       "        'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed_mesh&db=pccompound&cmd=Link&from_uid=2123',\n",
       "        'Value': {'Boolean': [True]}}]},\n",
       "     {'TOCHeading': 'Springer Nature References',\n",
       "      'Description': \"Literature references related to scientific contents from Springer Nature journals and books. These references have been ranked automatically by an algorithm which calculates the relevance for each substance in a Springer Nature document. It is based on: (1) the TF-IDF, adapted to chemical structures, (2) location information in the text (e.g. title, abstract, keywords), and (3) the document size.  Springer Nature aims to provide only highly qualitative and relevant content but references of lower relevance aren't withheld as they might contain also very useful information.\",\n",
       "      'Information': [{'ReferenceNumber': 42,\n",
       "        'Value': {'ExternalTableName': 'springernature'}}]},\n",
       "     {'TOCHeading': 'Thieme References',\n",
       "      'Description': 'Literature references related to scientific contents from Thieme Chemistry journals and books. The Thieme Chemistry content within this section is provided under a CC-BY-NC-ND 4.0 license (https://creativecommons.org/licenses/by-nc-nd/4.0/), unless otherwise stated.',\n",
       "      'Information': [{'ReferenceNumber': 45,\n",
       "        'Name': 'Thieme References',\n",
       "        'Value': {'ExternalTableName': 'ThiemeChemistry'}}]},\n",
       "     {'TOCHeading': 'Depositor Provided PubMed Citations',\n",
       "      'Description': 'A list of PubMed records about this compound, provided by the depositors of all PubChem substance records that are standardized into this compound.',\n",
       "      'Information': [{'ReferenceNumber': 50,\n",
       "        'Name': 'Depositor Provided PubMed Citations',\n",
       "        'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed&db=pccompound&cmd=Link&from_uid=2123',\n",
       "        'Value': {'ExternalTableName': 'collection=pubmed&pmidsrcs=xref',\n",
       "         'ExternalTableNumRows': 50}}]},\n",
       "     {'TOCHeading': 'Metabolite References',\n",
       "      'Description': 'General metabolite references for this compound, provided by the Human Metabolome Database (HMDB) and other sources.',\n",
       "      'URL': 'https://hmdb.ca/',\n",
       "      'Information': [{'ReferenceNumber': 22,\n",
       "        'Name': 'Metabolite References',\n",
       "        'Value': {'ExternalTableName': 'hmdb', 'ExternalTableNumRows': 4}}]},\n",
       "     {'TOCHeading': 'General References',\n",
       "      'Description': 'General references about this compound, collected from various sources.',\n",
       "      'DisplayControls': {'ListType': 'Numbered'},\n",
       "      'Information': [{'ReferenceNumber': 12,\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Keldsen N, Havsteen H, Vergote I, Bertelsen K, Jakobsen A: Altretamine (hexamethylmelamine) in the treatment of platinum-resistant ovarian cancer: a phase II study. Gynecol Oncol. 2003 Feb;88(2):118-22. [PMID:12586589]',\n",
       "           'Markup': [{'Start': 204,\n",
       "             'Length': 13,\n",
       "             'URL': 'https://www.ncbi.nlm.nih.gov/pubmed/12586589'},\n",
       "            {'Start': 59,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'},\n",
       "            {'Start': 72,\n",
       "             'Length': 18,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/hexamethylmelamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'},\n",
       "            {'Start': 112,\n",
       "             'Length': 8,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Platinum',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'Element-Platinum'}]},\n",
       "          {'String': 'Chan JK, Loizzi V, Manetta A, Berman ML: Oral altretamine used as salvage therapy in recurrent ovarian cancer. Gynecol Oncol. 2004 Jan;92(1):368-71. [PMID:14751188]',\n",
       "           'Markup': [{'Start': 150,\n",
       "             'Length': 13,\n",
       "             'URL': 'https://www.ncbi.nlm.nih.gov/pubmed/14751188'},\n",
       "            {'Start': 46,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]},\n",
       "          {'String': 'Malik IA: Altretamine is an effective palliative therapy of patients with recurrent epithelial ovarian cancer. Jpn J Clin Oncol. 2001 Feb;31(2):69-73. [PMID:11302345]',\n",
       "           'Markup': [{'Start': 152,\n",
       "             'Length': 13,\n",
       "             'URL': 'https://www.ncbi.nlm.nih.gov/pubmed/11302345'},\n",
       "            {'Start': 10,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]},\n",
       "          {'String': \"Damia G, D'Incalci M: Clinical pharmacokinetics of altretamine. Clin Pharmacokinet. 1995 Jun;28(6):439-48. [PMID:7656502]\",\n",
       "           'Markup': [{'Start': 108,\n",
       "             'Length': 12,\n",
       "             'URL': 'https://www.ncbi.nlm.nih.gov/pubmed/7656502'},\n",
       "            {'Start': 51,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}}]},\n",
       "     {'TOCHeading': 'Chemical Co-Occurrences in Literature',\n",
       "      'Description': 'Chemical co-occurrences in literature highlight chemicals mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.',\n",
       "      'URL': 'https://doi.org/10.3389/frma.2021.689059',\n",
       "      'Information': [{'ReferenceNumber': 50,\n",
       "        'Name': 'Co-Occurrence Panel',\n",
       "        'Value': {'StringWithMarkup': [{'String': 'ChemicalNeighbor'},\n",
       "          {'String': 'Chemical'},\n",
       "          {'String': 'ChemicalName_1'},\n",
       "          {'String': 'ChemicalName_2'},\n",
       "          {'String': 'SUMMARY_URL.cid'},\n",
       "          {'String': 'CID'},\n",
       "          {'String': 'CID'}]}}]},\n",
       "     {'TOCHeading': 'Chemical-Gene Co-Occurrences in Literature',\n",
       "      'Description': 'Chemical-gene co-occurrences in the literature highlight chemical-gene pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two.  Note that a co-occurring gene entity is organism non-specific and could refer to a gene, protein, or enzyme.  Also note that this content is not human curated.  It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.',\n",
       "      'URL': 'https://doi.org/10.3389/frma.2021.689059',\n",
       "      'Information': [{'ReferenceNumber': 50,\n",
       "        'Name': 'Co-Occurrence Panel',\n",
       "        'Value': {'StringWithMarkup': [{'String': 'ChemicalGeneSymbolNeighbor'},\n",
       "          {'String': 'Gene/Protein/Enzyme'},\n",
       "          {'String': 'ChemicalName'},\n",
       "          {'String': 'GeneSymbolName'},\n",
       "          {'String': 'SUMMARY_URL.genesymbol'},\n",
       "          {'String': 'CID'},\n",
       "          {'String': 'GeneSymbol'}]}}]},\n",
       "     {'TOCHeading': 'Chemical-Disease Co-Occurrences in Literature',\n",
       "      'Description': 'Chemical-disease co-occurrences in literature highlight chemical-disease pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.',\n",
       "      'URL': 'https://doi.org/10.3389/frma.2021.689059',\n",
       "      'Information': [{'ReferenceNumber': 50,\n",
       "        'Name': 'Co-Occurrence Panel',\n",
       "        'Value': {'StringWithMarkup': [{'String': 'ChemicalDiseaseNeighbor'},\n",
       "          {'String': 'Disease'},\n",
       "          {'String': 'ChemicalName'},\n",
       "          {'String': 'DiseaseName'},\n",
       "          {'String': 'https://meshb.nlm.nih.gov/record/ui?ui='},\n",
       "          {'String': 'CID'},\n",
       "          {'String': 'MeSH'}]}}]}]},\n",
       "   {'TOCHeading': 'Patents',\n",
       "    'Description': 'Patent applications/documents that mention this compound.',\n",
       "    'DisplayControls': {'ListType': 'Columns'},\n",
       "    'Section': [{'TOCHeading': 'Depositor-Supplied Patent Identifiers',\n",
       "      'Description': 'Patent identifiers provided by data depositors, along with information on those patents.',\n",
       "      'Information': [{'ReferenceNumber': 50,\n",
       "        'Value': {'ExternalTableName': 'patent'}},\n",
       "       {'ReferenceNumber': 50,\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Link to all deposited patent identifiers',\n",
       "           'Markup': [{'Start': 0,\n",
       "             'Length': 40,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/2123/xrefs/PatentID/TXT'}]}]}}]},\n",
       "     {'TOCHeading': 'WIPO PATENTSCOPE',\n",
       "      'Description': \"Use the provided link to show patents associated with this chemical structure in WIPO's PATENTSCOPE system.\",\n",
       "      'URL': 'https://www.wipo.int/patentscope/en/',\n",
       "      'Information': [{'ReferenceNumber': 69,\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Patents are available for this chemical structure:'},\n",
       "          {'String': 'https://patentscope.wipo.int/search/en/result.jsf?inchikey=UUVWYPNAQBNQJQ-UHFFFAOYSA-N',\n",
       "           'Markup': [{'Start': 0,\n",
       "             'Length': 86,\n",
       "             'URL': 'https://patentscope.wipo.int/search/en/result.jsf?inchikey=UUVWYPNAQBNQJQ-UHFFFAOYSA-N'}]}]}}]}]},\n",
       "   {'TOCHeading': 'Interactions and Pathways',\n",
       "    'Description': 'This section provides information on the biomolecular interactions of this compound with drugs, genes, proteins, etc., as well as the pathways in which this compound is involved.',\n",
       "    'Section': [{'TOCHeading': 'Chemical-Target Interactions',\n",
       "      'Description': 'Interactions between targets and this compound',\n",
       "      'Information': [{'ReferenceNumber': 5,\n",
       "        'Value': {'ExternalTableName': 'consolidatedcompoundtarget'}},\n",
       "       {'ReferenceNumber': 9,\n",
       "        'Value': {'ExternalTableName': 'consolidatedcompoundtarget'}},\n",
       "       {'ReferenceNumber': 10,\n",
       "        'Value': {'ExternalTableName': 'consolidatedcompoundtarget'}},\n",
       "       {'ReferenceNumber': 44,\n",
       "        'Value': {'ExternalTableName': 'consolidatedcompoundtarget'}}]},\n",
       "     {'TOCHeading': 'Drug-Drug Interactions',\n",
       "      'Description': 'Drug-drug interactions for this compound.  Drug-drug interactions occur when two or more drugs react with each other. This drug-drug interaction may cause you to experience an unexpected side effect. For example, mixing a drug you take to help you sleep (a sedative) and a drug you take for allergies (an antihistamine) can slow your reactions and make driving a car or operating machinery dangerous.',\n",
       "      'URL': 'https://www.fda.gov/drugs/resources-you-drugs/drug-interactions-what-you-should-know',\n",
       "      'Information': [{'ReferenceNumber': 12,\n",
       "        'Value': {'ExternalTableName': 'drugbankddi'}}]},\n",
       "     {'TOCHeading': 'Drug-Food Interactions',\n",
       "      'Description': 'Drug-food interactions for this compound. Drug-food/beverage interactions result from drugs reacting with foods or beverages. For example, mixing alcohol with some drugs may cause you to feel tired or slow your reactions.',\n",
       "      'URL': 'https://www.fda.gov/drugs/resources-you-drugs/drug-interactions-what-you-should-know',\n",
       "      'DisplayControls': {'ListType': 'Bulleted'},\n",
       "      'Information': [{'ReferenceNumber': 12,\n",
       "        'Value': {'StringWithMarkup': [{'String': 'Take after a meal. Take altretamine after meals and at bedtime.',\n",
       "           'Markup': [{'Start': 24,\n",
       "             'Length': 11,\n",
       "             'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/altretamine',\n",
       "             'Type': 'PubChem Internal Link',\n",
       "             'Extra': 'CID-2123'}]}]}}]}]},\n",
       "   {'TOCHeading': 'Biological Test Results',\n",
       "    'Description': 'A PubChem substance or compound summary page displays biological test results from the PubChem BioAssay database, if/as available, for the chemical structure currently displayed. You can embed biological test results displays within your own web pages, for a PubChem Compound or Substance of interest, by using the BioActivity Widget.',\n",
       "    'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/widgets',\n",
       "    'Section': [{'TOCHeading': 'BioAssay Results',\n",
       "      'Description': 'Bioactivity data for this compound, reported in PubChem BioAssay records.',\n",
       "      'Information': [{'ReferenceNumber': 50,\n",
       "        'Value': {'ExternalTableName': 'bioactivity'}}]}]},\n",
       "   {'TOCHeading': 'Classification',\n",
       "    'Description': 'A set of concepts and categories in a subject area or domain that shows their properties and the relations between them.',\n",
       "    'Section': [{'TOCHeading': 'MeSH Tree',\n",
       "      'Description': 'The Medical Subject Headings (MeSH) tree for this entity.  MeSH is a controlled and hierarchically-organized vocabulary produced by the National Library of Medicine.',\n",
       "      'URL': 'https://www.nlm.nih.gov/mesh',\n",
       "      'Information': [{'ReferenceNumber': 51,\n",
       "        'Name': 'HID',\n",
       "        'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=1',\n",
       "        'Value': {'Number': [1]}}]},\n",
       "     {'TOCHeading': 'NCI Thesaurus Tree',\n",
       "      'Description': 'NCI Thesaurus (NCIt) hierarchy',\n",
       "      'URL': 'https://ncithesaurus.nci.nih.gov',\n",
       "      'Information': [{'ReferenceNumber': 66,\n",
       "        'Name': 'HID',\n",
       "        'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=112',\n",
       "        'Value': {'Number': [112]}}]},\n",
       "     {'TOCHeading': 'ChEBI Ontology',\n",
       "      'Description': \"ChEBI Ontology tree.  ChEBI is an acronym for Chemical Entities of Biological Interest, which is a freely available dictionary of molecular entities focused on 'small' chemical compounds. ChEBI incorporates an ontological classification, whereby the relationships between molecular entities or classes of entities and their parents and/or children are specified.\",\n",
       "      'URL': 'https://www.ebi.ac.uk/chebi/',\n",
       "      'Information': [{'ReferenceNumber': 52,\n",
       "        'Name': 'HID',\n",
       "        'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=2',\n",
       "        'Value': {'Number': [2]}}]},\n",
       "     {'TOCHeading': 'KEGG: ATC',\n",
       "      'Description': 'Anatomical Therapeutic Chemical (ATC) classification tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).',\n",
       "      'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08303',\n",
       "      'Information': [{'ReferenceNumber': 53,\n",
       "        'Name': 'HID',\n",
       "        'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=16',\n",
       "        'Value': {'Number': [16]}}]},\n",
       "     {'TOCHeading': 'WHO ATC Classification System',\n",
       "      'Description': 'The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of drugs. This pharmaceutical coding system divides drugs into different groups according to the organ or system on which they act and/or their therapeutic and chemical characteristics. Each bottom-level ATC code stands for a pharmaceutically used substance, or a combination of substances, in a single indication (or use). This means that one drug can have more than one code: acetylsalicylic acid (aspirin), for example, has A01AD05 as a drug for local oral treatment, B01AC06 as a platelet inhibitor, and N02BA01 as an analgesic and antipyretic. On the other hand, several different brands share the same code if they have the same active substance and indications.',\n",
       "      'URL': 'https://www.who.int/tools/atc-ddd-toolkit/atc-classification',\n",
       "      'Information': [{'ReferenceNumber': 56,\n",
       "        'Name': 'HID',\n",
       "        'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=79',\n",
       "        'Value': {'Number': [79]}}]},\n",
       "     {'TOCHeading': 'FDA Pharm Classes',\n",
       "      'Description': 'Pharmacologic Class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of three attributes of the active moiety: mechanism of action (MOA), physiologic effect (PE) and chemical structure (CS).  An FDA \"Established Pharmacologic Class\" (EPC) text phrase is a pharmacologic class associated with an approved indication of an active moiety that the FDA has determined to be scientifically valid and clinically meaningful.',\n",
       "      'URL': 'https://www.fda.gov/industry/structured-product-labeling-resources/pharmacologic-class',\n",
       "      'Information': [{'ReferenceNumber': 55,\n",
       "        'Name': 'HID',\n",
       "        'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=78',\n",
       "        'Value': {'Number': [78]}}]},\n",
       "     {'TOCHeading': 'ChemIDplus',\n",
       "      'Description': 'Classification of this compound, provided by ChemIDplus, which is a free web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases.  ChemIDplus groups chemicals based on the source locators (i.e., what information resources have data for a given chemical).',\n",
       "      'URL': 'https://chem.nlm.nih.gov/chemidplus/',\n",
       "      'Information': [{'ReferenceNumber': 58,\n",
       "        'Name': 'HID',\n",
       "        'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=84',\n",
       "        'Value': {'Number': [84]}}]},\n",
       "     {'TOCHeading': 'CAMEO Chemicals',\n",
       "      'Description': 'CAMEO chemical reactivity classification from CAMEO Chemicals, which is a database of hazardous chemical datasheets that emergency responders and planners can use to get response recommendations and predict hazards (e.g., explosions or toxic fumes).',\n",
       "      'URL': 'https://cameochemicals.noaa.gov/',\n",
       "      'Information': [{'ReferenceNumber': 59,\n",
       "        'Name': 'HID',\n",
       "        'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=86',\n",
       "        'Value': {'Number': [86]}}]},\n",
       "     {'TOCHeading': 'ChEMBL Target Tree',\n",
       "      'Description': 'Classification of this entity in the context of targets, provided by ChEMBL.',\n",
       "      'URL': 'https://www.ebi.ac.uk/chembl/',\n",
       "      'Information': [{'ReferenceNumber': 60,\n",
       "        'Name': 'HID',\n",
       "        'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=87',\n",
       "        'Value': {'Number': [87]}}]},\n",
       "     {'TOCHeading': 'UN GHS Classification',\n",
       "      'Description': \"The United Nations' Globally Harmonized System of Classification and Labelling of Chemicals (GHS) provides a harmonized basis for globally uniform physical, environmental, and health and safety information on hazardous chemical substances and mixtures.\",\n",
       "      'URL': 'https://unece.org/about-ghs',\n",
       "      'Information': [{'ReferenceNumber': 57,\n",
       "        'Name': 'HID',\n",
       "        'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=83',\n",
       "        'Value': {'Number': [83]}}]},\n",
       "     {'TOCHeading': 'NORMAN Suspect List Exchange Classification',\n",
       "      'Description': 'A classification from the NORMAN Suspect List Exchange, which serve as a central access point to find lists of chemicals with environmental concerns.',\n",
       "      'URL': 'https://www.norman-network.com/nds/SLE/',\n",
       "      'Information': [{'ReferenceNumber': 61,\n",
       "        'Name': 'HID',\n",
       "        'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=101',\n",
       "        'Value': {'Number': [101]}}]},\n",
       "     {'TOCHeading': 'CCSBase Classification',\n",
       "      'Description': 'CCSbase is an integrated platform that contains collision cross section data for the compound.  The CCSbase classification groups the compounds by the type of adduct ions that can be formed from them (e.g., [M-H]-, [M+H]+, [M+Na]+, [M+K]+).',\n",
       "      'URL': 'https://ccsbase.net/',\n",
       "      'Information': [{'ReferenceNumber': 62,\n",
       "        'Name': 'HID',\n",
       "        'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=104',\n",
       "        'Value': {'Number': [104]}}]},\n",
       "     {'TOCHeading': 'EPA DSSTox Classification',\n",
       "      'Description': \"Classification from the U.S. Environmental Protection Agency's Distributed Structure-Searchable Toxicity (DSSTox) database. DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology. A distinguishing feature of this effort is the accurate mapping of bioassay and physicochemical property data associated with chemical substances to their corresponding chemical structures. \",\n",
       "      'URL': 'https://www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database',\n",
       "      'Information': [{'ReferenceNumber': 63,\n",
       "        'Name': 'HID',\n",
       "        'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=105',\n",
       "        'Value': {'Number': [105]}}]},\n",
       "     {'TOCHeading': 'EPA Substance Registry Services Tree',\n",
       "      'Description': \"Substance Registry Services (SRS) is the Environmental Protection Agency's (EPA) central system for information about substances that are tracked or regulated by EPA or other sources. It is a resource for basic information about chemicals, biological organisms, and other substances of interest to EPA and its state and tribal partners. SRS makes it possible to identify which EPA data systems, environmental statutes, or other sources have information about a substance and which synonym is used by that system or statute.\",\n",
       "      'Information': [{'ReferenceNumber': 67,\n",
       "        'Name': 'HID',\n",
       "        'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=123',\n",
       "        'Value': {'Number': [123]}}]}]}],\n",
       "  'Reference': [{'ReferenceNumber': 1,\n",
       "    'SourceName': 'CAMEO Chemicals',\n",
       "    'SourceID': '20475',\n",
       "    'Name': 'HEXAMETHYLMELAMINE',\n",
       "    'Description': \"CAMEO Chemicals is a chemical database designed for people who are involved in hazardous material incident response and planning. CAMEO Chemicals contains a library with thousands of datasheets containing response-related information and recommendations for hazardous materials that are commonly transported, used, or stored in the United States. CAMEO Chemicals was developed by the National Oceanic and Atmospheric Administration's Office of Response and Restoration in partnership with the Environmental Protection Agency's Office of Emergency Management.\",\n",
       "    'URL': 'https://cameochemicals.noaa.gov/chemical/20475',\n",
       "    'LicenseNote': 'CAMEO Chemicals and all other CAMEO products are available at no charge to those organizations and individuals (recipients) responsible for the safe handling of chemicals. However, some of the chemical data itself is subject to the copyright restrictions of the companies or organizations that provided the data.',\n",
       "    'LicenseURL': 'https://cameochemicals.noaa.gov/help/reference/terms_and_conditions.htm?d_f=false',\n",
       "    'ANID': 758833},\n",
       "   {'ReferenceNumber': 2,\n",
       "    'SourceName': 'CAS Common Chemistry',\n",
       "    'SourceID': '645-05-6',\n",
       "    'Name': 'Altretamine',\n",
       "    'Description': 'CAS Common Chemistry is an open community resource for accessing chemical information. Nearly 500,000 chemical substances from CAS REGISTRY cover areas of community interest, including common and frequently regulated chemicals, and those relevant to high school and undergraduate chemistry classes. This chemical information, curated by our expert scientists, is provided in alignment with our mission as a division of the American Chemical Society.',\n",
       "    'URL': 'https://commonchemistry.cas.org/detail?cas_rn=645-05-6',\n",
       "    'LicenseNote': 'The data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.',\n",
       "    'LicenseURL': 'https://creativecommons.org/licenses/by-nc/4.0/',\n",
       "    'ANID': 12684001},\n",
       "   {'ReferenceNumber': 6,\n",
       "    'SourceName': 'ChemIDplus',\n",
       "    'SourceID': '0000645056',\n",
       "    'Name': 'Altretamine [USAN:USP:INN:BAN]',\n",
       "    'Description': 'ChemIDplus is a free, web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases, including the TOXNET system.',\n",
       "    'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0000645056',\n",
       "    'LicenseURL': 'https://www.nlm.nih.gov/copyright.html',\n",
       "    'IsToxnet': True,\n",
       "    'ANID': 777328},\n",
       "   {'ReferenceNumber': 12,\n",
       "    'SourceName': 'DrugBank',\n",
       "    'SourceID': 'DB00488',\n",
       "    'Name': 'Altretamine',\n",
       "    'Description': 'The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information.',\n",
       "    'URL': 'https://www.drugbank.ca/drugs/DB00488',\n",
       "    'LicenseNote': \"Creative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode)\",\n",
       "    'LicenseURL': 'https://www.drugbank.ca/legal/terms_of_use',\n",
       "    'ANID': 3603256},\n",
       "   {'ReferenceNumber': 13,\n",
       "    'SourceName': 'DTP/NCI',\n",
       "    'SourceID': 'NSC 758231',\n",
       "    'Name': 'altretamine',\n",
       "    'Description': 'The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate the discovery and development of new cancer therapeutic agents.',\n",
       "    'URL': 'https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=758231',\n",
       "    'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.',\n",
       "    'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse',\n",
       "    'ANID': 6608258},\n",
       "   {'ReferenceNumber': 14,\n",
       "    'SourceName': 'DTP/NCI',\n",
       "    'SourceID': 'NSC 13875',\n",
       "    'Name': 'altretamine',\n",
       "    'Description': 'The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate the discovery and development of new cancer therapeutic agents.',\n",
       "    'URL': 'https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=13875',\n",
       "    'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.',\n",
       "    'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse',\n",
       "    'ANID': 6866545},\n",
       "   {'ReferenceNumber': 15,\n",
       "    'SourceName': 'EPA DSSTox',\n",
       "    'SourceID': 'DTXSID4022579',\n",
       "    'Name': 'Hexamethylmelamine',\n",
       "    'Description': 'DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology.',\n",
       "    'URL': 'https://comptox.epa.gov/dashboard/DTXSID4022579',\n",
       "    'LicenseURL': 'https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources',\n",
       "    'ANID': 1150777},\n",
       "   {'ReferenceNumber': 17,\n",
       "    'SourceName': 'European Chemicals Agency (ECHA)',\n",
       "    'SourceID': '211-428-4',\n",
       "    'Name': 'Altretamine',\n",
       "    'Description': \"The European Chemicals Agency (ECHA) is an agency of the European Union which is the driving force among regulatory authorities in implementing the EU's groundbreaking chemicals legislation for the benefit of human health and the environment as well as for innovation and competitiveness.\",\n",
       "    'URL': 'https://echa.europa.eu/substance-information/-/substanceinfo/100.010.391',\n",
       "    'LicenseNote': 'Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: \"Source: European Chemicals Agency, http://echa.europa.eu/\". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.',\n",
       "    'LicenseURL': 'https://echa.europa.eu/web/guest/legal-notice',\n",
       "    'ANID': 2065511},\n",
       "   {'ReferenceNumber': 18,\n",
       "    'SourceName': 'FDA Global Substance Registration System (GSRS)',\n",
       "    'SourceID': 'Q8BIH59O7H',\n",
       "    'Name': 'ALTRETAMINE',\n",
       "    'Description': 'The FDA Global Substance Registration System (GSRS) enables the efficient and accurate exchange of information on what substances are in regulated products. Instead of relying on names, which vary across regulatory domains, countries, and regions, the GSRS knowledge base makes it possible for substances to be defined by standardized, scientific descriptions.',\n",
       "    'URL': 'https://gsrs.ncats.nih.gov/ginas/app/beta/substances/Q8BIH59O7H',\n",
       "    'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.',\n",
       "    'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking',\n",
       "    'ANID': 5835572},\n",
       "   {'ReferenceNumber': 21,\n",
       "    'SourceName': 'Hazardous Substances Data Bank (HSDB)',\n",
       "    'SourceID': '7559',\n",
       "    'Name': 'ALTRETAMINE',\n",
       "    'Description': 'The Hazardous Substances Data Bank (HSDB) is a toxicology database that focuses on the toxicology of potentially hazardous chemicals. It provides information on human exposure, industrial hygiene, emergency handling procedures, environmental fate, regulatory requirements, nanomaterials, and related areas. The information in HSDB has been assessed by a Scientific Review Panel.',\n",
       "    'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/hsdb/7559',\n",
       "    'LicenseURL': 'https://www.nlm.nih.gov/web_policies.html',\n",
       "    'IsToxnet': True,\n",
       "    'ANID': 5116},\n",
       "   {'ReferenceNumber': 22,\n",
       "    'SourceName': 'Human Metabolome Database (HMDB)',\n",
       "    'SourceID': 'HMDB0014631',\n",
       "    'Name': 'Altretamine',\n",
       "    'Description': 'The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.',\n",
       "    'URL': 'http://www.hmdb.ca/metabolites/HMDB0014631',\n",
       "    'LicenseNote': '\\tHMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.',\n",
       "    'LicenseURL': 'http://www.hmdb.ca/citing',\n",
       "    'ANID': 2151124},\n",
       "   {'ReferenceNumber': 4,\n",
       "    'SourceName': 'ChEBI',\n",
       "    'SourceID': 'CHEBI:OBO:2123',\n",
       "    'Name': 'Hexamethylmelamine',\n",
       "    'Description': 'Chemical Entities of Biological Interest (ChEBI) is a database and ontology of molecular entities focused on \\'small\\' chemical compounds, that is part of the Open Biomedical Ontologies effort. The term \"molecular entity\" refers to any constitutionally or isotopically distinct atom, molecule, ion, ion pair, radical, radical ion, complex, conformer, etc., identifiable as a separately distinguishable entity.',\n",
       "    'URL': 'http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:24564',\n",
       "    'ANID': 2501709},\n",
       "   {'ReferenceNumber': 20,\n",
       "    'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Q8BIH59O7H',\n",
       "    'Name': 'ALTRETAMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/industry/structured-product-labeling-resources/pharmacologic-class',\n",
       "    'URL': 'https://dailymed.nlm.nih.gov/dailymed/browse-drug-classes.cfm',\n",
       "    'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.',\n",
       "    'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking',\n",
       "    'ANID': 6489741},\n",
       "   {'ReferenceNumber': 27,\n",
       "    'SourceName': 'LiverTox',\n",
       "    'SourceID': 'Altretamine',\n",
       "    'Name': 'Altretamine',\n",
       "    'Description': 'LIVERTOX provides up-to-date, accurate, and easily accessed information on the diagnosis, cause, frequency, patterns, and management of liver injury attributable to prescription and nonprescription medications, herbals and dietary supplements.',\n",
       "    'URL': 'https://www.ncbi.nlm.nih.gov/books/n/livertox/Altretamine/',\n",
       "    'LicenseURL': 'https://www.nlm.nih.gov/copyright.html',\n",
       "    'IsToxnet': True,\n",
       "    'ANID': 2261606},\n",
       "   {'ReferenceNumber': 31,\n",
       "    'SourceName': 'NCI Thesaurus (NCIt)',\n",
       "    'SourceID': 'C544::Compound',\n",
       "    'Description': 'NCI Thesaurus (NCIt), from the U.S. National Cancer Institute, provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.',\n",
       "    'URL': 'https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C544',\n",
       "    'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.',\n",
       "    'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse',\n",
       "    'ANID': 14394580},\n",
       "   {'ReferenceNumber': 30,\n",
       "    'SourceName': 'NCI Investigational Drugs',\n",
       "    'SourceID': '13875',\n",
       "    'Name': 'HEXAMETHYLMELAMINE',\n",
       "    'Description': 'An investigational drug is one that is under study but does not have permission from the U.S. Food and Drug Administration (FDA) to be legally marketed and sold in the United States. NCI provides the investigational drug to the physicians who are participating in clinical trials or TRC protocols. For more information please visit NCI investigational drug website: https://www.cancer.gov/about-cancer/treatment/drugs/investigational-drug-access-fact-sheet',\n",
       "    'URL': 'http://dtp.nci.nih.gov/NCI-InvestigationalDrugsCI92/13875%20(1992).txt',\n",
       "    'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse',\n",
       "    'ANID': 2266222},\n",
       "   {'ReferenceNumber': 3,\n",
       "    'SourceName': 'CCSbase',\n",
       "    'SourceID': 'CCSBASE_FC9EA4664C',\n",
       "    'Name': 'ALTRETAMINE',\n",
       "    'Description': 'CCSbase curates experimental collision cross section values measured on various ion mobility platforms as a resource for the research community. CCSbase also builds prediction models for comprehensive prediction of collision cross sections for a given molecule.',\n",
       "    'ANID': 9267022},\n",
       "   {'ReferenceNumber': 5,\n",
       "    'SourceName': 'ChEMBL',\n",
       "    'SourceID': 'CHEMBL1455::Compound',\n",
       "    'Description': 'ChEMBL or ChEMBLdb is a manually curated chemical database of bioactive molecules with drug-like properties. It is maintained by the European Bioinformatics Institute (EBI), of the European Molecular Biology Laboratory (EMBL), based at the Wellcome Trust Genome Campus, Hinxton, UK.',\n",
       "    'URL': 'https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1455/',\n",
       "    'LicenseNote': \"Access to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).\",\n",
       "    'LicenseURL': 'http://www.ebi.ac.uk/Information/termsofuse.html',\n",
       "    'ANID': 12650059},\n",
       "   {'ReferenceNumber': 9,\n",
       "    'SourceName': 'Comparative Toxicogenomics Database (CTD)',\n",
       "    'SourceID': 'D006585::Compound',\n",
       "    'Name': 'Altretamine',\n",
       "    'Description': 'CTD is a robust, publicly available database that aims to advance understanding about how environmental exposures affect human health.',\n",
       "    'URL': 'https://ctdbase.org/detail.go?type=chem&acc=D006585',\n",
       "    'LicenseNote': 'It is to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of NC State University.',\n",
       "    'LicenseURL': 'http://ctdbase.org/about/legal.jsp',\n",
       "    'ANID': 9024039},\n",
       "   {'ReferenceNumber': 10,\n",
       "    'SourceName': 'Drug Gene Interaction database (DGIdb)',\n",
       "    'SourceID': 'CHEMBL1455_ALTRETAMINE',\n",
       "    'Name': 'ALTRETAMINE',\n",
       "    'Description': 'The Drug Gene Interaction Database (DGIdb, www.dgidb.org) is a web resource that consolidates disparate data sources describing drug - gene interactions and gene druggability.',\n",
       "    'URL': 'https://www.dgidb.org/drugs/ALTRETAMINE',\n",
       "    'LicenseNote': 'The data used in DGIdb is all open access and where possible made available as raw data dumps in the downloads section.',\n",
       "    'LicenseURL': 'http://www.dgidb.org/downloads',\n",
       "    'ANID': 19818516},\n",
       "   {'ReferenceNumber': 44,\n",
       "    'SourceName': 'Therapeutic Target Database (TTD)',\n",
       "    'SourceID': 'D02LPF',\n",
       "    'Name': 'Altretamine',\n",
       "    'Description': 'Therapeutic Target Database (TTD) is a database to provide information about the known and explored therapeutic protein and nucleic acid targets, the targeted disease, pathway information and the corresponding drugs directed at each of these targets.',\n",
       "    'URL': 'https://idrblab.net/ttd/data/drug/details/D02LPF',\n",
       "    'ANID': 19764697},\n",
       "   {'ReferenceNumber': 7,\n",
       "    'SourceName': 'ChemIDplus',\n",
       "    'SourceID': 'r_134976605',\n",
       "    'Description': 'The toxicity data was from the legacy RTECS data set in ChemIDplus.',\n",
       "    'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0000645056',\n",
       "    'LicenseURL': 'https://www.nlm.nih.gov/copyright.html',\n",
       "    'IsToxnet': True,\n",
       "    'ANID': 19467171},\n",
       "   {'ReferenceNumber': 8,\n",
       "    'SourceName': 'ClinicalTrials.gov',\n",
       "    'SourceID': 'cid2123',\n",
       "    'Description': 'ClinicalTrials.gov is an NIH registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.',\n",
       "    'URL': 'https://clinicaltrials.gov/',\n",
       "    'LicenseNote': 'The ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.',\n",
       "    'LicenseURL': 'https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use',\n",
       "    'ANID': 5191345},\n",
       "   {'ReferenceNumber': 11,\n",
       "    'SourceName': 'Drug Induced Liver Injury Rank (DILIrank) Dataset',\n",
       "    'SourceID': 'LT00502',\n",
       "    'Name': 'altretamine',\n",
       "    'Description': 'Drug-Induced Liver Injury Rank (DILIrank) Dataset is a list of drugs ranked by their risk for developing DILI in humans.',\n",
       "    'URL': 'https://www.fda.gov/science-research/liver-toxicity-knowledge-base-ltkb/drug-induced-liver-injury-rank-dilirank-dataset',\n",
       "    'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.',\n",
       "    'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking',\n",
       "    'ANID': 12652367},\n",
       "   {'ReferenceNumber': 16,\n",
       "    'SourceName': 'European Chemicals Agency (ECHA)',\n",
       "    'SourceID': '66399',\n",
       "    'Name': 'Altretamine',\n",
       "    'Description': 'The information provided here is aggregated from the \"Notified classification and labelling\" from ECHA\\'s C&L Inventory. Read more: https://echa.europa.eu/information-on-chemicals/cl-inventory-database',\n",
       "    'URL': 'https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/66399',\n",
       "    'LicenseNote': 'Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: \"Source: European Chemicals Agency, http://echa.europa.eu/\". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.',\n",
       "    'LicenseURL': 'https://echa.europa.eu/web/guest/legal-notice',\n",
       "    'ANID': 1870682},\n",
       "   {'ReferenceNumber': 19,\n",
       "    'SourceName': 'FDA Orange Book',\n",
       "    'SourceID': 'org_2123',\n",
       "    'Description': 'The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).',\n",
       "    'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book',\n",
       "    'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.',\n",
       "    'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking',\n",
       "    'ANID': 397939},\n",
       "   {'ReferenceNumber': 23,\n",
       "    'SourceName': 'Human Metabolome Database (HMDB)',\n",
       "    'SourceID': 'HMDB0014631_msms_374910',\n",
       "    'Name': 'HMDB0014631_msms_374910',\n",
       "    'Description': 'The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.',\n",
       "    'URL': 'https://hmdb.ca/metabolites/HMDB0014631#spectra',\n",
       "    'LicenseNote': '\\tHMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.',\n",
       "    'LicenseURL': 'http://www.hmdb.ca/citing',\n",
       "    'ANID': 15332981},\n",
       "   {'ReferenceNumber': 24,\n",
       "    'SourceName': 'Human Metabolome Database (HMDB)',\n",
       "    'SourceID': 'HMDB0014631_msms_450612',\n",
       "    'Name': 'HMDB0014631_msms_450612',\n",
       "    'Description': 'The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.',\n",
       "    'URL': 'https://hmdb.ca/metabolites/HMDB0014631#spectra',\n",
       "    'LicenseNote': '\\tHMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.',\n",
       "    'LicenseURL': 'http://www.hmdb.ca/citing',\n",
       "    'ANID': 15332982},\n",
       "   {'ReferenceNumber': 25,\n",
       "    'SourceName': 'Human Metabolome Database (HMDB)',\n",
       "    'SourceID': 'HMDB0014631_msms_451653',\n",
       "    'Name': 'HMDB0014631_msms_451653',\n",
       "    'Description': 'The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.',\n",
       "    'URL': 'https://hmdb.ca/metabolites/HMDB0014631#spectra',\n",
       "    'LicenseNote': '\\tHMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.',\n",
       "    'LicenseURL': 'http://www.hmdb.ca/citing',\n",
       "    'ANID': 15332983},\n",
       "   {'ReferenceNumber': 36,\n",
       "    'SourceName': 'NIST Mass Spectrometry Data Center',\n",
       "    'SourceID': 'MS-MS #1 for UUVWYPNAQBNQJQ-UHFFFAOYSA-N',\n",
       "    'Name': 'Altretamine',\n",
       "    'Description': 'The NIST Mass Spectrometry Data Center, a Group in the Biomolecular Measurement Division (BMD), develops evaluated mass spectral libraries and provides related software tools. These products are intended to assist compound identification by providing reference mass spectra for GC/MS (by electron ionization) and LC-MS/MS (by tandem mass spectrometry) as well as gas phase retention indices for GC.',\n",
       "    'URL': 'http://www.nist.gov/srd/nist1a.cfm',\n",
       "    'LicenseURL': 'https://www.nist.gov/srd/public-law',\n",
       "    'ANID': 290312},\n",
       "   {'ReferenceNumber': 26,\n",
       "    'SourceName': 'Japan Chemical Substance Dictionary (Nikkaji)',\n",
       "    'SourceID': 'J7.067J',\n",
       "    'Description': 'The Japan Chemical Substance Dictionary (Nikkaji) has a search system that helps obtain knowledge from dissimilar fields and discover concepts that cross boundaries of specializations.',\n",
       "    'URL': 'http://jglobal.jst.go.jp/en/redirect?Nikkaji_No=J7.067J',\n",
       "    'ANID': 22127929},\n",
       "   {'ReferenceNumber': 28,\n",
       "    'SourceName': 'MassBank of North America (MoNA)',\n",
       "    'SourceID': 'CCMSLIB00000078079',\n",
       "    'Name': 'Altretamine (Hexalen)',\n",
       "    'Description': 'MassBank of North America (MoNA) is a metadata-centric, auto-curating repository designed for efficient storage and querying of mass spectral records.',\n",
       "    'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=exists(compound.metaData.name:%27InChIKey%27%20and%20compound.metaData.value:%27UUVWYPNAQBNQJQ-UHFFFAOYSA-N%27)',\n",
       "    'LicenseNote': 'The content of the MoNA database is licensed under CC BY 4.0.',\n",
       "    'LicenseURL': 'https://mona.fiehnlab.ucdavis.edu/documentation/license',\n",
       "    'ANID': 3429096},\n",
       "   {'ReferenceNumber': 29,\n",
       "    'SourceName': 'Metabolomics Workbench',\n",
       "    'SourceID': '42833',\n",
       "    'Name': 'Altretamine',\n",
       "    'Description': 'The Metabolomics Workbench serves as a national and international repository for metabolomics data and metadata and provides analysis tools and access to metabolite standards, protocols, tutorials, training, and more.',\n",
       "    'URL': 'https://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=42833',\n",
       "    'ANID': 20204268},\n",
       "   {'ReferenceNumber': 32,\n",
       "    'SourceName': 'NIST Mass Spectrometry Data Center',\n",
       "    'SourceID': 'GC-MS #1 for UUVWYPNAQBNQJQ-UHFFFAOYSA-N',\n",
       "    'Name': 'Altretamine',\n",
       "    'Description': 'The NIST Mass Spectrometry Data Center, a Group in the Biomolecular Measurement Division (BMD), develops evaluated mass spectral libraries and provides related software tools. These products are intended to assist compound identification by providing reference mass spectra for GC/MS (by electron ionization) and LC-MS/MS (by tandem mass spectrometry) as well as gas phase retention indices for GC.',\n",
       "    'URL': 'http://www.nist.gov/srd/nist1a.cfm',\n",
       "    'LicenseURL': 'https://www.nist.gov/srd/public-law',\n",
       "    'ANID': 195962},\n",
       "   {'ReferenceNumber': 33,\n",
       "    'SourceName': 'NIST Mass Spectrometry Data Center',\n",
       "    'SourceID': 'GC-MS #2 for UUVWYPNAQBNQJQ-UHFFFAOYSA-N',\n",
       "    'Name': 'Altretamine',\n",
       "    'Description': 'The NIST Mass Spectrometry Data Center, a Group in the Biomolecular Measurement Division (BMD), develops evaluated mass spectral libraries and provides related software tools. These products are intended to assist compound identification by providing reference mass spectra for GC/MS (by electron ionization) and LC-MS/MS (by tandem mass spectrometry) as well as gas phase retention indices for GC.',\n",
       "    'URL': 'http://www.nist.gov/srd/nist1a.cfm',\n",
       "    'LicenseURL': 'https://www.nist.gov/srd/public-law',\n",
       "    'ANID': 262382},\n",
       "   {'ReferenceNumber': 34,\n",
       "    'SourceName': 'NIST Mass Spectrometry Data Center',\n",
       "    'SourceID': 'GC-MS #3 for UUVWYPNAQBNQJQ-UHFFFAOYSA-N',\n",
       "    'Name': 'Altretamine',\n",
       "    'Description': 'The NIST Mass Spectrometry Data Center, a Group in the Biomolecular Measurement Division (BMD), develops evaluated mass spectral libraries and provides related software tools. These products are intended to assist compound identification by providing reference mass spectra for GC/MS (by electron ionization) and LC-MS/MS (by tandem mass spectrometry) as well as gas phase retention indices for GC.',\n",
       "    'URL': 'http://www.nist.gov/srd/nist1a.cfm',\n",
       "    'LicenseURL': 'https://www.nist.gov/srd/public-law',\n",
       "    'ANID': 276925},\n",
       "   {'ReferenceNumber': 35,\n",
       "    'SourceName': 'NIST Mass Spectrometry Data Center',\n",
       "    'SourceID': 'GC-MS #4 for UUVWYPNAQBNQJQ-UHFFFAOYSA-N',\n",
       "    'Name': 'Altretamine',\n",
       "    'Description': 'The NIST Mass Spectrometry Data Center, a Group in the Biomolecular Measurement Division (BMD), develops evaluated mass spectral libraries and provides related software tools. These products are intended to assist compound identification by providing reference mass spectra for GC/MS (by electron ionization) and LC-MS/MS (by tandem mass spectrometry) as well as gas phase retention indices for GC.',\n",
       "    'URL': 'http://www.nist.gov/srd/nist1a.cfm',\n",
       "    'LicenseURL': 'https://www.nist.gov/srd/public-law',\n",
       "    'ANID': 276941},\n",
       "   {'ReferenceNumber': 39,\n",
       "    'SourceName': 'SpectraBase',\n",
       "    'SourceID': 'FvbGVtIvisa',\n",
       "    'Name': 'Altretamine',\n",
       "    'Description': 'Wiley Science Solutions (https://sciencesolutions.wiley.com) is a leading publisher of spectral databases and KnowItAll spectroscopy software. SpectraBase provides fast text access to hundreds of thousands of NMR, IR, Raman, UV-Vis, and mass spectra.',\n",
       "    'URL': 'https://spectrabase.com/spectrum/FvbGVtIvisa',\n",
       "    'ANID': 10090118},\n",
       "   {'ReferenceNumber': 40,\n",
       "    'SourceName': 'SpectraBase',\n",
       "    'SourceID': '5UoszugBcm0',\n",
       "    'Name': \"1,3,5-Triazine-2,4,6-triamine, N,N,N',N',N'',N''-hexamethyl-\",\n",
       "    'Description': 'Wiley Science Solutions (https://sciencesolutions.wiley.com) is a leading publisher of spectral databases and KnowItAll spectroscopy software. SpectraBase provides fast text access to hundreds of thousands of NMR, IR, Raman, UV-Vis, and mass spectra.',\n",
       "    'URL': 'https://spectrabase.com/spectrum/5UoszugBcm0',\n",
       "    'ANID': 10090119},\n",
       "   {'ReferenceNumber': 37,\n",
       "    'SourceName': 'NMRShiftDB',\n",
       "    'SourceID': '20146930',\n",
       "    'Description': 'NMRShiftDB(2) is a NMR database (web database) for organic structures and their nuclear magnetic resonance (nmr) spectra. It allows for spectrum prediction (13C, 1H and other nuclei) as well as for searching spectra, structures and other properties. http://nmrshiftdb.nmr.uni-koeln.de/',\n",
       "    'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/49761506',\n",
       "    'ANID': 6458673},\n",
       "   {'ReferenceNumber': 38,\n",
       "    'SourceName': 'SpectraBase',\n",
       "    'SourceID': '5lB7glbBkvK',\n",
       "    'Name': '[4,6-bis(dimethylamino)-s-triazin-2-yl]-dimethyl-amine',\n",
       "    'Description': 'Wiley Science Solutions (https://sciencesolutions.wiley.com) is a leading publisher of spectral databases and KnowItAll spectroscopy software. SpectraBase provides fast text access to hundreds of thousands of NMR, IR, Raman, UV-Vis, and mass spectra.',\n",
       "    'URL': 'https://spectrabase.com/spectrum/5lB7glbBkvK',\n",
       "    'ANID': 4768287},\n",
       "   {'ReferenceNumber': 41,\n",
       "    'SourceName': 'SpectraBase',\n",
       "    'SourceID': '4vJEUG2IL9D',\n",
       "    'Name': '2,4,6-Tris(dimethylamino)-1,3,5-triazine',\n",
       "    'Description': 'Wiley Science Solutions (https://sciencesolutions.wiley.com) is a leading publisher of spectral databases and KnowItAll spectroscopy software. SpectraBase provides fast text access to hundreds of thousands of NMR, IR, Raman, UV-Vis, and mass spectra.',\n",
       "    'URL': 'https://spectrabase.com/spectrum/4vJEUG2IL9D',\n",
       "    'ANID': 10090122},\n",
       "   {'ReferenceNumber': 42,\n",
       "    'SourceName': 'Springer Nature',\n",
       "    'SourceID': '15043824-686560652',\n",
       "    'Description': \"Springer Nature is the world's largest academic book publisher, publisher of the world's most influential journals, and a pioneer in the field of open research. SpringerLink provides electronic access to its book and journal content.\",\n",
       "    'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/?source=15745&sourceid=15043824-686560652',\n",
       "    'ANID': 3855890},\n",
       "   {'ReferenceNumber': 43,\n",
       "    'SourceName': 'SpringerMaterials',\n",
       "    'SourceID': 'smsid_siulkegtazyazxdn',\n",
       "    'Name': '2,4,6-tris(dimethylamino)-1,3,5-triazine',\n",
       "    'Description': 'Springer Nature is the leading scientific publisher in the fields of science and related areas. The company not only publishes best-in-class scientific journals and books but is also a well-known organization compiling databases for scientific applications. Amongst these databases, SpringerMaterials helps scientist to find and use property data of materials and chemical substances.',\n",
       "    'URL': 'https://materials.springer.com/substanceprofile/docs/smsid_siulkegtazyazxdn',\n",
       "    'ANID': 8751193},\n",
       "   {'ReferenceNumber': 45,\n",
       "    'SourceName': 'Thieme Chemistry',\n",
       "    'SourceID': '15043824-686560652',\n",
       "    'Description': 'Thieme Chemistry is part of the privately owned Thieme Group and publishes highly evaluated information about synthetic and general chemistry for professional chemists and advanced students since 1909. \\n \\nOur portfolio includes the journals SYNFACTS, SYNLETT, SYNTHESIS and SynOpen, the synthetic methodology reference work Science of Synthesis, the German chemical encyclopedia ROEMPP, and monographs in electronic and printed format. The Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license (https://creativecommons.org/licenses/by-nc-nd/4.0/), unless otherwise stated.',\n",
       "    'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/?source=22163&sourceid=15043824-686560652',\n",
       "    'LicenseNote': 'The Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license, unless otherwise stated.',\n",
       "    'LicenseURL': 'https://creativecommons.org/licenses/by-nc-nd/4.0/',\n",
       "    'ANID': 5323517},\n",
       "   {'ReferenceNumber': 46,\n",
       "    'SourceName': 'WHO Anatomical Therapeutic Chemical (ATC) Classification',\n",
       "    'SourceID': 'L01XX03',\n",
       "    'Name': 'Altretamine',\n",
       "    'Description': 'The WHO Anatomical Therapeutic Chemical (ATC) Classification System is a classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.',\n",
       "    'URL': 'https://www.whocc.no/atc_ddd_index/?code=L01XX03',\n",
       "    'LicenseNote': 'Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.',\n",
       "    'LicenseURL': 'https://www.whocc.no/copyright_disclaimer/',\n",
       "    'ANID': 24381706},\n",
       "   {'ReferenceNumber': 47,\n",
       "    'SourceName': 'Wikidata',\n",
       "    'SourceID': 'Q415242',\n",
       "    'Name': 'Altretamine',\n",
       "    'Description': 'Link to the compound information in Wikidata.',\n",
       "    'URL': 'https://www.wikidata.org/wiki/Q415242',\n",
       "    'LicenseNote': 'CCZero',\n",
       "    'LicenseURL': 'https://creativecommons.org/publicdomain/zero/1.0/',\n",
       "    'ANID': 16293224},\n",
       "   {'ReferenceNumber': 48,\n",
       "    'SourceName': 'Wikipedia',\n",
       "    'SourceID': 'wdQ415242',\n",
       "    'Name': 'Altretamine',\n",
       "    'Description': 'Link to the compound information in Wikipedia.',\n",
       "    'URL': 'https://en.wikipedia.org/wiki/Altretamine',\n",
       "    'ANID': 17360185},\n",
       "   {'ReferenceNumber': 49,\n",
       "    'SourceName': 'Medical Subject Headings (MeSH)',\n",
       "    'SourceID': '68006585',\n",
       "    'Name': 'Altretamine',\n",
       "    'Description': \"MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed.\",\n",
       "    'URL': 'https://www.ncbi.nlm.nih.gov/mesh/68006585',\n",
       "    'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.',\n",
       "    'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'},\n",
       "   {'ReferenceNumber': 50,\n",
       "    'SourceName': 'PubChem',\n",
       "    'SourceID': 'PubChem',\n",
       "    'Description': 'Data deposited in or computed by PubChem',\n",
       "    'URL': 'https://pubchem.ncbi.nlm.nih.gov'},\n",
       "   {'ReferenceNumber': 51,\n",
       "    'SourceName': 'Medical Subject Headings (MeSH)',\n",
       "    'SourceID': 'DescTree',\n",
       "    'Name': 'MeSH Tree',\n",
       "    'Description': 'MeSH (Medical Subject Headings) is the NLM controlled vocabulary thesaurus used for indexing articles for PubMed.',\n",
       "    'URL': 'http://www.nlm.nih.gov/mesh/meshhome.html',\n",
       "    'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.',\n",
       "    'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'},\n",
       "   {'ReferenceNumber': 52,\n",
       "    'SourceName': 'ChEBI',\n",
       "    'SourceID': 'OBO',\n",
       "    'Name': 'ChEBI Ontology',\n",
       "    'Description': 'The ChEBI Ontology is a structured classification of the entities contained within ChEBI.',\n",
       "    'URL': 'http://www.ebi.ac.uk/chebi/userManualForward.do#ChEBI%20Ontology'},\n",
       "   {'ReferenceNumber': 53,\n",
       "    'SourceName': 'KEGG',\n",
       "    'SourceID': 'br08303',\n",
       "    'Name': 'Anatomical Therapeutic Chemical (ATC) classification',\n",
       "    'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.',\n",
       "    'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08303.keg',\n",
       "    'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license',\n",
       "    'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'},\n",
       "   {'ReferenceNumber': 55,\n",
       "    'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'FDA_pharm_tree',\n",
       "    'Name': 'FDA Pharmacological Classification',\n",
       "    'Description': 'FDA published a final rule that amended the requirements for the content and format of approved labeling (prescribing information) for human prescription drug and biological products in January 2006.',\n",
       "    'URL': 'https://www.fda.gov/ForIndustry/DataStandards/StructuredProductLabeling/ucm162549.htm',\n",
       "    'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.',\n",
       "    'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking'},\n",
       "   {'ReferenceNumber': 56,\n",
       "    'SourceName': 'WHO Anatomical Therapeutic Chemical (ATC) Classification',\n",
       "    'SourceID': 'ATCTree',\n",
       "    'Name': 'ATC Code',\n",
       "    'Description': 'In the World Health Organization (WHO) Anatomical Therapeutic Chemical (ATC) classification system, the active substances are divided into different groups according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.',\n",
       "    'URL': 'https://www.whocc.no/atc_ddd_index/',\n",
       "    'LicenseNote': 'Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.',\n",
       "    'LicenseURL': 'https://www.whocc.no/copyright_disclaimer/'},\n",
       "   {'ReferenceNumber': 57,\n",
       "    'SourceName': 'UN Globally Harmonized System of Classification and Labelling of Chemicals (GHS)',\n",
       "    'SourceID': 'UN_GHS_tree',\n",
       "    'Name': 'GHS Classification Tree',\n",
       "    'Description': \"The United Nations' Globally Harmonized System of Classification and Labeling of Chemicals (GHS) provides a harmonized basis for globally uniform physical, environmental, and health and safety information on hazardous chemical substances and mixtures. It sets up criteria for the classification of chemicals for physical-chemical, health, and environmental hazards of chemical substances and mixtures and sets up standardized hazard information to facilitate global trade of chemicals.  Please note that obsolete codes are added in this classification for completeness purposes, as they are still in use. Any obsolete codes are annotated as such.\",\n",
       "    'URL': 'http://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html'},\n",
       "   {'ReferenceNumber': 58,\n",
       "    'SourceName': 'ChemIDplus',\n",
       "    'SourceID': 'ChemIDplus_tree',\n",
       "    'Name': 'ChemIDplus Chemical Information Classification',\n",
       "    'Description': 'ChemIDplus is a TOXNET (TOXicology Data NETwork) databases that contain chemicals and drugs related information. It is a product of the National Library of Medicine (NLM).',\n",
       "    'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/ChemIDplus',\n",
       "    'LicenseURL': 'https://www.nlm.nih.gov/copyright.html',\n",
       "    'IsToxnet': True},\n",
       "   {'ReferenceNumber': 59,\n",
       "    'SourceName': 'CAMEO Chemicals',\n",
       "    'SourceID': 'CameoReactivityTree',\n",
       "    'Name': 'CAMEO Chemical Reactivity Classification',\n",
       "    'Description': 'CAMEO Chemical Reactivity Classification was created based on the reactive groups.',\n",
       "    'URL': 'https://cameochemicals.noaa.gov/browse/react',\n",
       "    'LicenseNote': 'CAMEO Chemicals and all other CAMEO products are available at no charge to those organizations and individuals (recipients) responsible for the safe handling of chemicals. However, some of the chemical data itself is subject to the copyright restrictions of the companies or organizations that provided the data.',\n",
       "    'LicenseURL': 'https://cameochemicals.noaa.gov/help/reference/terms_and_conditions.htm?d_f=false'},\n",
       "   {'ReferenceNumber': 60,\n",
       "    'SourceName': 'ChEMBL',\n",
       "    'SourceID': 'Target Tree',\n",
       "    'Name': 'ChEMBL Protein Target Tree',\n",
       "    'Description': 'The ChEMBL Protein Target Tree is a structured classification of the protein target entities contained with the ChEMBL resource release version 31.',\n",
       "    'URL': 'https://www.ebi.ac.uk/chembl/g/#browse/targets',\n",
       "    'LicenseNote': \"Access to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).\",\n",
       "    'LicenseURL': 'http://www.ebi.ac.uk/Information/termsofuse.html'},\n",
       "   {'ReferenceNumber': 61,\n",
       "    'SourceName': 'NORMAN Suspect List Exchange',\n",
       "    'SourceID': 'norman_sle_tree',\n",
       "    'Name': 'NORMAN Suspect List Exchange Classification',\n",
       "    'Description': 'The NORMAN Suspect List Exchange (NORMAN-SLE) is a central access point for NORMAN members (and others) to find suspect lists relevant for their environmental monitoring questions.<br>Update: 2023-04-11 14:04:01',\n",
       "    'URL': 'https://www.norman-network.com/nds/SLE/',\n",
       "    'LicenseNote': 'Data: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0',\n",
       "    'LicenseURL': 'https://creativecommons.org/licenses/by/4.0/'},\n",
       "   {'ReferenceNumber': 62,\n",
       "    'SourceName': 'CCSbase',\n",
       "    'SourceID': 'ccsbase_tree',\n",
       "    'Name': 'CCSbase Classification',\n",
       "    'Description': 'CCSbase is an integrated platform consisting of a comprehensive database of Collision Cross Section (CCS) measurements taken from a variety of sources and a high-quality and high-throughput CCS prediction model trained with this database using machine learning.',\n",
       "    'URL': 'https://ccsbase.net/'},\n",
       "   {'ReferenceNumber': 63,\n",
       "    'SourceName': 'EPA DSSTox',\n",
       "    'SourceID': 'dsstoxlist_tree',\n",
       "    'Name': 'CompTox Chemicals Dashboard Chemical Lists',\n",
       "    'Description': 'This classification lists the chemical categories from the EPA CompTox Chemicals Dashboard.<br>Update: 2023-05-16 06:55:01',\n",
       "    'URL': 'https://comptox.epa.gov/dashboard/chemical-lists/',\n",
       "    'LicenseURL': 'https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources'},\n",
       "   {'ReferenceNumber': 66,\n",
       "    'SourceName': 'NCI Thesaurus (NCIt)',\n",
       "    'SourceID': 'NCIt',\n",
       "    'Name': 'NCI Thesaurus Tree',\n",
       "    'Description': 'The NCI Thesaurus (NCIt) provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.',\n",
       "    'URL': 'https://ncit.nci.nih.gov',\n",
       "    'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.',\n",
       "    'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse'},\n",
       "   {'ReferenceNumber': 67,\n",
       "    'SourceName': 'EPA Substance Registry Services',\n",
       "    'SourceID': 'epasrs_tree',\n",
       "    'Name': 'EPA SRS List Classification',\n",
       "    'Description': \"Substance Registry Services (SRS) is the Environmental Protection Agency's (EPA) central system for information about substances that are tracked or regulated by EPA or other sources. It is a resource for basic information about chemicals, biological organisms, and other substances of interest to EPA and its state and tribal partners. SRS makes it possible to identify which EPA data systems, environmental statutes, or other sources have information about a substance and which synonym is used by that system or statute.\",\n",
       "    'URL': 'https://sor.epa.gov/sor_internet/registry/substreg/LandingPage.do',\n",
       "    'LicenseURL': 'https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources'},\n",
       "   {'ReferenceNumber': 68,\n",
       "    'SourceName': 'Medical Subject Headings (MeSH)',\n",
       "    'SourceID': '68018906',\n",
       "    'Name': 'Antineoplastic Agents, Alkylating',\n",
       "    'Description': \"MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed.\",\n",
       "    'URL': 'https://www.ncbi.nlm.nih.gov/mesh/68018906',\n",
       "    'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.',\n",
       "    'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'},\n",
       "   {'ReferenceNumber': 69,\n",
       "    'SourceName': 'PATENTSCOPE (WIPO)',\n",
       "    'Name': 'SID 388320800',\n",
       "    'Description': 'The PATENTSCOPE database from WIPO includes patent and chemical structure search (with a free account) that gives access to millions of patent documents. The World Intellectual Property Organisation (WIPO) is a specialized United Nations (UN) agency headquartered in Geneva (Switzerland). Our mission is to lead the development of a balanced and effective international Intellectual Property (IP) system that enables innovation and creativity for the benefit of all. We help governments, businesses and society realize the benefits of Intellectual Property and are notably a world reference source for IP information.',\n",
       "    'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/388320800'},\n",
       "   {'ReferenceNumber': 70,\n",
       "    'SourceName': 'NCBI',\n",
       "    'SourceID': 'LinkOut',\n",
       "    'Description': 'LinkOut is a service that allows one to link directly from NCBI databases to a wide range of information and services beyond NCBI systems.',\n",
       "    'URL': 'https://www.ncbi.nlm.nih.gov/projects/linkout'}]}}"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "response_json"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "comp = pcp.Compound.from_cid(2123)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'altretamine'"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "comp.synonyms[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "TFMenv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.3"
  },
  "orig_nbformat": 4
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
